WO2015046365A1 - Emulsifiable formulation of liposoluble substance - Google Patents
Emulsifiable formulation of liposoluble substance Download PDFInfo
- Publication number
- WO2015046365A1 WO2015046365A1 PCT/JP2014/075499 JP2014075499W WO2015046365A1 WO 2015046365 A1 WO2015046365 A1 WO 2015046365A1 JP 2014075499 W JP2014075499 W JP 2014075499W WO 2015046365 A1 WO2015046365 A1 WO 2015046365A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- fat
- crocetin
- ester
- soluble
- norbixin
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7024—Esters of saccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/52—Adding ingredients
- A23L2/58—Colouring agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/40—Colouring or decolouring of foods
- A23L5/42—Addition of dyes or pigments, e.g. in combination with optical brighteners
- A23L5/43—Addition of dyes or pigments, e.g. in combination with optical brighteners using naturally occurring organic dyes or pigments, their artificial duplicates or their derivatives
- A23L5/44—Addition of dyes or pigments, e.g. in combination with optical brighteners using naturally occurring organic dyes or pigments, their artificial duplicates or their derivatives using carotenoids or xanthophylls
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/362—Polycarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/10—General cosmetic use
Definitions
- the present invention relates to an emulsifiable preparation of a fat-soluble substance in which the emulsifiability of the fat-soluble substance is improved, or the emulsifiability and stability of the fat-soluble carotenoid are improved. Moreover, this invention relates to the food-drinks, cosmetics, a pharmaceutical, etc. using the emulsifiable preparation of the said fat-soluble substance.
- Fat-soluble substances include various useful ingredients such as fat-soluble carotenoids, animal fats and oils, vegetable fats and oils, plant sterols, fat-soluble vitamins, and fragrances, and the range of use is in various fields such as foods, cosmetics, and pharmaceuticals.
- fat-soluble carotenoids are naturally occurring terpenoid pigments that exhibit yellow to red color, and are used as coloring agents in various fields such as foods and drinks, cosmetics, and pharmaceuticals.
- some fat-soluble carotenoids have not only been used as coloring agents but also have various physiological functions, and some are used as functional ingredients.
- astaxanthin is known to have an excellent antioxidant effect and is effective in preventing skin aging, anti-inflammatory, eye strain recovery, and the like. Fucoxanthin is also known to be excellent in antioxidant action and effective for apoptosis-inducing activity, antitumor, anti-obesity and the like.
- fat-soluble substances have low compatibility with water, and are conventionally used after being emulsified with a surfactant or the like to be dispersed in water.
- some fat-soluble substances are difficult to emulsify or become unstable when emulsified.
- fat-soluble carotenoids have an unstable structure and have a drawback that they are easily decomposed by oxygen, heat, moisture, etc. even when dispersed in an emulsified state.
- the fat-soluble carotenoid is decomposed, not only the appearance of the product is impaired due to fading, but also the functional property of the carotenoid cannot be exhibited, so the stability of the fat-soluble carotenoid can be improved.
- Planning is a major industrial issue. Therefore, establishment of a new technique for stably dispersing or emulsifying a fat-soluble substance in an aqueous system is required in the fields of foods and drinks, cosmetics, pharmaceuticals, and the like.
- An object of the present invention is to provide an emulsifiable preparation of a fat-soluble substance with improved emulsifiability of the fat-soluble substance. Moreover, the objective of this invention is providing the emulsifiable preparation of the fat-soluble substance which improved stability with the emulsifiability of a fat-soluble substance. Furthermore, this invention is providing food / beverage products, cosmetics, a pharmaceutical, etc. with which the emulsifiability of a fat-soluble substance is improving, or both the emulsifiability and stability of a fat-soluble substance are improving.
- the present inventors have found that at least one selected from the group consisting of crocetin, norbixin, and monoglycoside esters thereof is combined with a fat-soluble substance in the presence of water. It has been found that the emulsifiability of a fat-soluble substance can be remarkably improved by forming a body (micelle). It has also been found that the stability of a fat-soluble substance can be remarkably improved by coexisting with the complex (micelle) together with a diglycoside ester of crocetin and / or a diglycoside ester of norbixin. The present invention has been completed by further studies based on such knowledge.
- Item 1 An emulsifiable preparation of a fat-soluble substance comprising (A) a fat-soluble substance and (B) at least one selected from the group consisting of crocetin, norbixin, and monoglycoside esters thereof as micelle constituents.
- Item 2. Item 5. The emulsifiable preparation of a fat-soluble substance according to Item 1, further comprising (C) a diglycoside ester of crocetin and / or a diglycoside ester of norbixin.
- Item 3. Item 3.
- Item 4. Item 4. The emulsifiable preparation of a fat-soluble substance according to any one of Items 1 to 3, wherein the component (C) is crocin.
- Item 7. The emulsifiable preparation of a fat-soluble substance according to any one of Items 1 to 6, wherein the component (A) is a fat-soluble carotenoid and is used as a pigment preparation.
- Item 8. A hydrogel comprising a micelle comprising (A) a fat-soluble substance and (B) at least one selected from the group consisting of crocetin, norbixin, and monoglycoside esters thereof.
- Item 9. Item 9.
- Item 10 A food or drink containing a micelle comprising (A) a fat-soluble substance and (B) at least one selected from the group consisting of crocetin, norbixin, and monoglycoside esters thereof, or a dried product of the micelle.
- Item 11 Item 11.
- the food or drink according to Item 10 further comprising (C) a diglycoside ester of crocetin and / or a diglycoside ester of norbixin.
- a cosmetic comprising (A) a fat-soluble substance and (B) at least one selected from the group consisting of crocetin, norbixin, and monoglycoside esters thereof, or a dried product of the micelle.
- Item 13 Item 13.
- a pharmaceutical comprising a micelle comprising (A) a fat-soluble substance and (B) at least one selected from the group consisting of crocetin, norbixin, and monoglycoside esters thereof, or a dried product of the micelle.
- Item 15. Item 15.
- Item 16 An emulsifying agent for fat-soluble substances, comprising as an active ingredient at least one selected from the group consisting of crocetin, norbixin, and monoglycoside esters thereof.
- Item 17. The emulsifiability improver of a fat-soluble substance according to Item 16, which is a food or drink additive.
- Item 19. Item 19.
- Item 20. Use for manufacture of the emulsification improver of at least 1 sort (s) selected from the group which consists of crocetin, norbixin, and these monoglycoside ester.
- Item 21. Use for the manufacture of an absorption enhancer of at least one fat-soluble substance selected from the group consisting of crocetin, norbixin, and monoglycoside esters thereof.
- a method for emulsifying a fat-soluble substance comprising the step of emulsifying (A) a fat-soluble substance and (B) at least one selected from the group consisting of crocetin, norbixin, and monoglycoside esters thereof in the presence of water.
- the surfactant is used by forming at least one selected from the group consisting of crocetin, norbixin, and monoglycoside esters thereof together with a fat-soluble substance to form these micelles.
- the fat-soluble substance can be provided with excellent emulsifying properties.
- hydrophilicity is imparted to the fat-soluble substance so that it can be easily absorbed, and the transdermal or enteral absorption of the fat-soluble substance can be improved. .
- the storage stability means the property that the fat-soluble substance can be stably maintained by preventing discoloration of the fat-soluble substance and maintaining the functionality.
- A shows the result of HPLC analysis of gardenia yellow pigments on a high molecular weight fraction obtained by gel filtration of a fat-soluble carotenoid emulsion (Example 1);
- B shows a fat-soluble carotenoid aqueous dispersion ( As a result of HPLC analysis of gardenia yellow pigments for the low molecular weight fraction obtained by gel filtration in Example 1);
- C shows the result of HPLC analysis of paprika oleoresin for the high molecular weight fraction. Show.
- A shows the result of HPLC analysis of gardenia yellow pigments for the high molecular weight fraction obtained by gel filtration of the fat-soluble carotenoid emulsion (Example 2); B shows the high molecular weight fraction.
- the result of having analyzed paprika oleoresin by HPLC is shown.
- the high molecular weight fraction obtained by gel filtration of the fat-soluble carotenoid emulsion (Example 1) is subjected to a heat treatment at 50 ° C. for 20 hours and then subjected to HPLC for composition analysis.
- a result of emulsifying a solution containing soybean oil and crocetin-monogenthiobioside ester or crocetin-digentiobide ester and observing the appearance thereof is shown.
- the emulsifiable preparation of the fat-soluble substance of the present invention (hereinafter sometimes referred to as “the preparation of the present invention”) is the fat-soluble substance (hereinafter referred to as “component (A)”). And at least one selected from the group consisting of crocetin, crocetin-monoglycoside ester, and norbixin (hereinafter also referred to as “component (B)”) as a micelle component It is characterized by that.
- the preparation of the present invention is a preparation used as a source of a fat-soluble substance by being blended with various products such as foods, cosmetics, and medicines.
- the preparation of the present invention contains a fat-soluble carotenoid as a fat-soluble substance, a coloring agent or a pigment blended in various products such as foods, cosmetics, and pharmaceuticals as a functional source based on the fat-soluble carotenoid Used as a formulation.
- a coloring agent or a pigment blended in various products such as foods, cosmetics, and pharmaceuticals as a functional source based on the fat-soluble carotenoid Used as a formulation.
- Component (A) The preparation of the present invention contains a fat-soluble substance as component (A).
- the fat-soluble substance used in the present invention is not particularly limited as long as it is fat-soluble and requires dispersibility in water.
- fat-soluble carotenoids vegetable oils, animals Oils and fats, plant sterols, fat-soluble vitamins, higher fatty acids, essential oils and the like.
- the fat-soluble carotenoid may be any of carotene, xanthophyll, or apocartoid.
- carotene include ⁇ -carotene, ⁇ -carotene, ⁇ -carotene, lycopene, and the like.
- xanthophylls include actinioerythritol, canthaxanthin, capsorubin, cucurbitaxanthin A, cryptocapsin, astaxanthin, fucoxanthin, lutein, zeaxanthin, capsanthin, ⁇ -cryptoxanthin, violaxanthin, and derivatives thereof (fatty acids Monoester or diester) and the like.
- apocartoids examples include bixin, ⁇ -8′-apo-carotenal (apocarotenal), ⁇ -12′-apo-carotenal, derivatives thereof (such as esters with lower or higher alcohols), and the like. These fat-soluble carotenoids may be used individually by 1 type, and may be used in combination of 2 or more type.
- the origin and production method of fat-soluble carotenoids are not particularly limited, and may be those derived from natural products such as plants, animals and microorganisms, and those obtained by fermentation or synthesis methods. Good.
- natural pigments containing fat-soluble carotenoids can also be used as the component (A).
- natural pigments include red pepper pigment (paprika pigment, paprika oleoresin), anato pigment, imo carotene, Dunaliella carotene, carrot carotene, shrimp pigment, krill pigment, orange pigment, crab pigment, corn pigment, Examples include tomato pigments, palm oil carotene, phafia pigments, Beninoki powder pigments, Haematococcus alga pigments, and marigold pigments.
- vegetable oil examples include soybean oil, rice oil, salad oil, sesame oil, perilla oil, peanut oil, corn oil, rapeseed oil, coconut oil, palm oil, and hardened oils thereof. These vegetable fats and oils may be used alone or in combination of two or more.
- animal fats include fish oil, beef tallow, pork tallow, chicken oil, and hardened oils thereof. These animal fats and oils may be used individually by 1 type, and may be used in combination of 2 or more type.
- the plant sterol is a general term for sterols present in plants. Specifically, ⁇ -sitostanol, ⁇ -sitosterol, stigmasterol, campesterol, brassicasterol, brassicasterol, isofucosterol, 7- Examples thereof include stigmastenol, isofucostanol, stigmasteranol, 7-stigmasteranol, campestanol, cycloartenol, avenasterol, and glycosides thereof. These plant sterols may be used individually by 1 type, and may be used in combination of 2 or more type.
- fat-soluble vitamin examples include vitamin A, vitamin D3, vitamin E, vitamin F, vitamin K, and the like. These fat-soluble vitamins may be used alone or in combination of two or more.
- higher fatty acid examples include higher fatty acids having 12 to 30 carbon atoms such as docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), linoleic acid, and linolenic acid. These higher fatty acids may be used alone or in combination of two or more.
- DHA docosahexaenoic acid
- EPA eicosapentaenoic acid
- linoleic acid examples include linolenic acid. These higher fatty acids may be used alone or in combination of two or more.
- essential oil examples include peppermint oil, spearmint oil, bergamot oil, fennel oil, peppermint oil, lemon peel oil, and the like. These essential oils may be used individually by 1 type, and may be used in combination of 2 or more type.
- the type of the fat-soluble substance may be appropriately selected according to the functionality to be provided in the preparation of the present invention.
- the fat-soluble substance may be used alone or in combination of two or more.
- fat-soluble carotenoids vegetable oils and fats, and fat-soluble vitamins are preferable from the viewpoint of more effectively improving dispersibility or emulsification.
- the content of the component (A) is not particularly limited, and may be appropriately set according to the use of the preparation of the present invention, the type of fat-soluble substance, and the like.
- 0.00001 to 99.9 % By weight preferably 0.00005 to 99% by weight, more preferably 0.0001 to 99% by weight.
- Component (B) The preparation of the present invention contains at least one selected from the group consisting of crocetin, norbixin, and monoglycoside esters thereof as component (B) together with component (A). As shown in Test Example 1 to be described later, when the component (A) and the component (B) coexist in the presence of water, the component (B) and the component (A) are associated to form micelles. By forming such micelles, the emulsifiability of the fat-soluble substance can be remarkably improved.
- Crocetin is a water-soluble carotenoid in which R 1 and R 2 are hydrogen atoms in the following general formula (1).
- the crocetin used in the present invention may be a cis-trans isomer.
- crocetin monoglycoside ester (that is, crocetin-monoglycoside ester) has a structure in which a sugar is bonded to one of the carboxyl groups of crocetin by an ester bond.
- R 1 Is a water-soluble carotenoid in which R 2 is a sugar residue and R 2 is a hydrogen atom.
- the saccharide bound to crocetin in the monoglycoside ester of crocetin may be a monosaccharide or an oligosaccharide such as a disaccharide, an acid saccharide, or a tetrasaccharide.
- constituent sugars include monosaccharides such as glucose and (glucuronic acid); disaccharides such as gentiobiose, maltose, sucrose, and lactose (glucuronosylglucose and glucuronosylglucuronic acid); And trisaccharides such as maltotriose, raffinose, panose, glucuronosyl gentiobiose, glucosyl gentiobiose, and the like.
- monosaccharides such as glucose and (glucuronic acid)
- disaccharides such as gentiobiose, maltose, sucrose, and lactose (glucuronosylglucose and glucuronosylglucuronic acid)
- trisaccharides such as maltotriose, raffinose, panose, glucuronosyl gentiobiose, glucosyl gentiobiose, and the like.
- Examples of the saccharide having an ester bond to crocetin include monosaccharides and disaccharides, more preferably glucose and gentiobiose, and particularly preferably gentiobiose (that is, crocetin-monogenthiobioside ester; crocin-3).
- the position of the sugar residue bonded to the carboxyl group of crocetin is not particularly limited, but the hydroxyl group at the 1-position of the sugar may be ester-bonded to the carboxyl group of crocetin. preferable.
- the monoglycoside ester of crocetin used in the present invention may be a cis-trans isomer.
- Norbixin is a water-soluble carotenoid in which R 3 and R 4 are hydrogen atoms in the following general formula (2).
- the norbixin used in the present invention may be a cis-trans isomer.
- Norubixin monoglycoside ester (ie, norbixin-monoglycoside ester) has a structure in which a sugar is bonded to one of the carboxyl groups of norbixin by an ester bond.
- R 3 And R 4 is a water-soluble carotenoid in which one is a sugar residue and the other is a hydrogen atom.
- the norbixin-monoglycoside ester the kind of sugar bonded to crocetin, the preferred one, the binding site and the like are the same as in the case of the monoglycoside ester of crocetin.
- the monoglycoside ester of norbixin used in the present invention may be a cis-trans isomer.
- components (B) are not particularly limited in their origin and production method, and may be those extracted from natural products such as plants, animals, and microorganisms, and obtained by fermentation methods or synthetic methods. It may be what was made.
- crocetin, norbixin, crocetin-monoglycoside ester, more preferably crocetin, norbixin, crocetin-monogenthiobioside ester are preferable from the viewpoint of further improving the emulsifiability of the fat-soluble substance.
- Crocin-3 crocetin-monoglycoside ester, more preferably crocetin-monogentiobioside ester can be mentioned.
- natural pigments containing at least one of crocetin, norbixin, and monoglycoside esters thereof can also be used as component (B).
- natural pigments containing at least one of crocetin, norbixin, and monoglycoside esters thereof can also be used as component (B).
- gardenia yellow and saffron pigments are known to contain crocetin and crocetin-monogentiobioside ester, and gardenia yellow and / or saffron pigments are preferably used as component (B). be able to.
- component (B) one type may be selected from crocetin, norbixin, and monoglycoside esters thereof, or two or more types may be used in combination.
- the content of the component (B) is not particularly limited as long as it can form micelles with the fat-soluble substance.
- the total amount of the component (B) 0.0005 to 1000 parts by weight, preferably 0.001 to 500 parts by weight, and more preferably 0.002 to 200 parts by weight.
- the content of the component (B) is 0.5 ⁇ 10 ⁇ 5 to 10 g as the color value (E 10% 1 cm 2 ) of 5,000 per 1 g of the component (A), preferably 5,000 Examples include 0.1 ⁇ 10 ⁇ 4 to 5 g, and more preferably 0.2 ⁇ 10 ⁇ 4 to 2 g.
- component (C) Component
- the preparation of the present invention further includes diglycoside ester of crocetin and / or diglycoside ester of norbixin (hereinafter referred to as “component (C)”. May be included).
- component (C) diglycoside ester of crocetin and / or diglycoside ester of norbixin
- the stability of the fat-soluble substance can be remarkably improved.
- the component (C) was solubilized in water without being associated with the micelles of the components (A) and (B) in the presence of water. It exists in a state and plays the role which improves stability of a fat-soluble substance.
- the crocetin diglycoside ester (that is, crocetin-diglycoside ester) has a structure in which a sugar is bonded to each of two carboxyl groups of crocetin by an ester bond.
- the types of sugars bonded to the crocetin diglycoside ester, preferred ones, binding sites and the like are the same as those for the monoglycoside ester of crocetin.
- the two sugar residues bonded in the crocetin diglycoside ester may be the same or different from each other.
- the diglycoside ester of crocetin is preferably one in which two disaccharides are ester-bonded to crocetin, one in which monosaccharide and disaccharide are each ester-bonded to crocetin, or two monosaccharides are ester-bonded to crocetin. More preferably, crocetin has two gentiobiose ester-linked (crocin; crocetin-digentiobioside ester), crocetin has gentiobiose and glucose ester-linked (crocetin-monogentiobio) Side-monoglucoside ester), crocetin in which two glucoses are ester-linked (crocetin-diglucoside ester); particularly preferably crocin.
- the crocetin diglycoside ester used in the present invention may be a cis-trans isomer.
- the diglycoside ester of norbixin (ie, norbixin-diglycoside ester) has a structure in which a sugar is bonded to each of two carboxyl groups of norbixin by an ester bond.
- R 3 and A water-soluble carotenoid in which R 4 is a sugar residue are the same as those for the monoglycoside ester of crocetin.
- the two sugar residues bonded in the diglycoside ester of norbixin may be the same or different.
- the diglycoside ester of norbixin used in the present invention may be a cis-trans isomer.
- crocetin diglycoside ester is preferable, and crocin is more preferable from the viewpoint of further improving the stability of the fat-soluble substance.
- natural pigments containing crocetin diglycoside ester and / or norbixin diglycoside ester can also be used as component (C).
- natural pigments containing crocetin diglycoside ester and / or norbixin diglycoside ester can also be used as component (C).
- gardenia yellow pigment and saffron pigment contain crocin in addition to the component (B), and gardenia yellow pigment and / or saffron pigment are used as the source of the components (B) and (C). Therefore, since both the emulsifiability and stability of the fat-soluble substance excellent in the fat-soluble carotenoid can be provided, it can be suitably used in the fat-soluble carotenoid water-dispersible preparation of the present invention.
- one kind may be selected from crocetin diglycoside ester and norbixin diglycoside ester, or two or more kinds may be used in combination. .
- the content of the component (C) is not particularly limited.
- the total amount of the component (C) is 0.0005 to 1000 parts by weight, preferably 0, per 100 parts by weight of the component (A). 0.001 to 500 parts by weight, more preferably 0.002 to 200 parts by weight.
- the content of the component (C) is 0.5 ⁇ 10 ⁇ 5 to 10 g as the color value (E 10% 1 cm 2 ) of 5,000 per 1 g of the component (A), preferably 5,000 Examples include 0.1 ⁇ 10 ⁇ 4 to 5 g, and more preferably 0.2 ⁇ 10 ⁇ 4 to 2 g.
- the content of the gardenia yellow and / or saffron pigment is the above (A).
- the amount is 0.0005 to 1000 parts by weight, preferably 0.001 to 500 parts by weight, and more preferably 0.002 to 200 parts by weight per 100 parts by weight of the component.
- the gardenia yellow and / or saffron dye has a color value (E) per 1 g of the component (A).
- 10% 1 cm ) 5,000 is 0.5 ⁇ 10 ⁇ 5 to 10 g, preferably 0.1 ⁇ 10 ⁇ 4 to 5 g, and more preferably 0.2 ⁇ 10 ⁇ 4 to 2 g.
- the preparation of the present invention may contain water as a dispersion medium for the components (A) and (B) in addition to the components described above.
- an antioxidant, a thickener, a chelating agent, an emulsifying aid, a lower alcohol, a polyhydric alcohol, a pH adjuster, a buffer are added as necessary, as long as the effects of the present invention are not hindered.
- An additive component such as an agent may be included.
- the preparation of the present invention can stably emulsify a fat-soluble substance in water without containing a surfactant or an emulsifier, but may contain a surfactant or an emulsifier as necessary.
- Form of the present invention preparation is a preparation in which the fat-soluble substance exhibits good emulsifiability when added to water or a composition containing water by including the component (A) and the component (B) as micelle constituents.
- the preparation of the present invention may contain an emulsified preparation that contains water as a dispersion medium and is in an emulsified state, or is a self-emulsifying preparation that does not contain water and is in a non-emulsified state. May be.
- the component (A) and the component (B) are present in the form of micelles.
- the component (A) and the component (B) do not form micelles, but when added to and mixed with water or a composition containing water, the component (A) and the component (B) These micelles are formed, and the fat-soluble substance can be uniformly emulsified.
- the preparation of the present invention is an emulsified preparation in an emulsified state
- it may be not only liquid but also semi-solid such as paste.
- this invention formulation is a formulation for self-emulsification in the non-emulsified state, solid forms, such as a powder form and a granular form, are mentioned as the form.
- the preparation of the present invention is an emulsion preparation in which the (A) component and the (B) component are in the emulsified state by forming micelles, the water, the (A) component, the (B) component, and It can be prepared by adding and mixing component (C) and other additive components as necessary.
- component (C) and other additive components in the presence of water, when the components (A) and (B) are added and coexisted in the presence of water, they are mixed and emulsified to form micelles of the components (A) and (B).
- the preparation is uniformly emulsified.
- the component (C) may be partly hydrolyzed and converted into the component (B) by receiving heat or physical stimulation in the emulsifying step, so that the component (B) can be used instead of the component (B).
- the component (C) is added as a raw material and dispersed or emulsified so that a part of the component (C) is hydrolyzed in the presence of the component (A), the component (B) is added. At least, micelles of component (A) and component (B) can be formed.
- component (A) is co-existing with component (B) while forming micelles with a surfactant, emulsifier, etc., micelles of component (A) and component (B) may not be formed, Since it may take time to form, from the viewpoint of promoting micelle formation of the component (A) and the component (B), at the time of producing the preparation of the present invention, the component (A) and ( When the component (B) is allowed to coexist, it is desirable that the component (A) is kept in a state in which micelles are not formed with a surfactant or an emulsifier.
- the preparation of the present invention is a preparation for self-emulsification in which the component (A) and the component (B) do not form micelles
- the preparation is a semi-solid or solid form
- the emulsion preparation is prepared by the above method. After the production, it can be prepared by removing the water and subjecting it to a molding treatment such as powder or granule, if necessary.
- a self-emulsifying preparation it should also be prepared by simply adding (A) component, (B) component, and (C) component, if necessary, other additive components and mixing. Can do.
- the preparation of the present invention is used as an additive for supplying a fat-soluble substance to various products such as foods and drinks, cosmetics and pharmaceuticals.
- a fat-soluble carotenoid is used as the fat-soluble substance
- the preparation of the present invention is used as a pigment preparation (coloring agent) added to various products such as foods and drinks, cosmetics and pharmaceuticals.
- this invention formulation can emulsify a fat-soluble substance stably, it can be used for the said various products as a supply source of the fat-soluble substance whose absorbency was improved.
- the preparation of the present invention is used for the purpose of imparting the physiological function.
- a functional additive it can also be used by adding to various foods, cosmetics, pharmaceuticals and the like.
- the product to be added preferably contains water, but a product not containing water can also be added.
- a product not containing water can also be added.
- the preparation of the present invention can be preferably used.
- the preparation of the present invention can also be used as a source of a fat-soluble substance with enhanced absorbability. Therefore, even if water is not contained in the product to be added, the fat to the product is added. It can be used for the purpose of imparting physiological functionality with a soluble substance.
- hydrogel of the present invention is characterized by containing a micelle containing the components (A) and (B) and a gelling agent.
- a micelle containing the components (A) and (B) and a gelling agent.
- component (A) and component (B) used in the hydrogel of the present invention are the same as in the case of “1. Emulsifiable preparation of fat-soluble substance”.
- the content of the component (A) for example, it may be 0.00001 to 50% by weight, preferably 0.00005 to 45% by weight, and more preferably 0.0001 to 40%. % By weight.
- the hydrogel of the present invention may contain the component (C). By containing the component (C), it becomes possible to improve the stability of the fat-soluble carotenoid in the hydrogel.
- the type of the component (C) used in the hydrogel of the present invention, the ratio of the component (C) to the component (A), and the like are the same as in the case of “1. Emulsifiable preparation of fat-soluble substance”.
- the type of gelling agent contained in the hydrogel of the present invention is not particularly limited, and can be edible, cosmetically acceptable, or pharmaceutically acceptable depending on the use of the hydrogel. What is necessary is just to select suitably.
- Specific examples of gelling agents include carrageenan, gellan gum, locust bean gum, pectin, sodium alginate, gelatin, tragacanth, agar, xanthan, gum arabic, guar gum, tamarind gum, starch, dextrin, cellulose, curdlan, pullulan, Guar gum derivative, cellulose derivative, ⁇ -glucan, psyllium seed gum, microgel, carbomer, PVP, PVA, silica, bentonite, dextrin fatty acid ester, inulin fatty acid ester, silicone-based thickening gelling agent, polyamide resin, amino acid-based gelation Agents, salt-resistant thickeners and the like.
- These gelling agents may be used individually by 1 type, and may be used in combination of
- the content of the gelling agent may be appropriately set according to the type of gelling agent to be used, the gel strength to be imparted, fluidity, and the like. For example, 0.0001 to 98 % By weight, preferably 0.0005 to 97% by weight, more preferably 0.001 to 95% by weight.
- the hydrogel of the present invention includes sweeteners, fruit juices, fragrances, antioxidants, pH adjusters, pharmacological ingredients, moisturizing ingredients, whitening ingredients, etc., depending on the use of the hydrogel. It may be.
- the method for producing the hydrogel of the present invention is not particularly limited as long as the component (A) and the component (B) coexist in the hydrogel and form micelles.
- the method for producing the hydrogel of the present invention preferably includes a method of gelling after mixing water in which a gelling agent is dissolved, the preparation of the present invention, and other additive components as necessary. .
- the preparation of the present invention after mixing the water in which the gelling agent is dissolved, the component (A), the component (B), and the component (C), if necessary, other additive components Even if it is the method of making it gelatinize, the hydrogel of this invention can be obtained.
- the component (A) when the component (A) coexists with the component (B) in the state where the component is formed with a surfactant or an emulsifier, micelles of the component (A) and the component (B) are formed. Or when it takes time until the micelles are formed, when the hydrogel of the present invention is produced without using the preparation of the present invention, the component (A) When the component (B) is allowed to coexist, it is desirable that the component (A) is kept in a state in which micelles are not formed with a surfactant or an emulsifier.
- the fat-soluble substance is uniformly emulsified, has an excellent appearance, and further has improved absorbability of the fat-soluble substance (particularly the fat-soluble carotenoid). It can be used in fields such as cosmetics and pharmaceuticals.
- a product using the hydrogel of the present invention in the food and beverage field, jelly, a beverage blended with hydrogel, yogurt blended with hydrogel, and the like can be mentioned.
- a beverage blended with hydrogel, yogurt blended with hydrogel, and the like can be mentioned.
- gel-like cosmetics, sheet-like pack cosmetics, and the like can be given.
- sheet-like patches and the like can be mentioned.
- the food / beverage products, cosmetics, and pharmaceutical products of the present invention are characterized by containing micelles containing the component (A) and the component (B) or a dried product of the micelles.
- the food / beverage products, cosmetics and pharmaceuticals of the present invention include the hydrogel or a form containing it, as well as a form not containing hydrogel.
- fat-soluble substances are uniformly dispersed in the whole product or a predetermined part by including the micelle containing the component (A) and the component (B) or the dried product of the micelle. And can have excellent appearance properties.
- the absorbability of fat-soluble substances is improved, so that the functionality of the fat-soluble substances can be effectively enjoyed. You can also.
- component (A) and component (B) used in the food and drink, cosmetics and pharmaceuticals of the present invention, the ratio thereof, and the like are the same as in the case of “1. Emulsifiable preparation of fat-soluble substance”. It is.
- the content of the micelle containing the component (A) and the component (B) or the dried product of the micelle, the type of the component (A) to be used, the hydrogel Although it may be set as appropriate according to the degree of coloring, the functionality to be provided to the hydrogel, etc., for example, it is 0.00001 to 50% by weight, preferably 0.00005 in terms of the content of the component (A). To 45% by weight, more preferably 0.0001 to 40% by weight.
- the food / beverage products, cosmetics, and pharmaceuticals of the present invention may contain the component (C).
- the stability of the fat-soluble substance can be improved.
- the ratio of (C) component with respect to (A) component, etc. said "1. Emulsifiable preparation of fat-soluble substance”. Same as the case.
- the micelle containing the component (A) and the component (B) or a dried product of the micelles is contained. It is not particularly limited as long as it can be made.
- the method for producing the food / beverage products, cosmetics and pharmaceuticals of the present invention preferably includes a method of mixing the above-mentioned preparation of the present invention into the raw materials of the food / beverage products, cosmetics and pharmaceuticals and processing them into a desired form.
- the (A) component and the (B) component form micelles by coexisting in the presence of water, and the emulsifiability is improved, so the ingredients (A) and (B) in the raw materials for food and drink, cosmetics, and pharmaceuticals
- the micelles containing the components are once dispersed, even if water is removed by drying or the like, the fat-soluble substance becomes a dried product of micelles and maintains a uniformly dispersed state. Therefore, the food and drink, cosmetics, and pharmaceuticals of the present invention are not limited to forms containing water such as liquid, hydrogel, paste, etc., but dry micelles containing the components (A) and (B). It may be in a solid state.
- supplements such as a tablet, a granule, a powder agent, a capsule, a soft capsule, etc .; , Yakitori sauce, salmon grilled sauce, dumpling sauce, dumpling sauce, sauces (tonkatsu sauce, curry sauce, white sauce, demiglace sauce, tomato sauce, shrimp sauce, etc.), soups (kimchi hot pot soup, ramen soup) , Consommé soup, potage soup, clam chowder, etc.) and processed foods using these liquid seasonings; dairy products such as yogurt and cheese; jams such as strawberry jam, apple jam, blueberry jam and marmalade ; Processed meat products such as ham, sausage, grilled pork; Fish sausage, fish meat Fish, fish paste, salmon, bamboo rings, hampen, fried satsuma, and other marine products; salted, miso pickled, pickled in salmon, pickled in pickles, shallow pickled, pickled in
- the form of the cosmetic of the present invention is not particularly limited, and examples thereof include emulsions, creams, lotions, packs, cosmetic liquids, skin cleansing agents, makeup cosmetics, and the like.
- the form of the pharmaceutical product of the present invention is not particularly limited, but for example, preparations for internal use such as tablets, granules, powders, capsules, soft capsules, syrups, etc .; external preparations, inhalants, suppositories, etc. Skin or transmucosal preparations; injections and the like.
- Fat-soluble carotenoid emulsifier / absorptive improver As described above, the component (B) associates with a fat-soluble substance in the presence of water to form micelles, thereby improving the emulsifiability and absorbability of the fat-soluble substance. In order to improve, it can also be used as an emulsification improver of a fat-soluble substance or an absorbency improver of a fat-soluble substance.
- the fat-soluble substance emulsification improver and the fat-soluble substance absorbability improver of the present invention are added to various products containing water and a fat-soluble substance to improve the emulsifiability or absorbability of the fat-soluble carotenoid. Used in.
- the product to which the emulsifiability improver of the fat-soluble substance and the absorbency improver of the fat-soluble substance of the present invention are applied is not particularly limited as long as it contains water and the fat-soluble substance. Examples include pigment preparations containing fat-soluble carotenoids, raw materials for foods and drinks, raw materials for cosmetics, and raw materials for pharmaceuticals.
- the fat-soluble substance emulsification improver and the fat-soluble substance absorbability improver of the present invention are food and drink additives for improving the emulsifiability of the fat-soluble substance. Or, it is used as a food or drink additive for improving the absorption of fat-soluble substances.
- the type of the component (B) used, the type of the fat-soluble substance to be applied, the use mode, etc. are as described above. is there.
- Test Example 1 Evaluation of aqueous dispersion of fat-soluble carotenoid (1) Emulsification of fat-soluble carotenoid with crocetin-monogenthiobioside ester, crocetin, and norbixin 0.1 g of paprika oleoresin containing fat-soluble carotenoid was added to 20 g of water and stirred. It was completely separated and did not mix.
- Paprika oleoresin is a fat-soluble substance extracted from paprika or capsicum, and contains about 10% by weight of fat-soluble carotenoids such as capsanthin, ⁇ -cryptoxanthin, ⁇ -carotene, zeaxanthin, capsorbine.
- this mixture of paprika oleoresin and water was mixed with gardenia yellow starch [crocin 40% by weight, crocetin-monogenthiobioside ester 18% by weight, other crocin analogs (crocetin-digentiobide ester, crocetin-monogenthiobioside] -Monoglucoside ester, crocetin-diglucoside ester, crocetin-monoglucoside ester, etc.) 42 wt%], crocetin, or norbixin 0.16g was added and stirring was continued. After about 10 minutes, paprika oleoresin was dissolved in water. In a uniform dispersion state (emulsified state). Thereafter, the liquid was kept still, but it was not separated, and a uniform dispersed state (emulsified state) was maintained.
- gardenia yellow starch [crocin 40% by weight, crocetin-monogenthiobioside ester 18% by weight, other crocin analogs
- Capsanthin the main carotenoid of paprika oleoresin, has a molecular weight of 584, crocetin-monogentiobioside ester has a molecular weight of 652, and crocetin has a molecular weight of 328.
- capsanthin and crocetin-monogenthiobioside ester or crocetin are eluted simultaneously in the high molecular weight fraction.
- the orange color derived from paprika oleoresin was also confirmed visually in the high molecular weight fraction.
- the high molecular weight fraction and the low molecular weight fraction were analyzed by HPLC. Two types of HPLC analysis were performed: Method 1 below, which is suitable for analysis of gardenia yellow, and Method 2 below, which is suitable for analysis of paprika oleoresin.
- ⁇ Method 2 Analysis of paprika oleoresin>
- Low molecular fraction or high molecular weight fraction 100 ⁇ l, 50 wt% potassium hydroxide aqueous solution 10 ⁇ l and methanol 900 ⁇ l were mixed and allowed to stand at room temperature for 1 hour for saponification. Thereafter, the saponified solution was added to a 1: 1 mixed solvent of hexane and dimethyl ether and stirred to recover the ether layer.
- the obtained ether layer was dried and solidified by centrifugal concentration, and then dissolved in 100 ⁇ l of the following eluent for HPLC analysis to prepare a sample for HPLC analysis.
- the sample for HPLC analysis was subjected to HPLC analysis under the following conditions.
- FIG. 2A shows the result of HPLC analysis of the high molecular weight fraction by method 1
- FIG. 2B shows the result of HPLC analysis of the low molecular weight fraction by method 1
- FIG. 2C shows the method of high molecular weight fraction.
- 2 shows the result of HPLC analysis.
- FIGS. 2A and 2C fat-soluble carotenoids derived from paprika oleoresin and crocetin-monogentiobioside ester were detected from the high molecular weight fraction. This result indicates that a fat-soluble carotenoid and a crocetin-monogenthiobioside ester complex are formed, and the complex is dispersed in water as micelles.
- crocin was not detected in the high molecular weight fraction, but was detected alone in the low molecular weight fraction, and was not used for micelle formation, and was presumed to be in a single dispersed state.
- the low molecular fraction was analyzed by HPLC in Method 2, no paprika oleoresin-derived fat-soluble carotenoid was detected. From the above results, it was revealed that crocetin-monogenthiobioside ester improves the emulsifiability of fat-soluble carotenoids by forming micelles with fat-soluble carotenoids in paprika oleoresin.
- FIG. 3A shows the result of HPLC analysis of the high molecular weight fraction by Method 1
- FIG. 3B shows the result of HPLC analysis of the high molecular weight fraction by Method 2.
- This result also confirmed that crocetin formed micelles with fat-soluble carotenoids), and it became clear that the emulsifiability of fat-soluble carotenoids was improved by forming a complex (micelle) with crocetin. .
- Norbixin monoglycoside ester was not tested, but norbixin itself improved the water-dispersibility of fat-soluble carotenoids (Example 3), both crocetin and crocetin-monogentiobioside ester
- monoglycoside esters of norbixin can also form micelles with fat-soluble carotenoids and improve their emulsifiability. Is done. Therefore, the above results revealed that crocetin, norbixin, and their monoglycoside esters can improve the emulsifiability of fat-soluble carotenoids.
- Test Example 2 Evaluation of stability of fat-soluble carotenoid (1) Evaluation of stability improvement effect by crocin-1 High molecular weight fraction obtained by gel filtration of fat-soluble carotenoid emulsion (Example 1) in PD-10 column in Test Example 1 (containing micelle of fat-soluble carotenoid and crocetin-monogenthiobioside ester) Then, crocin was added and heat treatment was performed at 50 ° C. for 20 hours. For comparison, heat treatment was performed under the same conditions without adding crocin. After the heat treatment, the HPLC analysis of the method 2 was performed, and the fat-soluble carotenoid was measured.
- Examples 7 to 10 20 g of water was added to 20 g of water, [40% by weight of crocin, 18% by weight of crocetin-monogentiobioside ester, and other crocin analogs (crocetin-digentiobide ester, crocetin-monogentiobioside- Monoglycoside ester, crocetin-diglucoside ester, crocetin-monoglucoside ester, etc.) 42% by weight] were added in predetermined amounts shown in Table 2 and stirred to emulsify paprika oleoresin in water.
- each paprika oleoresin-containing preparation prepared above is stored at 50 ° C for 45 hours, and the capsanthin remaining in each paprika oleoresin-containing preparation (one of the fat-soluble carotenoids contained in paprika oleoresin) is measured over time.
- the residual ratio of capsanthin was calculated, and this was defined as the residual ratio of fat-soluble carotenoid.
- Capsanthin was measured by the HPLC analysis of Method 2 above.
- Table 2 shows the results obtained.
- paprika oleoresin was dispersed in water using a surfactant (Comparative Examples 2 to 4)
- the residual ratio of the fat-soluble carotenoid was significantly reduced in the accelerated test, and the stability of the fat-soluble carotenoid was insufficient.
- the fat-soluble carotenoid derived from paprika oleoresin has already formed micelles with the surfactant. Even when added, it is considered that the fat-soluble carotenoid could not form a complex (micelle) with the crocetin-monogentiobioside ester contained in gardenia yellow.
- Example 11 0.16 g of gardenia yellow pigment (40% by weight of crocin, 18% by weight of crocetin-monogentiobioside ester, 42% by weight of other crocin analogs) and 0.1 g of astaxanthin were added to 20 g of water. Astaxanthin was emulsified by stirring.
- Table 3 shows the obtained results. From this result, even when astaxanthin is used as a fat-soluble terpenoid, stability cannot be improved with a normal surfactant, but crocetin-monogentiobioside ester and astaxanthin can be obtained using gardenia yellow. It was revealed that the stability of astaxanthin can be remarkably improved by forming a complex (micelle) and coexisting crocin contained in gardenia yellow.
- Test Example 3 Evaluation of emulsifiability of vegetable oil (1) Emulsification of vegetable oil with crocetin-monogentiobioside ester A solution containing soybean oil and crocetin-monogentiobioside ester or crocetin-digentiobioside ester was prepared so as to have the composition shown in Table 4, and vortexed. The emulsification treatment was performed, and then the appearance was observed.
- the obtained soybean oil emulsion was diluted 2 times with water, and 1 ml of the obtained diluted solution was subjected to gel filtration using a PD-10 column (GE Healthcare Life Sciences) and eluted with water to 1 ml. Each sample was collected and fractionated into fractions 1 to 10 in order of elution.
- each obtained fraction is shown in FIG. As can be seen from FIG. 6, the fraction containing the emulsion was observed in fraction 2 (the second fraction collected). In addition, fractions 3 and 4 were yellow, and yellow was light in fraction 6, but yellow was again present in fractions 7 and above.
- the solution before the emulsification treatment, the obtained fraction 2, the mixed fraction of fractions 3 to 5, and the mixed fraction after fraction 7 were analyzed by HPLC.
- the HPLC analysis was performed under the same conditions as in Method 1 used for the analysis of gardenia yellow.
- soybean oil was contained about the fraction 2, after removing soybean oil (breaking an emulsion), it used for the HPLC analysis. Soybean oil was removed by passing fraction 2 through a column (Sep-Pak C18 Cartridges manufactured by Waters), adsorbing oily components to the column, and then eluting components other than soybean oil with methanol.
- Test Example 4 Evaluation of emulsifiability of vegetable oils and fats
- the raw materials shown in Table 6 were mixed and emulsified for 5 minutes at 10,000 rpm using a homogenizer (TK homomixer MARKII, manufactured by Primix Co., Ltd.).
- TK homomixer MARKII manufactured by Primix Co., Ltd.
- a preparation in which rapeseed oil was uniformly emulsified was obtained.
- the average particle size of micelles was measured with a laser diffraction particle size distribution analyzer (SALD2100, Shimadzu Corporation) using water as a diluent solvent and setting the refractive index to 1.60-0.10i.
- SALD2100 laser diffraction particle size distribution analyzer
- Test Example 5 Evaluation of emulsifiability of d- ⁇ -tocopherol
- the raw materials shown in Table 7 were mixed and emulsified at 10,000 rpm for 5 minutes using a homogenizer (TK homomixer MARK II, manufactured by Primix Co., Ltd.).
- TK homomixer MARK II manufactured by Primix Co., Ltd.
- a preparation in which d- ⁇ -tocopherol was uniformly emulsified was obtained.
- the average particle size of micelles was measured with a laser diffraction particle size distribution analyzer (SALD2100, Shimadzu Corporation) using water as a diluent solvent and setting the refractive index to 1.60-0.10i.
- SALD2100 laser diffraction particle size distribution analyzer
- Example 1 Beverage Using the paprika oleoresin-containing preparation obtained in Example 8, an orangeade was prepared according to the formulation shown in Table 8 below. Specifically, each raw material shown in Table 8 was mixed and heated in a container to obtain an orangeade. This orangeade contains 5 mg of paprika oleoresin derived from a paprika oleoresin water dispersible formulation.
- Example 2 Jelly Beverage Using the paprika oleoresin-containing preparation obtained in Example 8, an orange-flavored jelly drink was prepared according to the formulation shown in Table 9 below. Specifically, saccharides and agar are added to water and dissolved by heating, and then other raw materials are dissolved. Next, after adjusting to a predetermined pH, after passing through a primary sterilization step and filling an aluminum pouch with a spout 80 g / pack at a time, secondary sterilization was further performed to obtain a jelly beverage. 80 g of orange-flavored jelly beverage contains 4 mg of paprika oleoresin derived from a water-dispersible preparation of paprika oleoresin.
- Production Example 4 Cosmetic liquid Using the paprika oleoresin-containing preparation obtained in Example 8, a cosmetic liquid having the composition shown in Table 11 below was prepared according to a conventional method.
- Example 5 Energy drink Using the paprika oleoresin-containing preparation obtained in Example 8, an energy drink having the composition shown in Table 12 below was prepared. Specifically, energy drinks were obtained by mixing the raw materials shown in Table 12 and heating and filling the containers. This energy drink contains 5 mg of paprika oleoresin derived from a paprika oleoresin-containing preparation.
- Example 9 Sports drink Using the paprika oleoresin-containing preparation obtained in Example 8, a sports drink was prepared according to the formulation shown in Table 13 below. Specifically, sports drinks were obtained by mixing the raw materials shown in Table 13 and heating and filling the containers. This sports drink contains 5 mg of paprika oleoresin derived from a paprika oleoresin water-containing preparation.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Birds (AREA)
- Polymers & Plastics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Dispersion Chemistry (AREA)
- Hematology (AREA)
- Child & Adolescent Psychology (AREA)
- Obesity (AREA)
- Biochemistry (AREA)
- Pain & Pain Management (AREA)
- Ophthalmology & Optometry (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The purpose of the present invention is to provide an emulsifiable formulation of a liposoluble substance that improves the emulsifiability of the liposoluble substance. The water dispersibility of a liposoluble carotenoid can be improved greatly by forming a complex (micelle) of at least one selected from the group consisting of crocetin, norbixin, and monoglycoside esters thereof and a liposoluble carotenoid in the presence of water.
Description
本発明は、脂溶性物質の乳化性が向上、或いは脂溶性カロテノイドの乳化性と安定性とが向上している脂溶性物質の乳化性製剤に関する。また、本発明は、当該脂溶性物質の乳化性製剤を利用した飲食品、化粧料、医薬品等に関する。
The present invention relates to an emulsifiable preparation of a fat-soluble substance in which the emulsifiability of the fat-soluble substance is improved, or the emulsifiability and stability of the fat-soluble carotenoid are improved. Moreover, this invention relates to the food-drinks, cosmetics, a pharmaceutical, etc. using the emulsifiable preparation of the said fat-soluble substance.
脂溶性物質には、脂溶性カロテノイド、動物性油脂、植物性油脂、植物ステロール、脂溶性ビタミン、香料等の様々な有用成分があり、その利用範囲は食品、化粧品、医薬品等の多岐の分野に亘っている。例えば、脂溶性カロテノイドは、黄色から赤色を呈する天然に存在するテルペノイド類の色素であり、飲食品、化粧料、医薬品等の様々な分野で着色料として利用されている。また、脂溶性カロテノイドの中には、着色料としての使用に止まらず、各種の生理機能を有しているものも報告されており、機能性成分として使用されているものもある。例えば、アスタキサンチンには、抗酸化作用に優れており、皮膚老化防止、消炎、眼精疲労回復等に有効であることが知られている。また、フコキサンチンも、抗酸化作用に優れており、アポトーシス誘導活性、抗腫瘍、抗肥満等に有効であることが知られている。
Fat-soluble substances include various useful ingredients such as fat-soluble carotenoids, animal fats and oils, vegetable fats and oils, plant sterols, fat-soluble vitamins, and fragrances, and the range of use is in various fields such as foods, cosmetics, and pharmaceuticals. Across. For example, fat-soluble carotenoids are naturally occurring terpenoid pigments that exhibit yellow to red color, and are used as coloring agents in various fields such as foods and drinks, cosmetics, and pharmaceuticals. In addition, some fat-soluble carotenoids have not only been used as coloring agents but also have various physiological functions, and some are used as functional ingredients. For example, astaxanthin is known to have an excellent antioxidant effect and is effective in preventing skin aging, anti-inflammatory, eye strain recovery, and the like. Fucoxanthin is also known to be excellent in antioxidant action and effective for apoptosis-inducing activity, antitumor, anti-obesity and the like.
一方脂溶性物質は、水との相溶性が低く、従来、水に分散させるには界面活性剤等を用いて乳化させて使用されている。しかし、脂溶性物質には、乳化させるのが困難であったり、乳化させると不安定化されたりするものがある。特に、脂溶性カロテノイドは、不安定な構造であり、乳化状態で分散させても、酸素、熱、水分等によって分解され易いという欠点がある。脂溶性カロテノイドが分解されると、退色により製品の外観性状が損なわれるだけでなく、機能性カロテノイドの場合には所望の機能性を発揮し得えなくなるため、脂溶性カロテノイドの安定性の向上を図ることは、産業上の大きな課題となっている。そこで、脂溶性物質を水系で安定に分散又は乳化させる新たな技術を確立することが、飲食品、化粧料、医薬品等の分野において求められている。
On the other hand, fat-soluble substances have low compatibility with water, and are conventionally used after being emulsified with a surfactant or the like to be dispersed in water. However, some fat-soluble substances are difficult to emulsify or become unstable when emulsified. In particular, fat-soluble carotenoids have an unstable structure and have a drawback that they are easily decomposed by oxygen, heat, moisture, etc. even when dispersed in an emulsified state. When the fat-soluble carotenoid is decomposed, not only the appearance of the product is impaired due to fading, but also the functional property of the carotenoid cannot be exhibited, so the stability of the fat-soluble carotenoid can be improved. Planning is a major industrial issue. Therefore, establishment of a new technique for stably dispersing or emulsifying a fat-soluble substance in an aqueous system is required in the fields of foods and drinks, cosmetics, pharmaceuticals, and the like.
これまでに、脂溶性物質の水系での安定性を向上させる技術について種々検討がなされている。例えば、脂溶性カロテノイドに関する技術については、ルチン及び水溶性抗酸化剤と、食塩、塩化カルシウム、ミョウバンの少なくとも1種とを、色素液に接触させることにより、色素の安定化が図られることが報告されている(特許文献1)。また、琥珀粉末を使用することによってカロテノイド色素の変退色を防止できることも報告されている(特許文献2)。更に、アスタキサンチン、20μg/L以上の鉄イオン、及び鉄キレート剤を含む水系組成物が、アスタキサンチンの経時的安定性を向上させ得ることについても報告されている(特許文献3)。しかしながら、これらの技術では、脂溶性カロテノイドを分散させるために界面活性剤が必要とされ、更にその安定化のために多量の添加剤も必要となるため、適用可能な製品に制約があることに加え、製品の風味や使用感等に影響することも懸念される。
So far, various studies have been made on techniques for improving the stability of fat-soluble substances in water. For example, regarding the technology related to fat-soluble carotenoids, it is reported that the pigment can be stabilized by bringing rutin and a water-soluble antioxidant and at least one of sodium chloride, calcium chloride, and alum into contact with the pigment solution. (Patent Document 1). It has also been reported that the use of soot powder can prevent discoloration of carotenoid pigments (Patent Document 2). Furthermore, it has also been reported that an aqueous composition containing astaxanthin, 20 μg / L or more of iron ions, and an iron chelating agent can improve the astaxanthin stability over time (Patent Document 3). However, these technologies require a surfactant to disperse the fat-soluble carotenoid, and also require a large amount of additives to stabilize the product, which limits the applicable products. In addition, there is a concern that it may affect the flavor and feeling of use of the product.
このような従来技術を背景として、適用可能な製品に制約が少なく、製品の風味や使用感等にも影響を及ぼさない天然由来物質によって、脂溶性物質の乳化性を向上させ、更にはその安定性も向上させる技術の開発が望まれている。
Against the background of such conventional technology, the emulsifiability of fat-soluble substances is improved by the naturally-occurring substances that have few restrictions on applicable products and do not affect the flavor and feeling of use of the products, and further stabilize Development of technology that improves the performance is also desired.
本発明の目的は、脂溶性物質の乳化性を向上させた、脂溶性物質の乳化性製剤を提供することである。また、本発明の目的は、脂溶性物質の乳化性と共に、安定性を向上させた脂溶性物質の乳化性製剤を提供することである。更に、本発明は、脂溶性物質の乳化性が向上、或いは脂溶性物質の乳化性と安定性との双方が向上している飲食品、化粧料、医薬品等を提供することである。
An object of the present invention is to provide an emulsifiable preparation of a fat-soluble substance with improved emulsifiability of the fat-soluble substance. Moreover, the objective of this invention is providing the emulsifiable preparation of the fat-soluble substance which improved stability with the emulsifiability of a fat-soluble substance. Furthermore, this invention is providing food / beverage products, cosmetics, a pharmaceutical, etc. with which the emulsifiability of a fat-soluble substance is improving, or both the emulsifiability and stability of a fat-soluble substance are improving.
本発明者等は、前記課題を解決すべく鋭意検討を行ったところ、クロセチン、ノルビキシン、及びこれらのモノグリコシドエステルよりなる群から選択される少なくとも1種は、水存在下で脂溶性物質と複合体(ミセル)を形成することによって、脂溶性物質の乳化性を格段に向上させ得ることを見出した。また、前記複合体(ミセル)と共に、クロセチンのジグリコシドエステル及び/又はノルビキシンのジグリコシドエステルを共存させることによって、脂溶性物質の安定性を格段に向上させ得ることも見出した。本発明は、かかる知見に基づいて更に検討を重ねることにより完成したものである。
As a result of intensive studies to solve the above problems, the present inventors have found that at least one selected from the group consisting of crocetin, norbixin, and monoglycoside esters thereof is combined with a fat-soluble substance in the presence of water. It has been found that the emulsifiability of a fat-soluble substance can be remarkably improved by forming a body (micelle). It has also been found that the stability of a fat-soluble substance can be remarkably improved by coexisting with the complex (micelle) together with a diglycoside ester of crocetin and / or a diglycoside ester of norbixin. The present invention has been completed by further studies based on such knowledge.
即ち、本発明は、下記に掲げる態様の発明を提供する。
項1. (A)脂溶性物質と、(B)クロセチン、ノルビキシン、及びこれらのモノグリコシドエステルよりなる群から選択される少なくとも1種とを、ミセル構成成分として含む、脂溶性物質の乳化性製剤。
項2. 更に、(C)クロセチンのジグリコシドエステル及び/又はノルビキシンのジグリコシドエステルを含む、項1に記載の脂溶性物質の乳化性製剤。
項3. 前記(B)成分が、クロセチン、ノルビキシン、及びクロセチン-モノゲンチオビオシドエステルよりなる群から選択される少なくとも1種である、項1又は2に記載の脂溶性物質の乳化性製剤。
項4. 前記(C)成分が、クロシンである、項1~3のいずれかに記載の脂溶性物質の乳化性製剤。
項5. 前記(B)及び(C)成分として、クチナシ黄色素を含む、項2~4のいずれかに記載の脂溶性物質の乳化性製剤。
項6. 前記(A)成分が、脂溶性カロテノイド及び/又は植物性油脂である、項1~5のいずれかに記載の脂溶性物質の乳化性製剤。
項7. 前記(A)成分が脂溶性カロテノイドであり、色素製剤として使用される、項1~6のいずれかに記載の脂溶性物質の乳化性製剤。
項8. (A)脂溶性物質と、(B)クロセチン、ノルビキシン、及びこれらのモノグリコシドエステルよりなる群から選択される少なくとも1種とを含むミセルを含有する、ハイドロゲル。
項9. 更に、(C)クロセチンのジグリコシドエステル及び/又はノルビキシンのジグリコシドエステルを含む、項8に記載のハイドロゲル。
項10. (A)脂溶性物質と、(B)クロセチン、ノルビキシン、及びこれらのモノグリコシドエステルよりなる群から選択される少なくとも1種とを含むミセル、又は当該ミセルの乾燥物を含有する、飲食品。
項11. 更に、(C)クロセチンのジグリコシドエステル及び/又はノルビキシンのジグリコシドエステルを含む、項10に記載の飲食品。
項12. (A)脂溶性物質と、(B)クロセチン、ノルビキシン、及びこれらのモノグリコシドエステルよりなる群から選択される少なくとも1種とを含むミセル、又は当該ミセルの乾燥物を含有する、化粧料。
項13. 更に、(C)クロセチンのジグリコシドエステル及び/又はノルビキシンのジグリコシドエステルを含む、項12に記載の化粧料。
項14. (A)脂溶性物質と、(B)クロセチン、ノルビキシン、及びこれらのモノグリコシドエステルよりなる群から選択される少なくとも1種とを含むミセル、又は当該ミセルの乾燥物を含有する、医薬品。
項15. 更に、(C)クロセチンのジグリコシドエステル及び/又はノルビキシンのジグリコシドエステルを含む、項14に記載の医薬品。
項16. クロセチン、ノルビキシン、及びこれらのモノグリコシドエステルよりなる群から選択される少なくとも1種を有効成分とする、脂溶性物質の乳化性向上剤。
項17. 飲食品添加剤である、項16に記載の脂溶性物質の乳化性向上剤。
項18. クロセチン、ノルビキシン、及びこれらのモノグリコシドエステルよりなる群から選択される少なくとも1種を有効成分とする、脂溶性物質の吸収性向上剤。
項19. 飲食品添加剤である、項18に記載の脂溶性カロテノイドの吸収性向上剤。
項20. クロセチン、ノルビキシン、及びこれらのモノグリコシドエステルよりなる群から選択される少なくとも1種の、脂溶性物質の乳化性向上剤の製造のための使用。
項21. クロセチン、ノルビキシン、及びこれらのモノグリコシドエステルよりなる群から選択される少なくとも1種の、脂溶性物質の吸収性向上剤の製造のための使用。
項22.(A)脂溶性物質と、(B)クロセチン、ノルビキシン、及びこれらのモノグリコシドエステルよりなる群から選択される少なくとも1種とを水存在下で乳化させる工程を含む、脂溶性物質の乳化方法。 That is, this invention provides the invention of the aspect hung up below.
Item 1. An emulsifiable preparation of a fat-soluble substance comprising (A) a fat-soluble substance and (B) at least one selected from the group consisting of crocetin, norbixin, and monoglycoside esters thereof as micelle constituents.
Item 2. Item 5. The emulsifiable preparation of a fat-soluble substance according to Item 1, further comprising (C) a diglycoside ester of crocetin and / or a diglycoside ester of norbixin.
Item 3. Item 3. The emulsifiable preparation of a fat-soluble substance according to Item 1 or 2, wherein the component (B) is at least one selected from the group consisting of crocetin, norbixin, and crocetin-monogentiobioside ester.
Item 4. Item 4. The emulsifiable preparation of a fat-soluble substance according to any one of Items 1 to 3, wherein the component (C) is crocin.
Item 5. Item 5. The emulsifiable preparation of a fat-soluble substance according to any one of Items 2 to 4, comprising Gardenia yellow as the components (B) and (C).
Item 6. Item 6. The emulsifiable preparation of a fat-soluble substance according to any one of Items 1 to 5, wherein the component (A) is a fat-soluble carotenoid and / or vegetable oil.
Item 7. Item 7. The emulsifiable preparation of a fat-soluble substance according to any one of Items 1 to 6, wherein the component (A) is a fat-soluble carotenoid and is used as a pigment preparation.
Item 8. A hydrogel comprising a micelle comprising (A) a fat-soluble substance and (B) at least one selected from the group consisting of crocetin, norbixin, and monoglycoside esters thereof.
Item 9. Item 9. The hydrogel according to Item 8, further comprising (C) a diglycoside ester of crocetin and / or a diglycoside ester of norbixin.
Item 10. A food or drink containing a micelle comprising (A) a fat-soluble substance and (B) at least one selected from the group consisting of crocetin, norbixin, and monoglycoside esters thereof, or a dried product of the micelle.
Item 11. Item 11. The food or drink according toItem 10, further comprising (C) a diglycoside ester of crocetin and / or a diglycoside ester of norbixin.
Item 12. A cosmetic comprising (A) a fat-soluble substance and (B) at least one selected from the group consisting of crocetin, norbixin, and monoglycoside esters thereof, or a dried product of the micelle.
Item 13. Item 13. The cosmetic according to Item 12, further comprising (C) a diglycoside ester of crocetin and / or a diglycoside ester of norbixin.
Item 14. A pharmaceutical comprising a micelle comprising (A) a fat-soluble substance and (B) at least one selected from the group consisting of crocetin, norbixin, and monoglycoside esters thereof, or a dried product of the micelle.
Item 15. Item 15. The pharmaceutical according to Item 14, further comprising (C) a diglycoside ester of crocetin and / or a diglycoside ester of norbixin.
Item 16. An emulsifying agent for fat-soluble substances, comprising as an active ingredient at least one selected from the group consisting of crocetin, norbixin, and monoglycoside esters thereof.
Item 17. Item 17. The emulsifiability improver of a fat-soluble substance according to Item 16, which is a food or drink additive.
Item 18. An agent for improving the absorption of fat-soluble substances, comprising as an active ingredient at least one selected from the group consisting of crocetin, norbixin, and monoglycoside esters thereof.
Item 19. Item 19. The fat-soluble carotenoid absorptive improver according to Item 18, which is a food and drink additive.
Item 20. Use for manufacture of the emulsification improver of at least 1 sort (s) selected from the group which consists of crocetin, norbixin, and these monoglycoside ester.
Item 21. Use for the manufacture of an absorption enhancer of at least one fat-soluble substance selected from the group consisting of crocetin, norbixin, and monoglycoside esters thereof.
Item 22. A method for emulsifying a fat-soluble substance, comprising the step of emulsifying (A) a fat-soluble substance and (B) at least one selected from the group consisting of crocetin, norbixin, and monoglycoside esters thereof in the presence of water.
項1. (A)脂溶性物質と、(B)クロセチン、ノルビキシン、及びこれらのモノグリコシドエステルよりなる群から選択される少なくとも1種とを、ミセル構成成分として含む、脂溶性物質の乳化性製剤。
項2. 更に、(C)クロセチンのジグリコシドエステル及び/又はノルビキシンのジグリコシドエステルを含む、項1に記載の脂溶性物質の乳化性製剤。
項3. 前記(B)成分が、クロセチン、ノルビキシン、及びクロセチン-モノゲンチオビオシドエステルよりなる群から選択される少なくとも1種である、項1又は2に記載の脂溶性物質の乳化性製剤。
項4. 前記(C)成分が、クロシンである、項1~3のいずれかに記載の脂溶性物質の乳化性製剤。
項5. 前記(B)及び(C)成分として、クチナシ黄色素を含む、項2~4のいずれかに記載の脂溶性物質の乳化性製剤。
項6. 前記(A)成分が、脂溶性カロテノイド及び/又は植物性油脂である、項1~5のいずれかに記載の脂溶性物質の乳化性製剤。
項7. 前記(A)成分が脂溶性カロテノイドであり、色素製剤として使用される、項1~6のいずれかに記載の脂溶性物質の乳化性製剤。
項8. (A)脂溶性物質と、(B)クロセチン、ノルビキシン、及びこれらのモノグリコシドエステルよりなる群から選択される少なくとも1種とを含むミセルを含有する、ハイドロゲル。
項9. 更に、(C)クロセチンのジグリコシドエステル及び/又はノルビキシンのジグリコシドエステルを含む、項8に記載のハイドロゲル。
項10. (A)脂溶性物質と、(B)クロセチン、ノルビキシン、及びこれらのモノグリコシドエステルよりなる群から選択される少なくとも1種とを含むミセル、又は当該ミセルの乾燥物を含有する、飲食品。
項11. 更に、(C)クロセチンのジグリコシドエステル及び/又はノルビキシンのジグリコシドエステルを含む、項10に記載の飲食品。
項12. (A)脂溶性物質と、(B)クロセチン、ノルビキシン、及びこれらのモノグリコシドエステルよりなる群から選択される少なくとも1種とを含むミセル、又は当該ミセルの乾燥物を含有する、化粧料。
項13. 更に、(C)クロセチンのジグリコシドエステル及び/又はノルビキシンのジグリコシドエステルを含む、項12に記載の化粧料。
項14. (A)脂溶性物質と、(B)クロセチン、ノルビキシン、及びこれらのモノグリコシドエステルよりなる群から選択される少なくとも1種とを含むミセル、又は当該ミセルの乾燥物を含有する、医薬品。
項15. 更に、(C)クロセチンのジグリコシドエステル及び/又はノルビキシンのジグリコシドエステルを含む、項14に記載の医薬品。
項16. クロセチン、ノルビキシン、及びこれらのモノグリコシドエステルよりなる群から選択される少なくとも1種を有効成分とする、脂溶性物質の乳化性向上剤。
項17. 飲食品添加剤である、項16に記載の脂溶性物質の乳化性向上剤。
項18. クロセチン、ノルビキシン、及びこれらのモノグリコシドエステルよりなる群から選択される少なくとも1種を有効成分とする、脂溶性物質の吸収性向上剤。
項19. 飲食品添加剤である、項18に記載の脂溶性カロテノイドの吸収性向上剤。
項20. クロセチン、ノルビキシン、及びこれらのモノグリコシドエステルよりなる群から選択される少なくとも1種の、脂溶性物質の乳化性向上剤の製造のための使用。
項21. クロセチン、ノルビキシン、及びこれらのモノグリコシドエステルよりなる群から選択される少なくとも1種の、脂溶性物質の吸収性向上剤の製造のための使用。
項22.(A)脂溶性物質と、(B)クロセチン、ノルビキシン、及びこれらのモノグリコシドエステルよりなる群から選択される少なくとも1種とを水存在下で乳化させる工程を含む、脂溶性物質の乳化方法。 That is, this invention provides the invention of the aspect hung up below.
Item 11. Item 11. The food or drink according to
Item 12. A cosmetic comprising (A) a fat-soluble substance and (B) at least one selected from the group consisting of crocetin, norbixin, and monoglycoside esters thereof, or a dried product of the micelle.
Item 13. Item 13. The cosmetic according to Item 12, further comprising (C) a diglycoside ester of crocetin and / or a diglycoside ester of norbixin.
Item 14. A pharmaceutical comprising a micelle comprising (A) a fat-soluble substance and (B) at least one selected from the group consisting of crocetin, norbixin, and monoglycoside esters thereof, or a dried product of the micelle.
Item 16. An emulsifying agent for fat-soluble substances, comprising as an active ingredient at least one selected from the group consisting of crocetin, norbixin, and monoglycoside esters thereof.
Item 18. An agent for improving the absorption of fat-soluble substances, comprising as an active ingredient at least one selected from the group consisting of crocetin, norbixin, and monoglycoside esters thereof.
Item 19. Item 19. The fat-soluble carotenoid absorptive improver according to Item 18, which is a food and drink additive.
Item 21. Use for the manufacture of an absorption enhancer of at least one fat-soluble substance selected from the group consisting of crocetin, norbixin, and monoglycoside esters thereof.
本発明によれば、クロセチン、ノルビキシン、及びこれらのモノグリコシドエステルよりなる群から選択される少なくとも1種を、脂溶性物質と共存させてこれらのミセルを形成させることにより、界面活性剤を使用せずとも、脂溶性物質に優れた乳化性を備えさせることができる。また、本発明では、前記ミセルを形成することによって、脂溶性物質に親水性が付与されて吸収され易い形態になっており、脂溶性物質の経皮又は経腸吸収性を向上させることもできる。
According to the present invention, the surfactant is used by forming at least one selected from the group consisting of crocetin, norbixin, and monoglycoside esters thereof together with a fat-soluble substance to form these micelles. At least, the fat-soluble substance can be provided with excellent emulsifying properties. In the present invention, by forming the micelle, hydrophilicity is imparted to the fat-soluble substance so that it can be easily absorbed, and the transdermal or enteral absorption of the fat-soluble substance can be improved. .
また、本発明によれば、前記ミセルに、更にクロセチンのジグリコシドエステル及び/又はノルビキシンのジグリコシドエステルを共存させることによって、脂溶性物質に優れた乳化性だけでなく、その安定性も格段に向上させることができるので、脂溶性物質を含む各種製品の保存安定性を高めることができる。なお、本明細書において、保存安定性とは、脂溶性物質の変色防止、機能性維持等が実現され、脂溶性物質が安定に保持される特性を意味する。
In addition, according to the present invention, not only the emulsifiability of the fat-soluble substance but also the stability thereof is markedly improved by coexisting the micelle with a diglycoside ester of crocetin and / or a diglycoside ester of norbixin. Since it can improve, the storage stability of various products containing a fat-soluble substance can be improved. In the present specification, the storage stability means the property that the fat-soluble substance can be stably maintained by preventing discoloration of the fat-soluble substance and maintaining the functionality.
1.脂溶性物質の乳化性製剤
本発明の脂溶性物質の乳化性製剤(以下、「本発明製剤」と表記することもある)は、脂溶性物質(以下、「(A)成分」と表記することもある)と、クロセチン、クロセチン-モノグリコシドエステル、及びノルビキシンよりなる群から選択される少なくとも1種(以下、「(B)成分」と表記することもある)とを、ミセル構成成分として含有することを特徴とする。本発明製剤は、脂溶性物質の供給源として、食品、化粧料、医薬等の各種製品に配合して使用される製剤である。特に、本発明製剤は、脂溶性物質として脂溶性カロテノイドを含む場合には、着色料又は脂溶性カロテノイドに基づく機能性の供給源として、食品、化粧料、医薬等の各種製品に配合される色素製剤として使用される。以下、本発明製剤について、詳述する。 1. The emulsifiable preparation of the fat-soluble substance The emulsifiable preparation of the fat-soluble substance of the present invention (hereinafter sometimes referred to as “the preparation of the present invention”) is the fat-soluble substance (hereinafter referred to as “component (A)”). And at least one selected from the group consisting of crocetin, crocetin-monoglycoside ester, and norbixin (hereinafter also referred to as “component (B)”) as a micelle component It is characterized by that. The preparation of the present invention is a preparation used as a source of a fat-soluble substance by being blended with various products such as foods, cosmetics, and medicines. In particular, when the preparation of the present invention contains a fat-soluble carotenoid as a fat-soluble substance, a coloring agent or a pigment blended in various products such as foods, cosmetics, and pharmaceuticals as a functional source based on the fat-soluble carotenoid Used as a formulation. Hereinafter, the preparation of the present invention will be described in detail.
本発明の脂溶性物質の乳化性製剤(以下、「本発明製剤」と表記することもある)は、脂溶性物質(以下、「(A)成分」と表記することもある)と、クロセチン、クロセチン-モノグリコシドエステル、及びノルビキシンよりなる群から選択される少なくとも1種(以下、「(B)成分」と表記することもある)とを、ミセル構成成分として含有することを特徴とする。本発明製剤は、脂溶性物質の供給源として、食品、化粧料、医薬等の各種製品に配合して使用される製剤である。特に、本発明製剤は、脂溶性物質として脂溶性カロテノイドを含む場合には、着色料又は脂溶性カロテノイドに基づく機能性の供給源として、食品、化粧料、医薬等の各種製品に配合される色素製剤として使用される。以下、本発明製剤について、詳述する。 1. The emulsifiable preparation of the fat-soluble substance The emulsifiable preparation of the fat-soluble substance of the present invention (hereinafter sometimes referred to as “the preparation of the present invention”) is the fat-soluble substance (hereinafter referred to as “component (A)”). And at least one selected from the group consisting of crocetin, crocetin-monoglycoside ester, and norbixin (hereinafter also referred to as “component (B)”) as a micelle component It is characterized by that. The preparation of the present invention is a preparation used as a source of a fat-soluble substance by being blended with various products such as foods, cosmetics, and medicines. In particular, when the preparation of the present invention contains a fat-soluble carotenoid as a fat-soluble substance, a coloring agent or a pigment blended in various products such as foods, cosmetics, and pharmaceuticals as a functional source based on the fat-soluble carotenoid Used as a formulation. Hereinafter, the preparation of the present invention will be described in detail.
(A)成分
本発明製剤は、(A)成分として、脂溶性物質を含有する。 Component (A) The preparation of the present invention contains a fat-soluble substance as component (A).
本発明製剤は、(A)成分として、脂溶性物質を含有する。 Component (A) The preparation of the present invention contains a fat-soluble substance as component (A).
本発明で使用される脂溶性物質については、脂溶性であり、水への分散性が求められるものであるであることを限度として特に制限されないが、例えば、脂溶性カロテノイド、植物性油脂、動物性油脂、植物ステロール、脂溶性ビタミン、高級脂肪酸、精油等が挙げられる。
The fat-soluble substance used in the present invention is not particularly limited as long as it is fat-soluble and requires dispersibility in water. For example, fat-soluble carotenoids, vegetable oils, animals Oils and fats, plant sterols, fat-soluble vitamins, higher fatty acids, essential oils and the like.
前記脂溶性カロテノイドは、カロテン、キサントフィル、アポカルテノイドのいずれであってもよい。カロテンとしては、例えば、α-カロテン、β-カロテン、γ-カロテン、リコペン等が挙げられる。また、キサントフィルとしては、例えば、アクチニオエリスリトール、カンタキサンチン、カプソルビン、ククルビタキサンチンA、クリプトカプシン、アスタキサンチン、フコキサンチン、ルテイン、ゼアキサンチン、カプサンチン、β-クリプトキサンチン、ビオラキサンチン、これらの誘導体(脂肪酸とのモノエステル体又はジエステル体等)等が挙げられる。また、アポカルテノイドとしては、ビキシン、β-8'-アポ-カロテナール(アポカロテナール)、β-12'-アポ-カロテナール、これらの誘導体(低級又は高級アルコールとのエステル体等)等が挙げられる。これらの脂溶性カロテノイドは、1種単独で使用してもよく、また2種以上を組み合わせて使用してもよい。
The fat-soluble carotenoid may be any of carotene, xanthophyll, or apocartenoid. Examples of carotene include α-carotene, β-carotene, γ-carotene, lycopene, and the like. Examples of xanthophylls include actinioerythritol, canthaxanthin, capsorubin, cucurbitaxanthin A, cryptocapsin, astaxanthin, fucoxanthin, lutein, zeaxanthin, capsanthin, β-cryptoxanthin, violaxanthin, and derivatives thereof (fatty acids Monoester or diester) and the like. Examples of apocartenoids include bixin, β-8′-apo-carotenal (apocarotenal), β-12′-apo-carotenal, derivatives thereof (such as esters with lower or higher alcohols), and the like. These fat-soluble carotenoids may be used individually by 1 type, and may be used in combination of 2 or more type.
脂溶性カロテノイドは、その由来や製法については、特に制限されず、植物、動物、微生物等の天然物由来のもののであってもよく、また発酵法や合成法により得られたものであってもよい。
The origin and production method of fat-soluble carotenoids are not particularly limited, and may be those derived from natural products such as plants, animals and microorganisms, and those obtained by fermentation or synthesis methods. Good.
また、(A)成分として、脂溶性カロテノイドを含む天然色素を使用することもできる。このような天然色素として、具体的には、トウガラシ色素(パプリカ色素、パプリカオレオレジン)、アナトー色素、イモカロテン、デュナリエラカロテン、ニンジンカロテン、エビ色素、オキアミ色素、オレンジ色素、カニ色素、トウモロコシ色素、トマト色素、パーム油カロテン、ファフィア色素、ベニノキ末色素、ヘマトコッカス藻色素、マリーゴールド色素等が挙げられる。
Moreover, natural pigments containing fat-soluble carotenoids can also be used as the component (A). Specific examples of such natural pigments include red pepper pigment (paprika pigment, paprika oleoresin), anato pigment, imo carotene, Dunaliella carotene, carrot carotene, shrimp pigment, krill pigment, orange pigment, crab pigment, corn pigment, Examples include tomato pigments, palm oil carotene, phafia pigments, Beninoki powder pigments, Haematococcus alga pigments, and marigold pigments.
前記植物性油脂としては、具体的には、大豆油、米油、サラダ油、ゴマ油、シソ油、ピーナッツ油、コーン油、菜種油、ヤシ油、パーム油、及びこれらの硬化油等が挙げられる。これらの植物性油脂は、1種単独で使用してもよく、また2種以上を組み合わせて使用してもよい。
Specific examples of the vegetable oil include soybean oil, rice oil, salad oil, sesame oil, perilla oil, peanut oil, corn oil, rapeseed oil, coconut oil, palm oil, and hardened oils thereof. These vegetable fats and oils may be used alone or in combination of two or more.
前記動物性油脂としては、具体的には、魚油、牛脂、豚脂、鶏油、及びこれらの硬化油等が挙げられる。これらの動物性油脂は、1種単独で使用してもよく、また2種以上を組み合わせて使用してもよい。
Specific examples of animal fats include fish oil, beef tallow, pork tallow, chicken oil, and hardened oils thereof. These animal fats and oils may be used individually by 1 type, and may be used in combination of 2 or more type.
前記植物ステロールとは植物中に存在するステロール類の総称であり、具体的には、α-シトスタノール、β-シトステロール、スチグマステロール、カンペステロール、ブラシカステロール、ブラシカステロール、イソフコステロール、7-スチグマステノール、イソフコスタノール、スチグマスタノール、7-スチグマスタノール、カンペスタノール、シクロアルテノール、アベナステロール、これらの配糖体等が挙げられる。これらの植物ステロールは、1種単独で使用してもよく、また2種以上を組み合わせて使用してもよい。
The plant sterol is a general term for sterols present in plants. Specifically, α-sitostanol, β-sitosterol, stigmasterol, campesterol, brassicasterol, brassicasterol, isofucosterol, 7- Examples thereof include stigmastenol, isofucostanol, stigmasteranol, 7-stigmasteranol, campestanol, cycloartenol, avenasterol, and glycosides thereof. These plant sterols may be used individually by 1 type, and may be used in combination of 2 or more type.
前記脂溶性ビタミンとしては、具体的には、ビタミンA、ビタミンD3、ビタミンE、ビタミンF、ビタミンK等が挙げられる。これらの脂溶性ビタミンは、1種単独で使用してもよく、また2種以上を組み合わせて使用してもよい。
Specific examples of the fat-soluble vitamin include vitamin A, vitamin D3, vitamin E, vitamin F, vitamin K, and the like. These fat-soluble vitamins may be used alone or in combination of two or more.
前記高級脂肪酸としては、具体的には、ドコサヘキサエン酸(DHA)、エイコサペンタエン酸(EPA)、リノール酸、リノレン酸等の炭素数12~30の高級脂肪酸が挙げられる。これらの高級脂肪酸は、1種単独で使用してもよく、また2種以上を組み合わせて使用してもよい。
Specific examples of the higher fatty acid include higher fatty acids having 12 to 30 carbon atoms such as docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), linoleic acid, and linolenic acid. These higher fatty acids may be used alone or in combination of two or more.
前記精油としては、具体的には、ペパーミント油、スペアミント油、ベルガモット油、ウイキョウ油、ハッカ油、レモン果皮油等が挙げられる。これらの精油は、1種単独で使用してもよく、また2種以上を組み合わせて使用してもよい。
Specific examples of the essential oil include peppermint oil, spearmint oil, bergamot oil, fennel oil, peppermint oil, lemon peel oil, and the like. These essential oils may be used individually by 1 type, and may be used in combination of 2 or more type.
脂溶性物質は、本発明製剤に備えさせるべき機能性等に応じて、その種類を適宜選択すればよい。本発明製剤において、脂溶性物質は、1種単独で使用してもよく、また2種以上を組み合わせて使用してもよい。
The type of the fat-soluble substance may be appropriately selected according to the functionality to be provided in the preparation of the present invention. In the preparation of the present invention, the fat-soluble substance may be used alone or in combination of two or more.
これらの脂溶性物質の中でも、より一層効果的に分散性又は乳化性を向上させるという観点から、好ましくは脂溶性カロテノイド、植物性油脂、及び脂溶性ビタミンが挙げられる。
Among these fat-soluble substances, fat-soluble carotenoids, vegetable oils and fats, and fat-soluble vitamins are preferable from the viewpoint of more effectively improving dispersibility or emulsification.
本発明製剤において、(A)成分の含有量については、特に制限されず、本発明製剤の用途、脂溶性物質の種類等に応じて適宜設定すればよいが、例えば0.00001~99.9重量%、好ましくは0.00005~99重量%、更に好ましくは0.0001~99重量%が挙げられる。
In the preparation of the present invention, the content of the component (A) is not particularly limited, and may be appropriately set according to the use of the preparation of the present invention, the type of fat-soluble substance, and the like. For example, 0.00001 to 99.9 % By weight, preferably 0.00005 to 99% by weight, more preferably 0.0001 to 99% by weight.
(B)成分
本発明製剤は、前記(A)成分と共に、(B)成分として、クロセチン、ノルビキシン、及びこれらのモノグリコシドエステルよりなる群から選択される少なくとも1種を含有する。後述する試験例1に示されるように、水存在下で、前記(A)成分と(B)成分を共存させると、(B)成分と(A)成分が会合してミセルを形成する。このようなミセルを形成することによって、脂溶性物質の乳化性を格段に向上させることが可能になる。 Component (B) The preparation of the present invention contains at least one selected from the group consisting of crocetin, norbixin, and monoglycoside esters thereof as component (B) together with component (A). As shown in Test Example 1 to be described later, when the component (A) and the component (B) coexist in the presence of water, the component (B) and the component (A) are associated to form micelles. By forming such micelles, the emulsifiability of the fat-soluble substance can be remarkably improved.
本発明製剤は、前記(A)成分と共に、(B)成分として、クロセチン、ノルビキシン、及びこれらのモノグリコシドエステルよりなる群から選択される少なくとも1種を含有する。後述する試験例1に示されるように、水存在下で、前記(A)成分と(B)成分を共存させると、(B)成分と(A)成分が会合してミセルを形成する。このようなミセルを形成することによって、脂溶性物質の乳化性を格段に向上させることが可能になる。 Component (B) The preparation of the present invention contains at least one selected from the group consisting of crocetin, norbixin, and monoglycoside esters thereof as component (B) together with component (A). As shown in Test Example 1 to be described later, when the component (A) and the component (B) coexist in the presence of water, the component (B) and the component (A) are associated to form micelles. By forming such micelles, the emulsifiability of the fat-soluble substance can be remarkably improved.
クロセチンとは、下記一般式(1)において、R1及びR2が水素原子である水溶性カロテノイドである。本発明で使用されるクロセチンは、シス-トランス異性体であってもよい。
Crocetin is a water-soluble carotenoid in which R 1 and R 2 are hydrogen atoms in the following general formula (1). The crocetin used in the present invention may be a cis-trans isomer.
また、クロセチンのモノグリコシドエステル(即ち、クロセチン-モノグリコシドエステル)は、クロセチンのカルボキシル基の1つに、糖がエステル結合にて結合した構造を有し、前記一般式(1)において、R1が糖残基であり、R2が水素原子である水溶性カロテノイドである。クロセチンのモノグリコシドエステルにおいてクロセチンに結合している糖は、単糖類であってもよく、また二糖類、酸糖類、四糖類等のオリゴ糖類であってもよい。当該構成糖として、具体的には、グルコース、(グルクロン酸)等の単糖類;ゲンチオビオース、マルトース、スクロース、ラクトース、(グルクロノシルグルコース、 グルクロノシルグルクロン酸、)等の二糖類;ゲンチオトリオース、マルトトリオース、ラフィノース、パノース、グルクロノシルゲンチオビオース、グルコシルゲンチオビオース等の三糖類等が挙げられる。クロセチンにエステル結合している糖類として、好ましくは単糖類、二糖類、更に好ましくはグルコース、ゲンチオビオース、特に好ましくはゲンチオビオース(即ち、クロセチン-モノゲンチオビオシドエステル;クロシン-3)が挙げられる。また、クロセチンのモノグリコシドエステルにおいて、クロセチンのカルボキシル基に結合している糖残基の部位については、特に制限されないが、糖の1位の水酸基がクロセチンのカルボキシル基とエステル結合していることが好ましい。本発明で使用されるクロセチンのモノグリコシドエステルは、シス-トランス異性体であってもよい。
Further, crocetin monoglycoside ester (that is, crocetin-monoglycoside ester) has a structure in which a sugar is bonded to one of the carboxyl groups of crocetin by an ester bond. In the general formula (1), R 1 Is a water-soluble carotenoid in which R 2 is a sugar residue and R 2 is a hydrogen atom. The saccharide bound to crocetin in the monoglycoside ester of crocetin may be a monosaccharide or an oligosaccharide such as a disaccharide, an acid saccharide, or a tetrasaccharide. Specific examples of the constituent sugars include monosaccharides such as glucose and (glucuronic acid); disaccharides such as gentiobiose, maltose, sucrose, and lactose (glucuronosylglucose and glucuronosylglucuronic acid); And trisaccharides such as maltotriose, raffinose, panose, glucuronosyl gentiobiose, glucosyl gentiobiose, and the like. Examples of the saccharide having an ester bond to crocetin include monosaccharides and disaccharides, more preferably glucose and gentiobiose, and particularly preferably gentiobiose (that is, crocetin-monogenthiobioside ester; crocin-3). In the monoglycoside ester of crocetin, the position of the sugar residue bonded to the carboxyl group of crocetin is not particularly limited, but the hydroxyl group at the 1-position of the sugar may be ester-bonded to the carboxyl group of crocetin. preferable. The monoglycoside ester of crocetin used in the present invention may be a cis-trans isomer.
ノルビキシンとは、下記一般式(2)において、R3及びR4が水素原子である水溶性カロテノイドである。本発明で使用されるノルビキシンは、シス-トランス異性体であってもよい。
Norbixin is a water-soluble carotenoid in which R 3 and R 4 are hydrogen atoms in the following general formula (2). The norbixin used in the present invention may be a cis-trans isomer.
また、ノルビキシンのモノグリコシドエステル(即ち、ノルビキシン-モノグリコシドエステル)は、ノルビキシンのカルボキシル基の1つに、糖がエステル結合にて結合した構造を有し、前記一般式(2)において、R3及びR4の一方が糖残基であり、他方が水素原子である水溶性カロテノイドである。ノルビキシン-モノグリコシドエステルにおいてクロセチンに結合している糖の種類、好ましいもの、結合部位等については、前記クロセチンのモノグリコシドエステルの場合と同様である。本発明で使用されるノルビキシンのモノグリコシドエステルは、シス-トランス異性体であってもよい。
Norubixin monoglycoside ester (ie, norbixin-monoglycoside ester) has a structure in which a sugar is bonded to one of the carboxyl groups of norbixin by an ester bond. In the general formula (2), R 3 And R 4 is a water-soluble carotenoid in which one is a sugar residue and the other is a hydrogen atom. In the norbixin-monoglycoside ester, the kind of sugar bonded to crocetin, the preferred one, the binding site and the like are the same as in the case of the monoglycoside ester of crocetin. The monoglycoside ester of norbixin used in the present invention may be a cis-trans isomer.
また、これらの(B)成分は、その由来や製法については、特に制限されず、植物、動物、微生物等の天然物から抽出されたものであってもよく、また発酵法や合成法により得られたものであってもよい。
These components (B) are not particularly limited in their origin and production method, and may be those extracted from natural products such as plants, animals, and microorganisms, and obtained by fermentation methods or synthetic methods. It may be what was made.
これらの(B)成分の中でも、脂溶性物質の乳化性をより一層向上させるという観点から、好ましくはクロセチン、ノルビキシン、クロセチン-モノグリコシドエステル、更に好ましくはクロセチン、ノルビキシン、クロセチン-モノゲンチオビオシドエステル(クロシン-3)が挙げられる。特に、植物油の乳化性をより一層向上させるという観点からは、クロセチン-モノグリコシドエステル、更に好ましくはクロセチン-モノゲンチオビオシドエステルが挙げられる。
Among these components (B), crocetin, norbixin, crocetin-monoglycoside ester, more preferably crocetin, norbixin, crocetin-monogenthiobioside ester are preferable from the viewpoint of further improving the emulsifiability of the fat-soluble substance. (Crocin-3). In particular, from the viewpoint of further improving the emulsifiability of the vegetable oil, crocetin-monoglycoside ester, more preferably crocetin-monogentiobioside ester can be mentioned.
また、(B)成分として、クロセチン、ノルビキシン、及びこれらのモノグリコシドエステルの少なくとも1種を含む天然色素を使用することもできる。例えば、クチナシ黄色素、サフラン色素には、クロセチン、クロセチン-モノゲンチオビオシドエステルが含まれていることが知られており、クチナシ黄色素及び/又はサフラン色素を(B)成分として好適に使用することができる。
Moreover, natural pigments containing at least one of crocetin, norbixin, and monoglycoside esters thereof can also be used as component (B). For example, gardenia yellow and saffron pigments are known to contain crocetin and crocetin-monogentiobioside ester, and gardenia yellow and / or saffron pigments are preferably used as component (B). be able to.
本発明製剤において、(B)成分として、クロセチン、ノルビキシン、及びこれらのモノグリコシドエステルの中から、1種を選択して使用してもよく、また2種以上を組み合せて使用してもよい。
In the preparation of the present invention, as component (B), one type may be selected from crocetin, norbixin, and monoglycoside esters thereof, or two or more types may be used in combination.
本発明製剤において、(B)成分の含有量については、前記脂溶性物質とミセルを形成できることを限度として特に制限されないが、例えば、前記(A)成分100重量部当たり、(B)成分が総量で0.0005~1000重量部、好ましくは0.001~500重量部、更に好ましくは0.002~200重量部が挙げられる。また、例えば、(B)成分の含有量として、前記(A)成分1g当たり、(B)成分が色価(E10%
1cm)5,000として0.5×10-5~10g、好ましくは0.1×10-4~5g、更に好ましくは0.2×10-4 ~2gが挙げられる。
In the preparation of the present invention, the content of the component (B) is not particularly limited as long as it can form micelles with the fat-soluble substance.For example, per 100 parts by weight of the component (A), the total amount of the component (B) 0.0005 to 1000 parts by weight, preferably 0.001 to 500 parts by weight, and more preferably 0.002 to 200 parts by weight. In addition, for example, the content of the component (B) is 0.5 × 10 −5 to 10 g as the color value (E 10% 1 cm 2 ) of 5,000 per 1 g of the component (A), preferably 5,000 Examples include 0.1 × 10 −4 to 5 g, and more preferably 0.2 × 10 −4 to 2 g.
(C)成分
本発明製剤は、前記(A)成分及び(B)成分に加えて、更に、クロセチンのジグリコシドエステル及び/又はノルビキシンのジグリコシドエステル(以下、「(C)成分」と表記することもある)を含んでいてもよい。前記(A)成分及び(B)成分と共に、(C)成分を含有することによって、脂溶性物質(特に、脂溶性カロテノイド)の安定性を格段に向上させることが可能になる。なお、後述する試験例2に示されているように、(C)成分は、水存在下では、前記(A)成分と(B)成分のミセルに会合せずに、水に可溶化された状態で存在して、脂溶性物質の安定性を向上させる役割を果たす。 (C) Component In addition to the above components (A) and (B), the preparation of the present invention further includes diglycoside ester of crocetin and / or diglycoside ester of norbixin (hereinafter referred to as “component (C)”. May be included). By containing the component (C) together with the components (A) and (B), the stability of the fat-soluble substance (particularly the fat-soluble carotenoid) can be remarkably improved. As shown in Test Example 2 described later, the component (C) was solubilized in water without being associated with the micelles of the components (A) and (B) in the presence of water. It exists in a state and plays the role which improves stability of a fat-soluble substance.
本発明製剤は、前記(A)成分及び(B)成分に加えて、更に、クロセチンのジグリコシドエステル及び/又はノルビキシンのジグリコシドエステル(以下、「(C)成分」と表記することもある)を含んでいてもよい。前記(A)成分及び(B)成分と共に、(C)成分を含有することによって、脂溶性物質(特に、脂溶性カロテノイド)の安定性を格段に向上させることが可能になる。なお、後述する試験例2に示されているように、(C)成分は、水存在下では、前記(A)成分と(B)成分のミセルに会合せずに、水に可溶化された状態で存在して、脂溶性物質の安定性を向上させる役割を果たす。 (C) Component In addition to the above components (A) and (B), the preparation of the present invention further includes diglycoside ester of crocetin and / or diglycoside ester of norbixin (hereinafter referred to as “component (C)”. May be included). By containing the component (C) together with the components (A) and (B), the stability of the fat-soluble substance (particularly the fat-soluble carotenoid) can be remarkably improved. As shown in Test Example 2 described later, the component (C) was solubilized in water without being associated with the micelles of the components (A) and (B) in the presence of water. It exists in a state and plays the role which improves stability of a fat-soluble substance.
クロセチンのジグリコシドエステル(即ち、クロセチン-ジグリコシドエステル)は、クロセチンの2つカルボキシル基のそれぞれに、糖がエステル結合にて結合した構造を有し、前記一般式(1)において、R1及びR2が糖残基である水溶性カロテノイドである。クロセチンのジグリコシドエステルに結合している糖の種類、好ましいもの、結合部位等については、前記クロセチンのモノグリコシドエステルの場合と同様である。また、クロセチンのジグリコシドエステルにおいて結合している2つの糖残基は、互いに同一であっても異なっていてもよい。クロセチンのジグリコシドエステルとして、好ましくは、クロセチンに2つの2糖類がエステル結合しているもの、クロセチンに単糖類と二糖類がそれぞれエステル結合しているもの、クロセチンに2つの単糖類がエステル結合しているもの;更に好ましくは、クロセチンに2つのゲンチオビオースがエステル結合しているもの(クロシン;クロセチン-ジゲンチオビオシドエステル)、クロセチンにゲンチオビオースとグルコースがエステル結合しているもの(クロセチン-モノゲンチオビオシド-モノグルコシドエステル)、クロセチンに2つのグルコースがエステル結合しているもの(クロセチン-ジグルコシドエステル);特に好ましくはクロシンが挙げられる。本発明で使用されるクロセチンのジグリコシドエステルは、シス-トランス異性体であってもよい。
The crocetin diglycoside ester (that is, crocetin-diglycoside ester) has a structure in which a sugar is bonded to each of two carboxyl groups of crocetin by an ester bond. In the general formula (1), R 1 and A water-soluble carotenoid in which R 2 is a sugar residue. The types of sugars bonded to the crocetin diglycoside ester, preferred ones, binding sites and the like are the same as those for the monoglycoside ester of crocetin. Also, the two sugar residues bonded in the crocetin diglycoside ester may be the same or different from each other. The diglycoside ester of crocetin is preferably one in which two disaccharides are ester-bonded to crocetin, one in which monosaccharide and disaccharide are each ester-bonded to crocetin, or two monosaccharides are ester-bonded to crocetin. More preferably, crocetin has two gentiobiose ester-linked (crocin; crocetin-digentiobioside ester), crocetin has gentiobiose and glucose ester-linked (crocetin-monogentiobio) Side-monoglucoside ester), crocetin in which two glucoses are ester-linked (crocetin-diglucoside ester); particularly preferably crocin. The crocetin diglycoside ester used in the present invention may be a cis-trans isomer.
ノルビキシンのジグリコシドエステル(即ち、ノルビキシン-ジグリコシドエステル)は、ノルビキシンの2つカルボキシル基のそれぞれに、糖がエステル結合にて結合した構造を有し、前記一般式(2)において、R3及びR4が糖残基である水溶性カロテノイドである。クロセチンのジグリコシドエステルに結合している糖の種類、好ましいもの、結合部位等については、前記クロセチンのモノグリコシドエステルの場合と同様である。また、ノルビキシンのジグリコシドエステルにおいて結合している2つの糖残基は、同一であっても異なってもよい。本発明で使用されるノルビキシンのジグリコシドエステルは、シス-トランス異性体であってもよい。
The diglycoside ester of norbixin (ie, norbixin-diglycoside ester) has a structure in which a sugar is bonded to each of two carboxyl groups of norbixin by an ester bond. In the general formula (2), R 3 and A water-soluble carotenoid in which R 4 is a sugar residue. The types of sugars bonded to the crocetin diglycoside ester, preferred ones, binding sites and the like are the same as those for the monoglycoside ester of crocetin. Further, the two sugar residues bonded in the diglycoside ester of norbixin may be the same or different. The diglycoside ester of norbixin used in the present invention may be a cis-trans isomer.
これらの(C)成分の中でも、脂溶性物質の安定性をより一層向上させるという観点から、好ましくはクロセチンのジグリコシドエステル、更に好ましくはクロシンが挙げられる。
Among these (C) components, crocetin diglycoside ester is preferable, and crocin is more preferable from the viewpoint of further improving the stability of the fat-soluble substance.
また、(C)成分として、クロセチンのジグリコシドエステル及び/又はノルビキシンのジグリコシドエステルを含む天然色素を使用することもできる。例えば、クチナシ黄色素及びサフラン色素には、前記(B)成分に加えてクロシンが含まれており、クチナシ黄色素及び/又はサフラン色素は、前記(B)成分と(C)成分の供給源になり、脂溶性カロテノイドに優れた脂溶性物質の乳化性と安定性との双方を備えさせ得るため、本発明の脂溶性カロテノイド水分散性製剤において好適に使用することができる。
In addition, natural pigments containing crocetin diglycoside ester and / or norbixin diglycoside ester can also be used as component (C). For example, gardenia yellow pigment and saffron pigment contain crocin in addition to the component (B), and gardenia yellow pigment and / or saffron pigment are used as the source of the components (B) and (C). Therefore, since both the emulsifiability and stability of the fat-soluble substance excellent in the fat-soluble carotenoid can be provided, it can be suitably used in the fat-soluble carotenoid water-dispersible preparation of the present invention.
本発明製剤において、(C)成分として、クロセチンのジグリコシドエステル及びノルビキシンのジグリコシドエステルの中から、1種を選択して使用してもよく、また2種以上を組み合せて使用してもよい。
In the preparation of the present invention, as the component (C), one kind may be selected from crocetin diglycoside ester and norbixin diglycoside ester, or two or more kinds may be used in combination. .
本発明製剤において、(C)成分の含有量については、特に制限されないが、例えば、前記(A)成分100重量部当たり、(C)成分が総量で0.0005~1000重量部、好ましくは0.001~500重量部、更に好ましくは0.002~200重量部が挙げられる。また、例えば、(C)成分の含有量として、前記(A)成分1g当たり、(C)成分が色価(E10%
1cm)5,000として0.5×10-5~10g、好ましくは0.1×10-4~5g、更に好ましくは0.2×10-4 ~2gが挙げられる。
In the preparation of the present invention, the content of the component (C) is not particularly limited. For example, the total amount of the component (C) is 0.0005 to 1000 parts by weight, preferably 0, per 100 parts by weight of the component (A). 0.001 to 500 parts by weight, more preferably 0.002 to 200 parts by weight. Further, for example, the content of the component (C) is 0.5 × 10 −5 to 10 g as the color value (E 10% 1 cm 2 ) of 5,000 per 1 g of the component (A), preferably 5,000 Examples include 0.1 × 10 −4 to 5 g, and more preferably 0.2 × 10 −4 to 2 g.
また、本発明製剤において、前記(B)成分及び(C)成分として、クチナシ黄色素及び/又はサフラン色素を使用する場合、当該クチナシ黄色素及び/又はサフラン色素の含有量として、前記(A)成分100重量部当たり、0.0005~1000重量部、好ましくは0.001~500重量部、更に好ましくは0.002~200重量部が挙げられる。また、例えば、前記(B)成分及び(C)成分として、クチナシ黄色素及び/又はサフラン色素を使用する場合、前記(A)成分1g当たり、クチナシ黄色素及び/又はサフラン色素が色価(E10%
1cm)5,000として0.5×10-5~10g、好ましくは0.1×10-4~5g、更に好ましくは0.2×10-4~2gが挙げられる。
Further, in the preparation of the present invention, when the gardenia yellow and / or saffron pigment is used as the component (B) and the component (C), the content of the gardenia yellow and / or saffron pigment is the above (A). The amount is 0.0005 to 1000 parts by weight, preferably 0.001 to 500 parts by weight, and more preferably 0.002 to 200 parts by weight per 100 parts by weight of the component. Further, for example, when gardenia yellow and / or saffron dye is used as the component (B) and component (C), the gardenia yellow and / or saffron dye has a color value (E) per 1 g of the component (A). 10% 1 cm ) 5,000 is 0.5 × 10 −5 to 10 g, preferably 0.1 × 10 −4 to 5 g, and more preferably 0.2 × 10 −4 to 2 g.
他の成分
本発明製剤は、前記成分以外に前記(A)成分及び(B)成分の分散媒として水を含有してもよい。また、本発明製剤には、本発明の効果を妨げない範囲で、必要に応じて、酸化防止剤、増粘剤、キレート剤、乳化助剤、低級アルコール、多価アルコール、pH調整剤、緩衝剤等の添加成分を含んでいてもよい。 Other Components The preparation of the present invention may contain water as a dispersion medium for the components (A) and (B) in addition to the components described above. In the preparation of the present invention, an antioxidant, a thickener, a chelating agent, an emulsifying aid, a lower alcohol, a polyhydric alcohol, a pH adjuster, a buffer are added as necessary, as long as the effects of the present invention are not hindered. An additive component such as an agent may be included.
本発明製剤は、前記成分以外に前記(A)成分及び(B)成分の分散媒として水を含有してもよい。また、本発明製剤には、本発明の効果を妨げない範囲で、必要に応じて、酸化防止剤、増粘剤、キレート剤、乳化助剤、低級アルコール、多価アルコール、pH調整剤、緩衝剤等の添加成分を含んでいてもよい。 Other Components The preparation of the present invention may contain water as a dispersion medium for the components (A) and (B) in addition to the components described above. In the preparation of the present invention, an antioxidant, a thickener, a chelating agent, an emulsifying aid, a lower alcohol, a polyhydric alcohol, a pH adjuster, a buffer are added as necessary, as long as the effects of the present invention are not hindered. An additive component such as an agent may be included.
また、本発明製剤は、界面活性剤や乳化剤を含まなくとも、脂溶性物質を水に安定に乳化させることができるが、必要に応じて、界面活性剤や乳化剤が含まれていてもよい。
In addition, the preparation of the present invention can stably emulsify a fat-soluble substance in water without containing a surfactant or an emulsifier, but may contain a surfactant or an emulsifier as necessary.
形態
本発明製剤は、(A)成分と(B)成分をミセル構成成分として含むことにより、水又は水を含む組成物に添加された際に脂溶性物質が良好な乳化性を示す製剤である。本発明製剤は、水を分散媒として含有しており、乳化状態になっている乳化製剤あってもよく、また水を含有しておらず、非乳化状態になっている自己乳化用製剤であってもよい。前記乳化製剤では、(A)成分と(B)成分がミセルを形成した状態で存在する。また、前記自己乳化用製剤は、(A)成分と(B)成分はミセルを形成していないが、水又は水を含む組成物に添加して混合すると、(A)成分と(B)成分のミセルが形成され、脂溶性物質を均一に乳化させることができる。 Form of the present invention preparation is a preparation in which the fat-soluble substance exhibits good emulsifiability when added to water or a composition containing water by including the component (A) and the component (B) as micelle constituents. . The preparation of the present invention may contain an emulsified preparation that contains water as a dispersion medium and is in an emulsified state, or is a self-emulsifying preparation that does not contain water and is in a non-emulsified state. May be. In the emulsified preparation, the component (A) and the component (B) are present in the form of micelles. Further, in the preparation for self-emulsification, the component (A) and the component (B) do not form micelles, but when added to and mixed with water or a composition containing water, the component (A) and the component (B) These micelles are formed, and the fat-soluble substance can be uniformly emulsified.
本発明製剤は、(A)成分と(B)成分をミセル構成成分として含むことにより、水又は水を含む組成物に添加された際に脂溶性物質が良好な乳化性を示す製剤である。本発明製剤は、水を分散媒として含有しており、乳化状態になっている乳化製剤あってもよく、また水を含有しておらず、非乳化状態になっている自己乳化用製剤であってもよい。前記乳化製剤では、(A)成分と(B)成分がミセルを形成した状態で存在する。また、前記自己乳化用製剤は、(A)成分と(B)成分はミセルを形成していないが、水又は水を含む組成物に添加して混合すると、(A)成分と(B)成分のミセルが形成され、脂溶性物質を均一に乳化させることができる。 Form of the present invention preparation is a preparation in which the fat-soluble substance exhibits good emulsifiability when added to water or a composition containing water by including the component (A) and the component (B) as micelle constituents. . The preparation of the present invention may contain an emulsified preparation that contains water as a dispersion medium and is in an emulsified state, or is a self-emulsifying preparation that does not contain water and is in a non-emulsified state. May be. In the emulsified preparation, the component (A) and the component (B) are present in the form of micelles. Further, in the preparation for self-emulsification, the component (A) and the component (B) do not form micelles, but when added to and mixed with water or a composition containing water, the component (A) and the component (B) These micelles are formed, and the fat-soluble substance can be uniformly emulsified.
本発明製剤が、乳化状態になっている乳化製剤である場合には、液状のみならず、ペースト状等の半固体状であってもよい。また、本発明製剤が、非乳化状態になっている自己乳化用製剤である場合には、その形態としては、粉末状、顆粒状等の固体状が挙げられる。
When the preparation of the present invention is an emulsified preparation in an emulsified state, it may be not only liquid but also semi-solid such as paste. Moreover, when this invention formulation is a formulation for self-emulsification in the non-emulsified state, solid forms, such as a powder form and a granular form, are mentioned as the form.
製造方法
本発明製剤が、(A)成分と(B)成分がミセルを形成して乳化状態になっている乳化製剤の場合であれば、水に、(A)成分、(B)成分、及び必要に応じて(C)成分、他の添加成分を添加し、混合することによって調製することができる。水存在下で、前記(A)成分及び(B)成分を添加してこれらを共存させて混合、乳化すると、(A)成分と(B)成分のミセルが形成され、脂溶性物質が水に均一に乳化した製剤になる。また、前記(C)成分は、乳化させる工程において、熱や物理的刺激を受けて一部が加水分解されて前記(B)成分に変換されることもあるので、前記(B)成分の代わりに前記(C)成分を原料として添加し、(A)成分との共存下で前記(C)成分の一部が加水分解するよう分散化又は乳化を行えば、前記(B)成分を添加せずとも、(A)成分と(B)成分のミセルを形成することができる。 Production method If the preparation of the present invention is an emulsion preparation in which the (A) component and the (B) component are in the emulsified state by forming micelles, the water, the (A) component, the (B) component, and It can be prepared by adding and mixing component (C) and other additive components as necessary. In the presence of water, when the components (A) and (B) are added and coexisted in the presence of water, they are mixed and emulsified to form micelles of the components (A) and (B). The preparation is uniformly emulsified. In addition, the component (C) may be partly hydrolyzed and converted into the component (B) by receiving heat or physical stimulation in the emulsifying step, so that the component (B) can be used instead of the component (B). When the component (C) is added as a raw material and dispersed or emulsified so that a part of the component (C) is hydrolyzed in the presence of the component (A), the component (B) is added. At least, micelles of component (A) and component (B) can be formed.
本発明製剤が、(A)成分と(B)成分がミセルを形成して乳化状態になっている乳化製剤の場合であれば、水に、(A)成分、(B)成分、及び必要に応じて(C)成分、他の添加成分を添加し、混合することによって調製することができる。水存在下で、前記(A)成分及び(B)成分を添加してこれらを共存させて混合、乳化すると、(A)成分と(B)成分のミセルが形成され、脂溶性物質が水に均一に乳化した製剤になる。また、前記(C)成分は、乳化させる工程において、熱や物理的刺激を受けて一部が加水分解されて前記(B)成分に変換されることもあるので、前記(B)成分の代わりに前記(C)成分を原料として添加し、(A)成分との共存下で前記(C)成分の一部が加水分解するよう分散化又は乳化を行えば、前記(B)成分を添加せずとも、(A)成分と(B)成分のミセルを形成することができる。 Production method If the preparation of the present invention is an emulsion preparation in which the (A) component and the (B) component are in the emulsified state by forming micelles, the water, the (A) component, the (B) component, and It can be prepared by adding and mixing component (C) and other additive components as necessary. In the presence of water, when the components (A) and (B) are added and coexisted in the presence of water, they are mixed and emulsified to form micelles of the components (A) and (B). The preparation is uniformly emulsified. In addition, the component (C) may be partly hydrolyzed and converted into the component (B) by receiving heat or physical stimulation in the emulsifying step, so that the component (B) can be used instead of the component (B). When the component (C) is added as a raw material and dispersed or emulsified so that a part of the component (C) is hydrolyzed in the presence of the component (A), the component (B) is added. At least, micelles of component (A) and component (B) can be formed.
(A)成分が界面活性剤や乳化剤等でミセルを形成している状態で(B)成分と共存させると、(A)成分と(B)成分のミセル)が形成されなかったり、当該ミセルが形成されるまでに時間を要したりする場合があるため、(A)成分と(B)成分のミセル形成を促進させるという観点から、本発明製剤の製造時に、水中で(A)成分と(B)成分を共存させる際には、(A)成分は界面活性剤や乳化剤等でミセルを形成していない状態にしておくことが望ましい。
If component (A) is co-existing with component (B) while forming micelles with a surfactant, emulsifier, etc., micelles of component (A) and component (B) may not be formed, Since it may take time to form, from the viewpoint of promoting micelle formation of the component (A) and the component (B), at the time of producing the preparation of the present invention, the component (A) and ( When the component (B) is allowed to coexist, it is desirable that the component (A) is kept in a state in which micelles are not formed with a surfactant or an emulsifier.
また、本発明製剤が(A)成分と(B)成分がミセルを形成していない自己乳化用製剤の場合であれば、半固体状又は固体状の場合であれば、前記方法で乳化製剤を製造した後に、水を除去し、必要に応じて、粉末状、顆粒状等の固体状にする成型処理に供することによって調製することができる。また、自己乳化用製剤の場合であれば、単に、(A)成分、(B)成分、及び必要に応じて(C)成分、他の添加成分を添加し、混合することによっても調製することができる。
Further, if the preparation of the present invention is a preparation for self-emulsification in which the component (A) and the component (B) do not form micelles, if the preparation is a semi-solid or solid form, the emulsion preparation is prepared by the above method. After the production, it can be prepared by removing the water and subjecting it to a molding treatment such as powder or granule, if necessary. In the case of a self-emulsifying preparation, it should also be prepared by simply adding (A) component, (B) component, and (C) component, if necessary, other additive components and mixing. Can do.
用途
本発明製剤は、脂溶性物質を供給するための添加剤として、飲食品、化粧料、医薬品等の各種製品に添加して使用される。特に、脂溶性物質として脂溶性カロテノイドを使用している場合には、本発明製剤は、色素製剤(着色料)として、飲食品、化粧料、医薬品等の各種製品に添加して使用される。また、本発明製剤は、脂溶性物質を安定に乳化できるので、吸収性が高められた脂溶性物質の供給源として、前記各種製品に使用することができる。更に、前記(A)成分として生理機能を有する脂溶性物質(例えば、アスタキサンチン、フコキサンチン等の脂溶性カロテノイド)を使用する場合には、本発明製剤は、当該生理機能性の付与の目的で、機能性添加剤として、食品、化粧料、医薬品等の各種に添加して使用することもできる。 Application The preparation of the present invention is used as an additive for supplying a fat-soluble substance to various products such as foods and drinks, cosmetics and pharmaceuticals. In particular, when a fat-soluble carotenoid is used as the fat-soluble substance, the preparation of the present invention is used as a pigment preparation (coloring agent) added to various products such as foods and drinks, cosmetics and pharmaceuticals. Moreover, since this invention formulation can emulsify a fat-soluble substance stably, it can be used for the said various products as a supply source of the fat-soluble substance whose absorbency was improved. Furthermore, when using a fat-soluble substance having a physiological function as the component (A) (for example, a fat-soluble carotenoid such as astaxanthin or fucoxanthin), the preparation of the present invention is used for the purpose of imparting the physiological function. As a functional additive, it can also be used by adding to various foods, cosmetics, pharmaceuticals and the like.
本発明製剤は、脂溶性物質を供給するための添加剤として、飲食品、化粧料、医薬品等の各種製品に添加して使用される。特に、脂溶性物質として脂溶性カロテノイドを使用している場合には、本発明製剤は、色素製剤(着色料)として、飲食品、化粧料、医薬品等の各種製品に添加して使用される。また、本発明製剤は、脂溶性物質を安定に乳化できるので、吸収性が高められた脂溶性物質の供給源として、前記各種製品に使用することができる。更に、前記(A)成分として生理機能を有する脂溶性物質(例えば、アスタキサンチン、フコキサンチン等の脂溶性カロテノイド)を使用する場合には、本発明製剤は、当該生理機能性の付与の目的で、機能性添加剤として、食品、化粧料、医薬品等の各種に添加して使用することもできる。 Application The preparation of the present invention is used as an additive for supplying a fat-soluble substance to various products such as foods and drinks, cosmetics and pharmaceuticals. In particular, when a fat-soluble carotenoid is used as the fat-soluble substance, the preparation of the present invention is used as a pigment preparation (coloring agent) added to various products such as foods and drinks, cosmetics and pharmaceuticals. Moreover, since this invention formulation can emulsify a fat-soluble substance stably, it can be used for the said various products as a supply source of the fat-soluble substance whose absorbency was improved. Furthermore, when using a fat-soluble substance having a physiological function as the component (A) (for example, a fat-soluble carotenoid such as astaxanthin or fucoxanthin), the preparation of the present invention is used for the purpose of imparting the physiological function. As a functional additive, it can also be used by adding to various foods, cosmetics, pharmaceuticals and the like.
本発明製剤は、脂溶性物質の乳化性が向上しているため、添加対象となる製品は水を含むものであることが好ましいが、水を含まない製品も添加対象とすることができる。例えば、製造工程において混合される際は水と共存するが、乾燥処理等によって最終的に水が除去される製品については、製造工程において脂溶性物質の乳化性が向上していることが求められるため、本発明製剤を好適に使用することができる。更に、前述するように、本発明製剤は、吸収性が高められた脂溶性物質の供給源としても使用できるため、添加対象となる製品に水が含まれていなくても、当該製品への脂溶性物質による生理機能性の付与の目的で使用することができる。
In the preparation of the present invention, since the emulsifiability of the fat-soluble substance is improved, the product to be added preferably contains water, but a product not containing water can also be added. For example, products that coexist with water when mixed in the manufacturing process but are finally removed by drying or the like are required to have improved emulsifiability of the fat-soluble substance in the manufacturing process. Therefore, the preparation of the present invention can be preferably used. Furthermore, as described above, the preparation of the present invention can also be used as a source of a fat-soluble substance with enhanced absorbability. Therefore, even if water is not contained in the product to be added, the fat to the product is added. It can be used for the purpose of imparting physiological functionality with a soluble substance.
2.ハイドロゲル
本発明のハイドロゲルは、前記(A)成分と(B)成分を含むミセル、及びゲル化剤を含有することを特徴とする。ハイドロゲル中で、(A)成分及び(B)成分を共存させてこれらのミセルを形成することにより、ハイドロゲル内での脂溶性物質の乳化性が向上し、ハイドロゲルが均一に着色される。 2. Hydrogel The hydrogel of the present invention is characterized by containing a micelle containing the components (A) and (B) and a gelling agent. By forming these micelles by coexisting components (A) and (B) in the hydrogel, the emulsifiability of the fat-soluble substance in the hydrogel is improved and the hydrogel is uniformly colored. .
本発明のハイドロゲルは、前記(A)成分と(B)成分を含むミセル、及びゲル化剤を含有することを特徴とする。ハイドロゲル中で、(A)成分及び(B)成分を共存させてこれらのミセルを形成することにより、ハイドロゲル内での脂溶性物質の乳化性が向上し、ハイドロゲルが均一に着色される。 2. Hydrogel The hydrogel of the present invention is characterized by containing a micelle containing the components (A) and (B) and a gelling agent. By forming these micelles by coexisting components (A) and (B) in the hydrogel, the emulsifiability of the fat-soluble substance in the hydrogel is improved and the hydrogel is uniformly colored. .
本発明のハイドロゲルに使用される(A)成分及び(B)成分の種類、これらの比率等については、前記「1.脂溶性物質の乳化性製剤」の場合と同様である。
The types of component (A) and component (B) used in the hydrogel of the present invention, the ratio thereof, and the like are the same as in the case of “1. Emulsifiable preparation of fat-soluble substance”.
本発明のハイドロゲルにおいて、前記(A)成分と(B)成分のミセルの含有量については、使用する(A)成分の種類、ハイドロゲルの着色の程度、ハイドロゲルに備えさせる機能性等に応じて適宜設定すればよいが、例えば、前記(A)成分の含有量に換算して、0.00001~50重量%、好ましくは0.00005~45重量%、更に好ましくは0.0001~40重量%が挙げられる。
In the hydrogel of the present invention, the content of the micelles of the component (A) and the component (B), the type of the component (A) to be used, the degree of coloring of the hydrogel, the functionality provided for the hydrogel, etc. Depending on the content of the component (A), for example, it may be 0.00001 to 50% by weight, preferably 0.00005 to 45% by weight, and more preferably 0.0001 to 40%. % By weight.
また、本発明のハイドロゲルには、前記(C)成分が含まれていてもよい。(C)成分を含有することにより、ハイドロゲル内の脂溶性カロテノイドの安定性を向上させることが可能になる。本発明のハイドロゲルに使用される(C)成分の種類、(A)成分に対する(C)成分の比率等については、前記「1.脂溶性物質の乳化性製剤」の場合と同様である。
The hydrogel of the present invention may contain the component (C). By containing the component (C), it becomes possible to improve the stability of the fat-soluble carotenoid in the hydrogel. The type of the component (C) used in the hydrogel of the present invention, the ratio of the component (C) to the component (A), and the like are the same as in the case of “1. Emulsifiable preparation of fat-soluble substance”.
本発明のハイドロゲルに含まれるゲル化剤の種類については、特に制限されず、当該ハイドロゲルの用途に応じて、可食できるもの、香粧学的に許容されるもの、薬学的に許容されるもの等を適宜選択すればよい。ゲル化剤として、具体的には、カラギーナン、ジェランガム、ローカストビーンガム、ペクチン、アルギン酸ナトリウム、ゼラチン、トラガント、寒天、キサンタン、アラビアゴム、グアガム、タマリンドガム、澱粉、デキストリン、セルロース、カードラン、プルラン、グアガム誘導体、セルロース誘導体、βグルカン、サイリウムシードガム、ミクロゲル、カルボマー、PVP、PVA、シリカ、ベントナイト、デキストリン酸脂肪エステル、イヌリン酸脂肪エステル、シリコーン系増粘ゲル化剤、ポリアミド樹脂、アミノ酸系ゲル化剤、耐塩性増粘剤等が挙げられる。これらのゲル化剤は、1種単独で使用してもよく、また2種以上を組み合わせて使用してもよい。
The type of gelling agent contained in the hydrogel of the present invention is not particularly limited, and can be edible, cosmetically acceptable, or pharmaceutically acceptable depending on the use of the hydrogel. What is necessary is just to select suitably. Specific examples of gelling agents include carrageenan, gellan gum, locust bean gum, pectin, sodium alginate, gelatin, tragacanth, agar, xanthan, gum arabic, guar gum, tamarind gum, starch, dextrin, cellulose, curdlan, pullulan, Guar gum derivative, cellulose derivative, β-glucan, psyllium seed gum, microgel, carbomer, PVP, PVA, silica, bentonite, dextrin fatty acid ester, inulin fatty acid ester, silicone-based thickening gelling agent, polyamide resin, amino acid-based gelation Agents, salt-resistant thickeners and the like. These gelling agents may be used individually by 1 type, and may be used in combination of 2 or more type.
本発明のハイドロゲルにおいて、ゲル化剤の含有量については、使用するゲル化剤の種類、付与すべきゲル強度や流動性等に応じて適宜設定すればよいが、例えば、0.0001~98重量%、好ましくは0.0005~97重量%、更に好ましくは0.001~95重量%が挙げられる。
In the hydrogel of the present invention, the content of the gelling agent may be appropriately set according to the type of gelling agent to be used, the gel strength to be imparted, fluidity, and the like. For example, 0.0001 to 98 % By weight, preferably 0.0005 to 97% by weight, more preferably 0.001 to 95% by weight.
本発明のハイドロゲルには、前記成分の他に、当該ハイドロゲルの用途に応じて、甘味料、果汁、香料、酸化防止剤、pH調整剤、薬理成分、保湿成分、美白成分等が含まれていてもよい。
In addition to the above components, the hydrogel of the present invention includes sweeteners, fruit juices, fragrances, antioxidants, pH adjusters, pharmacological ingredients, moisturizing ingredients, whitening ingredients, etc., depending on the use of the hydrogel. It may be.
本発明のハイドロゲルの製造方法としては、ハイドロゲル内で前記(A)成分と(B)成分が共存してそれらがミセルを形成している限り特に制限されない。本発明のハイドロゲルの製造方法としては、好ましくは、ゲル化剤を溶解させた水と、前記本発明製剤と、必要に応じて他の添加成分を混合した後に、ゲル化させる方法が挙げられる。但し、前記本発明製剤を使用せずに、ゲル化剤を溶解させた水と、(A)成分、(B)成分、及び必要に応じて(C)成分、他の添加成分を混合した後にゲル化させる方法であっても、本発明のハイドロゲルを得ることができる。なお、前述するように、(A)成分が界面活性剤や乳化剤等でミセルを形成している状態で(B)成分と共存させると、(A)成分と(B)成分のミセルが形成されなかったり、当該ミセルが形成されるまでに時間を要したりすることがあるため、前記本発明製剤を使用せずに本発明のハイドロゲルを製造する場合には、水中で(A)成分と(B)成分を共存させる際に、(A)成分は界面活性剤や乳化剤等でミセルを形成していない状態にしておくことが望ましい。
The method for producing the hydrogel of the present invention is not particularly limited as long as the component (A) and the component (B) coexist in the hydrogel and form micelles. The method for producing the hydrogel of the present invention preferably includes a method of gelling after mixing water in which a gelling agent is dissolved, the preparation of the present invention, and other additive components as necessary. . However, without using the preparation of the present invention, after mixing the water in which the gelling agent is dissolved, the component (A), the component (B), and the component (C), if necessary, other additive components Even if it is the method of making it gelatinize, the hydrogel of this invention can be obtained. As described above, when the component (A) coexists with the component (B) in the state where the component is formed with a surfactant or an emulsifier, micelles of the component (A) and the component (B) are formed. Or when it takes time until the micelles are formed, when the hydrogel of the present invention is produced without using the preparation of the present invention, the component (A) When the component (B) is allowed to coexist, it is desirable that the component (A) is kept in a state in which micelles are not formed with a surfactant or an emulsifier.
本発明のハイドロゲルは、脂溶性物質が均一に乳化しており、優れた外観性状を備え、更に当該脂溶性物質(特に、脂溶性カロテノイド)の吸収性も高められているので、飲食品、化粧料、医薬品等の分野で使用することができる。例えば、本発明のハイドロゲルを利用した製品としては、飲食品分野であれば、ゼリー、ハイドロゲルを配合した飲料、ハイドロゲルを配合したヨーグルト等が挙げられる。また、化粧料分野であれば、ゲル状の化粧料、シート状のパック化粧料等が挙げられる。更に、医薬品の分野であれば、シート状の貼付剤等が挙げられる。
In the hydrogel of the present invention, the fat-soluble substance is uniformly emulsified, has an excellent appearance, and further has improved absorbability of the fat-soluble substance (particularly the fat-soluble carotenoid). It can be used in fields such as cosmetics and pharmaceuticals. For example, as a product using the hydrogel of the present invention, in the food and beverage field, jelly, a beverage blended with hydrogel, yogurt blended with hydrogel, and the like can be mentioned. In the cosmetic field, gel-like cosmetics, sheet-like pack cosmetics, and the like can be given. Furthermore, in the field of pharmaceuticals, sheet-like patches and the like can be mentioned.
3.飲食品、化粧料、医薬品
本発明の飲食品、化粧料、及び医薬品は、前記(A)成分と(B)成分を含むミセル又は当該ミセルの乾燥物を含有することを特徴とする。本発明の飲食品、化粧料、及び医薬品には、前記ハイドロゲル又はそれを含む形態ものの他、ハイドロゲルを含まない形態も包含される。飲食品、化粧料、及び医薬品中で、前記(A)成分と(B)成分含むミセル又は当該ミセルの乾燥物を含有させることにより、これらの製品全体又は所定部位において脂溶性物質が均一に分散しており、優れた外観性状を備えることができる。また、本発明の飲食品、化粧料、及び医薬品では、脂溶性物質(特に、脂溶性カロテノイド)の吸収性が向上しているので、当該脂溶性物質が有する機能性を効果的に享受させることもできる。 3. Food / beverage products, cosmetics, pharmaceuticals The food / beverage products, cosmetics, and pharmaceutical products of the present invention are characterized by containing micelles containing the component (A) and the component (B) or a dried product of the micelles. The food / beverage products, cosmetics and pharmaceuticals of the present invention include the hydrogel or a form containing it, as well as a form not containing hydrogel. In foods, beverages, cosmetics, and pharmaceuticals, fat-soluble substances are uniformly dispersed in the whole product or a predetermined part by including the micelle containing the component (A) and the component (B) or the dried product of the micelle. And can have excellent appearance properties. Moreover, in the food / beverage products, cosmetics, and pharmaceuticals of the present invention, the absorbability of fat-soluble substances (particularly fat-soluble carotenoids) is improved, so that the functionality of the fat-soluble substances can be effectively enjoyed. You can also.
本発明の飲食品、化粧料、及び医薬品は、前記(A)成分と(B)成分を含むミセル又は当該ミセルの乾燥物を含有することを特徴とする。本発明の飲食品、化粧料、及び医薬品には、前記ハイドロゲル又はそれを含む形態ものの他、ハイドロゲルを含まない形態も包含される。飲食品、化粧料、及び医薬品中で、前記(A)成分と(B)成分含むミセル又は当該ミセルの乾燥物を含有させることにより、これらの製品全体又は所定部位において脂溶性物質が均一に分散しており、優れた外観性状を備えることができる。また、本発明の飲食品、化粧料、及び医薬品では、脂溶性物質(特に、脂溶性カロテノイド)の吸収性が向上しているので、当該脂溶性物質が有する機能性を効果的に享受させることもできる。 3. Food / beverage products, cosmetics, pharmaceuticals The food / beverage products, cosmetics, and pharmaceutical products of the present invention are characterized by containing micelles containing the component (A) and the component (B) or a dried product of the micelles. The food / beverage products, cosmetics and pharmaceuticals of the present invention include the hydrogel or a form containing it, as well as a form not containing hydrogel. In foods, beverages, cosmetics, and pharmaceuticals, fat-soluble substances are uniformly dispersed in the whole product or a predetermined part by including the micelle containing the component (A) and the component (B) or the dried product of the micelle. And can have excellent appearance properties. Moreover, in the food / beverage products, cosmetics, and pharmaceuticals of the present invention, the absorbability of fat-soluble substances (particularly fat-soluble carotenoids) is improved, so that the functionality of the fat-soluble substances can be effectively enjoyed. You can also.
本発明の飲食品、化粧料、及び医薬品に使用される(A)成分及び(B)成分の種類、これらの比率等については、前記「1.脂溶性物質の乳化性製剤」の場合と同様である。
The types of component (A) and component (B) used in the food and drink, cosmetics and pharmaceuticals of the present invention, the ratio thereof, and the like are the same as in the case of “1. Emulsifiable preparation of fat-soluble substance”. It is.
本発明の飲食品、化粧料、及び医薬品において、前記(A)成分と(B)成分を含むミセル又は当該ミセルの乾燥物の含有量については、使用する(A)成分の種類、ハイドロゲルの着色の程度、ハイドロゲルに備えさせる機能性等に応じて適宜設定すればよいが、例えば、前記(A)成分の含有量に換算して、0.00001~50重量%、好ましくは0.00005~45重量%、更に好ましくは0.0001~40重量%が挙げられる。
In the food and drink, cosmetics and pharmaceuticals of the present invention, the content of the micelle containing the component (A) and the component (B) or the dried product of the micelle, the type of the component (A) to be used, the hydrogel Although it may be set as appropriate according to the degree of coloring, the functionality to be provided to the hydrogel, etc., for example, it is 0.00001 to 50% by weight, preferably 0.00005 in terms of the content of the component (A). To 45% by weight, more preferably 0.0001 to 40% by weight.
また、本発明の飲食品、化粧料、及び医薬品には、前記(C)成分が含まれていてもよい。(C)成分を含有することにより、脂溶性物質の安定性を向上させることが可能になる。本発明の飲食品、化粧料、及び医薬品に使用される(C)成分の種類、(A)成分に対する(C)成分の比率等については、前記「1.脂溶性物質の乳化性製剤」の場合と同様である。
The food / beverage products, cosmetics, and pharmaceuticals of the present invention may contain the component (C). By containing the component (C), the stability of the fat-soluble substance can be improved. About the kind of (C) component used for the food / beverage products, cosmetics, and pharmaceuticals of this invention, the ratio of (C) component with respect to (A) component, etc., said "1. Emulsifiable preparation of fat-soluble substance". Same as the case.
本発明の飲食品、化粧料、及び医薬品の製造方法としては、飲食品、化粧料、及び医薬品の内で、前記(A)成分と(B)成分を含むミセル又は当該ミセルの乾燥物を含有させ得る限り特に制限されない。本発明の飲食品、化粧料、及び医薬品の製造方法として、好ましくは、飲食品、化粧料、及び医薬品の原料に、前記本発明製剤を混合し、所望の形態に加工する方法が挙げられる。但し、水存在下で、飲食品、化粧料、及び医薬品の原料と、(A)成分、(B)成分、及び必要に応じて(C)成分を混合し、所望の形態に加工する方法であっても、前記(A)成分と(B)成分のミセルが形成され得るので、前記本発明製剤を使用せずに、本発明の飲食品、化粧料、及び医薬品を製造することも可能である。なお、前述するように、(A)成分が界面活性剤や乳化剤等でミセルを形成している状態で(B)成分と共存させると、(A)成分と(B)成分のミセルが形成されなかったり、当該ミセルが形成されるまでに時間を要したりすることがあるため、前記本発明製剤を使用せずに本発明の飲食品、化粧料、及び医薬品を製造する場合には、水中で(A)成分と(B)成分を共存させる際に、(A)成分は界面活性剤や乳化剤等でミセルを形成していない状態にしておくことが望ましい。
As a method for producing foods and beverages, cosmetics and pharmaceuticals of the present invention, among the foods and beverages, cosmetics and pharmaceuticals, the micelle containing the component (A) and the component (B) or a dried product of the micelles is contained. It is not particularly limited as long as it can be made. The method for producing the food / beverage products, cosmetics and pharmaceuticals of the present invention preferably includes a method of mixing the above-mentioned preparation of the present invention into the raw materials of the food / beverage products, cosmetics and pharmaceuticals and processing them into a desired form. However, in the presence of water, it is a method of mixing raw materials for foods and drinks, cosmetics, and pharmaceuticals with (A) component, (B) component, and (C) component as necessary, and processing it into the desired form. Even so, since the micelles of the component (A) and the component (B) can be formed, it is also possible to produce the food, drink, cosmetics and pharmaceuticals of the present invention without using the preparation of the present invention. is there. As described above, when the component (A) coexists with the component (B) in the state where the component is formed with a surfactant or an emulsifier, micelles of the component (A) and the component (B) are formed. Or when it is necessary to produce the micelles, it takes time to form the micelles. When the components (A) and (B) are allowed to coexist, it is desirable that the component (A) is kept in a state where micelles are not formed with a surfactant, an emulsifier or the like.
前記(A)成分と(B)成分は、水存在下で共存することによってミセルを形成し、乳化性が向上するので飲食品、化粧料、及び医薬品の原料に(A)成分と(B)成分を含むミセルを一旦分散させた後には、乾燥等によって水を除去しても、脂溶性物質はミセルの乾燥物となって均一に分散した状態は維持される。従って、本発明の飲食品、化粧料、及び医薬品は、液状、ハイドロゲル状、ペースト状等の水を含有する形態に限らず、(A)成分と(B)成分を含むミセルの乾燥物を含む固体状であってもよい。
The (A) component and the (B) component form micelles by coexisting in the presence of water, and the emulsifiability is improved, so the ingredients (A) and (B) in the raw materials for food and drink, cosmetics, and pharmaceuticals After the micelles containing the components are once dispersed, even if water is removed by drying or the like, the fat-soluble substance becomes a dried product of micelles and maintains a uniformly dispersed state. Therefore, the food and drink, cosmetics, and pharmaceuticals of the present invention are not limited to forms containing water such as liquid, hydrogel, paste, etc., but dry micelles containing the components (A) and (B). It may be in a solid state.
本発明の飲食品の形態としては、特に制限されないが、前述するハイドロゲルを含む飲食品以外では、例えば、錠剤、顆粒剤、粉剤、カプセル剤、ソフトカプセル剤等のサプリメント;タレ類(焼肉のタレ、焼き鳥のタレ、蒲焼きのタレ、餃子のタレ、団子のタレ等)、ソース類(とんかつソース、カレーソース、ホワイトソース、デミグラスソース、トマトソース、エビチリソース等)、スープ類(キムチ鍋スープ、ラーメンスープ、コンソメスープ、ポタージュスープ、クラムチャウダー等)の液状調味料、及びこれらの液状調味料を用いた加工食品;ヨーグルト、チーズ等の乳製品;イチゴジャム、リンゴジャム、ブルーベリージャム、マーマレード等のジャム類;ハム、ソーセージ、焼き豚等の畜肉加工品;魚肉ソーセージ、魚肉ハム、魚肉すり身、蒲鉾、竹輪、はんぺん、薩摩揚げ等の水産練り製品;塩漬け、味噌漬け、粕漬け、麹漬け、浅漬け、糠漬け、酢漬け、もろみ漬け、梅漬け、福神漬、しば漬等の漬物類;うどん、ソバ、冷麦、そうめん、中華そば、スパゲッティ、マカロニ、ビーフン、はるさめ等の麺類;ガム、チョコレート、ソフトキャンディー、ハードキャンディー、ビスケット、クッキー、クラッカー、おかき、煎餅、膨化スナック等の菓子類;アイスクリーム、ソフトクリーム、シャーベット、氷菓等の冷菓類;清涼飲料、乳飲料、乳酸菌飲料、炭酸飲料、果汁飲料、野菜飲料、野菜・果実飲料、粉末飲料、ゼリー飲料、コーヒー飲料、紅茶飲料、緑茶飲料、スポーツ飲料、栄養飲料、エナジードリンク、アルコール飲料、ノンアルコール飲料等の飲料類等が挙げられる
Although it does not restrict | limit especially as a form of the food / beverage products of this invention, For example, supplements, such as a tablet, a granule, a powder agent, a capsule, a soft capsule, etc .; , Yakitori sauce, salmon grilled sauce, dumpling sauce, dumpling sauce, sauces (tonkatsu sauce, curry sauce, white sauce, demiglace sauce, tomato sauce, shrimp sauce, etc.), soups (kimchi hot pot soup, ramen soup) , Consommé soup, potage soup, clam chowder, etc.) and processed foods using these liquid seasonings; dairy products such as yogurt and cheese; jams such as strawberry jam, apple jam, blueberry jam and marmalade ; Processed meat products such as ham, sausage, grilled pork; Fish sausage, fish meat Fish, fish paste, salmon, bamboo rings, hampen, fried satsuma, and other marine products; salted, miso pickled, pickled in salmon, pickled in pickles, shallow pickled, pickled in pickles, pickled in vinegar, pickled in moromi, pickled in plums, Fukujin pickled, shiba pickled, etc .; Noodles such as udon, buckwheat, cold wheat, somen, Chinese noodles, spaghetti, macaroni, rice noodles, harusame; sweets such as gum, chocolate, soft candy, hard candy, biscuits, cookies, crackers, rice crackers, rice crackers, swollen snacks; ice Frozen confectionery such as cream, soft cream, sherbet, ice confectionery; soft drink, milk drink, lactic acid bacteria drink, carbonated drink, fruit juice drink, vegetable drink, vegetable / fruit drink, powdered drink, jelly drink, coffee drink, tea drink, green tea drink , Sports drinks, nutrition drinks, energy drinks, alcoholic drinks, non-alcoholic drinks, etc. And the like beverages, etc.
また、本発明の化粧料の形態としては、特に制限されないが、例えば、乳液、クリーム、化粧水(ローション)、パック、美容液、皮膚洗浄剤、メーキャップ化粧料等が挙げられる。
The form of the cosmetic of the present invention is not particularly limited, and examples thereof include emulsions, creams, lotions, packs, cosmetic liquids, skin cleansing agents, makeup cosmetics, and the like.
また、本発明の医薬品の形態としては、特に制限されないが、例えば、錠剤、顆粒剤、粉剤、カプセル剤、ソフトカプセル剤、シロップ剤等の内服用製剤;外用剤、吸入剤、坐剤等の経皮又は経粘膜用製剤;注射剤等が挙げられる。
Further, the form of the pharmaceutical product of the present invention is not particularly limited, but for example, preparations for internal use such as tablets, granules, powders, capsules, soft capsules, syrups, etc .; external preparations, inhalants, suppositories, etc. Skin or transmucosal preparations; injections and the like.
4.脂溶性カロテノイドの乳化性向上剤・吸収性向上剤
前述するように、前記(B)成分は、水存在下で脂溶性物質会合してミセルを形成し、脂溶性物質の乳化性や吸収性を向上させるため、脂溶性物質の乳化性向上剤、又は脂溶性物質の吸収性向上剤として使用することもできる。 4). Fat-soluble carotenoid emulsifier / absorptive improver As described above, the component (B) associates with a fat-soluble substance in the presence of water to form micelles, thereby improving the emulsifiability and absorbability of the fat-soluble substance. In order to improve, it can also be used as an emulsification improver of a fat-soluble substance or an absorbency improver of a fat-soluble substance.
前述するように、前記(B)成分は、水存在下で脂溶性物質会合してミセルを形成し、脂溶性物質の乳化性や吸収性を向上させるため、脂溶性物質の乳化性向上剤、又は脂溶性物質の吸収性向上剤として使用することもできる。 4). Fat-soluble carotenoid emulsifier / absorptive improver As described above, the component (B) associates with a fat-soluble substance in the presence of water to form micelles, thereby improving the emulsifiability and absorbability of the fat-soluble substance. In order to improve, it can also be used as an emulsification improver of a fat-soluble substance or an absorbency improver of a fat-soluble substance.
本発明の脂溶性物質の乳化性向上剤、及び脂溶性物質の吸収性向上剤は、水と脂溶性物質を含む各種製品に添加して、脂溶性カロテノイドの乳化性又は吸収性を向上させる目的で使用される。本発明の脂溶性物質の乳化性向上剤、及び脂溶性物質の吸収性向上剤の適用対象となる製品としては、水と脂溶性物質を含んでいることを限度として特に制限されないが、具体的には、脂溶性カロテノイドを含有する色素製剤、飲食品原料、化粧料原料、医薬品原料等が挙げられる。また、本発明の脂溶性物質の乳化性向上剤、及び脂溶性物質の吸収性向上剤は、例えば飲食品分野で適用する場合には、脂溶性物質の乳化性の向上用の飲食品添加剤、又は脂溶性物質の吸収性向上用の飲食品添加剤として使用される。
The fat-soluble substance emulsification improver and the fat-soluble substance absorbability improver of the present invention are added to various products containing water and a fat-soluble substance to improve the emulsifiability or absorbability of the fat-soluble carotenoid. Used in. The product to which the emulsifiability improver of the fat-soluble substance and the absorbency improver of the fat-soluble substance of the present invention are applied is not particularly limited as long as it contains water and the fat-soluble substance. Examples include pigment preparations containing fat-soluble carotenoids, raw materials for foods and drinks, raw materials for cosmetics, and raw materials for pharmaceuticals. In addition, the fat-soluble substance emulsification improver and the fat-soluble substance absorbability improver of the present invention, for example, when applied in the food and drink field, are food and drink additives for improving the emulsifiability of the fat-soluble substance. Or, it is used as a food or drink additive for improving the absorption of fat-soluble substances.
脂溶性物質の乳化性向上剤、及び脂溶性物質の吸収性向上剤において、使用される(B)成分の種類、適用対象となる脂溶性物質の種類、使用態様等については、前記の通りである。
In the emulsifiability improver of the fat-soluble substance and the absorbency improver of the fat-soluble substance, the type of the component (B) used, the type of the fat-soluble substance to be applied, the use mode, etc. are as described above. is there.
以下、実施例を挙げて本発明を更に詳細に説明するが、本発明はこれらの実施例に限定されるものではない。
Hereinafter, the present invention will be described in more detail with reference to examples, but the present invention is not limited to these examples.
試験例1:脂溶性カロテノイドの水分散の評価
(1)クロセチン-モノゲンチオビオシドエステル、クロセチン、及びノルビキシンによる脂溶性カロテノイドの乳化
脂溶性カロテノイドを含むパプリカオレオレジン0.1gを水20g中に添加し、攪拌したところ、パプリカオレオレジンと水は完全に分離状態にあり、混ざり合わなかった。なお、パプリカオレオレジンは、パプリカまたはトウガラシから抽出した脂溶性物質であり、カプサンチン、β-クリプトキサンチン、β-カロテン、ゼアキサンチン、カプソルビン等の脂溶性カロテノイドが10重量%程度含有されている。 Test Example 1: Evaluation of aqueous dispersion of fat-soluble carotenoid
(1) Emulsification of fat-soluble carotenoid with crocetin-monogenthiobioside ester, crocetin, and norbixin 0.1 g of paprika oleoresin containing fat-soluble carotenoid was added to 20 g of water and stirred. It was completely separated and did not mix. Paprika oleoresin is a fat-soluble substance extracted from paprika or capsicum, and contains about 10% by weight of fat-soluble carotenoids such as capsanthin, β-cryptoxanthin, β-carotene, zeaxanthin, capsorbine.
(1)クロセチン-モノゲンチオビオシドエステル、クロセチン、及びノルビキシンによる脂溶性カロテノイドの乳化
脂溶性カロテノイドを含むパプリカオレオレジン0.1gを水20g中に添加し、攪拌したところ、パプリカオレオレジンと水は完全に分離状態にあり、混ざり合わなかった。なお、パプリカオレオレジンは、パプリカまたはトウガラシから抽出した脂溶性物質であり、カプサンチン、β-クリプトキサンチン、β-カロテン、ゼアキサンチン、カプソルビン等の脂溶性カロテノイドが10重量%程度含有されている。 Test Example 1: Evaluation of aqueous dispersion of fat-soluble carotenoid
(1) Emulsification of fat-soluble carotenoid with crocetin-monogenthiobioside ester, crocetin, and norbixin 0.1 g of paprika oleoresin containing fat-soluble carotenoid was added to 20 g of water and stirred. It was completely separated and did not mix. Paprika oleoresin is a fat-soluble substance extracted from paprika or capsicum, and contains about 10% by weight of fat-soluble carotenoids such as capsanthin, β-cryptoxanthin, β-carotene, zeaxanthin, capsorbine.
次いで、このパプリカオレオレジンと水の混合物に、クチナシ黄色素 [クロシン40重量%、クロセチン-モノゲンチオビオシドエステル18重量%、その他クロシン類縁体(クロセチン-ジゲンチオビドエステル、クロセチン-モノゲンチオビオシド-モノグルコシドエステル、クロセチン-ジグルコシドエステル、クロセチン-モノグルコシドエステル他)42重量%]、クロセチン、又はノルビキシン0.16g添加し、攪拌を続けたところ、10分程度経過したところでパプリカオレオレジンが水中で均一な分散状態(乳化状態)になった。その後、静置を続けたが、分離することは無く均一な分散状態(乳化状態)が保たれていた。
Next, this mixture of paprika oleoresin and water was mixed with gardenia yellow starch [crocin 40% by weight, crocetin-monogenthiobioside ester 18% by weight, other crocin analogs (crocetin-digentiobide ester, crocetin-monogenthiobioside] -Monoglucoside ester, crocetin-diglucoside ester, crocetin-monoglucoside ester, etc.) 42 wt%], crocetin, or norbixin 0.16g was added and stirring was continued. After about 10 minutes, paprika oleoresin was dissolved in water. In a uniform dispersion state (emulsified state). Thereafter, the liquid was kept still, but it was not separated, and a uniform dispersed state (emulsified state) was maintained.
また、脂溶性カロテノイドとして、パプリカオレオレジンの代わりにリコペン又はルテインを使用して同様に試験を行ったところ、リコペン又はルテインと水の混合物では、完全に分離状態であったが、クチナシ黄色素を添加して撹拌することにより、脂溶性カロテノイドが水中で均一な分散状態(乳化状態)になり、静置を続けてもその状態を安定に維持できていた。
In addition, as a fat-soluble carotenoid, when lycopene or lutein was used instead of paprika oleoresin, the same test was performed, and the mixture of lycopene or lutein and water was completely separated. By adding and stirring, the fat-soluble carotenoid became a uniformly dispersed state (emulsified state) in water, and the state could be maintained stably even if it was allowed to stand still.
本試験結果を表1に纏め、本試験で使用したクチナシ黄色素をHPLCに供して組成分析した結果を図1に示す。
The results of this test are summarized in Table 1, and the results of composition analysis of the gardenia yellow pigment used in this test by HPLC are shown in FIG.
(2)脂溶性カロテノイドとクロセチン-モノゲンチオビオシドエステル又はクロセチンとの複合体(ミセル)形成の確認
前記実施例1で得られた脂溶性カロテノイド乳化液をパプリカオレオレジン濃度が0.01~0.02重量%程度となるように水で希釈し、得られた希釈液2mlを、PD-10カラム(GEヘルスケアライフサイエンス社製)を用いたゲル濾過に供し、分子量が1000以下の高分子量画分と、分子量が1000未満の低分子量画分に分画した。パプリカオレオレジンの主カロテノイドのカプサンチンは分子量584、クロセチン-モノゲンチオビオシドエステル分子量は652、クロセチンは分子量328であるので、カプサンチンとクロセチン-モノゲンチオビオシドエステル又はクロセチンとのミセル形成が起こっていれば高分子量画分にカプサンチンとクロセチン-モノゲンチオビオシドエステル又はクロセチンが同時に溶出される。 (2) Confirmation of formation of complex (micelle) of fat-soluble carotenoid and crocetin-monogenthiobioside ester or crocetin The paprika oleoresin concentration of 0.01 to 0 was used for the fat-soluble carotenoid emulsion obtained in Example 1 above. The resulting diluted solution (2 ml) was subjected to gel filtration using a PD-10 column (manufactured by GE Healthcare Life Sciences) to obtain a high molecular weight having a molecular weight of 1000 or less. The fraction was fractionated into a low molecular weight fraction having a molecular weight of less than 1000. Capsanthin, the main carotenoid of paprika oleoresin, has a molecular weight of 584, crocetin-monogentiobioside ester has a molecular weight of 652, and crocetin has a molecular weight of 328. For example, capsanthin and crocetin-monogenthiobioside ester or crocetin are eluted simultaneously in the high molecular weight fraction.
前記実施例1で得られた脂溶性カロテノイド乳化液をパプリカオレオレジン濃度が0.01~0.02重量%程度となるように水で希釈し、得られた希釈液2mlを、PD-10カラム(GEヘルスケアライフサイエンス社製)を用いたゲル濾過に供し、分子量が1000以下の高分子量画分と、分子量が1000未満の低分子量画分に分画した。パプリカオレオレジンの主カロテノイドのカプサンチンは分子量584、クロセチン-モノゲンチオビオシドエステル分子量は652、クロセチンは分子量328であるので、カプサンチンとクロセチン-モノゲンチオビオシドエステル又はクロセチンとのミセル形成が起こっていれば高分子量画分にカプサンチンとクロセチン-モノゲンチオビオシドエステル又はクロセチンが同時に溶出される。 (2) Confirmation of formation of complex (micelle) of fat-soluble carotenoid and crocetin-monogenthiobioside ester or crocetin The paprika oleoresin concentration of 0.01 to 0 was used for the fat-soluble carotenoid emulsion obtained in Example 1 above. The resulting diluted solution (2 ml) was subjected to gel filtration using a PD-10 column (manufactured by GE Healthcare Life Sciences) to obtain a high molecular weight having a molecular weight of 1000 or less. The fraction was fractionated into a low molecular weight fraction having a molecular weight of less than 1000. Capsanthin, the main carotenoid of paprika oleoresin, has a molecular weight of 584, crocetin-monogentiobioside ester has a molecular weight of 652, and crocetin has a molecular weight of 328. For example, capsanthin and crocetin-monogenthiobioside ester or crocetin are eluted simultaneously in the high molecular weight fraction.
高分子量画分には目視でもパプリカオレオレジン由来のオレンジ色が確認された。高分子量画分及び低分子量画分をHPLCで分析した。HPLC分析は、クチナシ黄色素類の分析に適した下記方法1と、パプリカオレオレジンの分析に適した下記方法2の2種類を行った。
The orange color derived from paprika oleoresin was also confirmed visually in the high molecular weight fraction. The high molecular weight fraction and the low molecular weight fraction were analyzed by HPLC. Two types of HPLC analysis were performed: Method 1 below, which is suitable for analysis of gardenia yellow, and Method 2 below, which is suitable for analysis of paprika oleoresin.
<方法1:クチナシ黄色素類の分析>
高分子量画分と低分子量画分を、下記条件でHPLC分析に供した。
溶離液A:1重量%酢酸水溶液
溶離液B:アセトニトリル
グラジエント:
0分 → 20分 → 30分 → 35分
溶離液A 80容量% 20容量% 20容量% 80容量%
溶離液B 20容量% 80容量% 80容量% 20容量%
カラム:SunFireC18カラム 5μm、4.6×250mm、Waters社製
カラム温度:40℃
流速:1.0ml/min
検出器:UV 440nm <Method 1: Analysis of Gardenia yellow primaries>
The high molecular weight fraction and the low molecular weight fraction were subjected to HPLC analysis under the following conditions.
Eluent A: 1% by weight acetic acid aqueous solution Eluent B: Acetonitrile Gradient:
0 minutes → 20 minutes → 30 minutes → 35 minutes Eluent A 80% byvolume 20% by volume 20% by volume 80% by volume
Eluent B 20% by volume 80% by volume 80% by volume 20% by volume
Column:SunFireC18 column 5 μm, 4.6 × 250 mm, manufactured by Waters Column temperature: 40 ° C.
Flow rate: 1.0ml / min
Detector: UV 440nm
高分子量画分と低分子量画分を、下記条件でHPLC分析に供した。
溶離液A:1重量%酢酸水溶液
溶離液B:アセトニトリル
グラジエント:
0分 → 20分 → 30分 → 35分
溶離液A 80容量% 20容量% 20容量% 80容量%
溶離液B 20容量% 80容量% 80容量% 20容量%
カラム:SunFireC18カラム 5μm、4.6×250mm、Waters社製
カラム温度:40℃
流速:1.0ml/min
検出器:UV 440nm <Method 1: Analysis of Gardenia yellow primaries>
The high molecular weight fraction and the low molecular weight fraction were subjected to HPLC analysis under the following conditions.
Eluent A: 1% by weight acetic acid aqueous solution Eluent B: Acetonitrile Gradient:
0 minutes → 20 minutes → 30 minutes → 35 minutes Eluent A 80% by
Column:
Flow rate: 1.0ml / min
Detector: UV 440nm
<方法2:パプリカオレオレジンの分析>
低分子画分又は高分子量画分100μl、50重量%水酸化カリウム水溶液10μl、及びメタノール900μlを混合し、室温で1時間静置してケン化を行った。その後、ヘキサン及びジメチルエーテルの容量1:1の混合溶媒に、前記ケン化後の溶液を添加して撹拌し、エーテル層を回収した。得られたエーテル層を遠心濃縮にて乾固させた後に、下記HPLC分析用の溶離液100μlに溶解させてHPLC分析用検体とした。当該HPLC分析用検体について、下記条件でHPLC分析に供した。
溶離液:アセトニトリル70容量%及びエタノール30容量%(濃度一定)
カラム:SunFireC18カラム 5μm、4.6×250mm、Waters社製
カラム温度:40℃
流速:1.0ml/min
検出器:UV 450nm <Method 2: Analysis of paprika oleoresin>
Low molecular fraction or highmolecular weight fraction 100 μl, 50 wt% potassium hydroxide aqueous solution 10 μl and methanol 900 μl were mixed and allowed to stand at room temperature for 1 hour for saponification. Thereafter, the saponified solution was added to a 1: 1 mixed solvent of hexane and dimethyl ether and stirred to recover the ether layer. The obtained ether layer was dried and solidified by centrifugal concentration, and then dissolved in 100 μl of the following eluent for HPLC analysis to prepare a sample for HPLC analysis. The sample for HPLC analysis was subjected to HPLC analysis under the following conditions.
Eluent:acetonitrile 70% by volume and ethanol 30% by volume (concentration constant)
Column:SunFireC18 column 5 μm, 4.6 × 250 mm, manufactured by Waters Column temperature: 40 ° C.
Flow rate: 1.0ml / min
Detector: UV 450nm
低分子画分又は高分子量画分100μl、50重量%水酸化カリウム水溶液10μl、及びメタノール900μlを混合し、室温で1時間静置してケン化を行った。その後、ヘキサン及びジメチルエーテルの容量1:1の混合溶媒に、前記ケン化後の溶液を添加して撹拌し、エーテル層を回収した。得られたエーテル層を遠心濃縮にて乾固させた後に、下記HPLC分析用の溶離液100μlに溶解させてHPLC分析用検体とした。当該HPLC分析用検体について、下記条件でHPLC分析に供した。
溶離液:アセトニトリル70容量%及びエタノール30容量%(濃度一定)
カラム:SunFireC18カラム 5μm、4.6×250mm、Waters社製
カラム温度:40℃
流速:1.0ml/min
検出器:UV 450nm <Method 2: Analysis of paprika oleoresin>
Low molecular fraction or high
Eluent:
Column:
Flow rate: 1.0ml / min
Detector: UV 450nm
図2のAに高分子量画分について方法1にてHPLC分析した結果、図2のBに低分子量画分について方法1にてHPLC分析した結果、及び図2のCに高分子量画分について方法2にてHPLC分析した結果を示す。図2のA及びCに示されるように、高分子量画分からは、パプリカオレオレジン由来の脂溶性カロテノイドとクロセチン-モノゲンチオビオシドエステルが検出された。この結果は、脂溶性カロテノイドとクロセチン-モノゲンチオビオシドエステル複合体が形成されて、当該複合体がミセルとして水に分散していることを示している。一方、クロシンは、高分子量画分では検出されず、低分子量画分に単独で検出されており、ミセル形成には用いられず、単独分散状態であると推察された。また、低分子画分についても、方法2にてHPLC分析したところ、パプリカオレオレジン由来の脂溶性カロテノイドは検出されなかった。以上の結果から、クロセチン-モノゲンチオビオシドエステルが、パプリカオレオレジン中の脂溶性カロテノイドとのミセルを形成することによって、脂溶性カロテノイドの乳化性を向上させていることが明らかとなった。
FIG. 2A shows the result of HPLC analysis of the high molecular weight fraction by method 1, FIG. 2B shows the result of HPLC analysis of the low molecular weight fraction by method 1, and FIG. 2C shows the method of high molecular weight fraction. 2 shows the result of HPLC analysis. As shown in FIGS. 2A and 2C, fat-soluble carotenoids derived from paprika oleoresin and crocetin-monogentiobioside ester were detected from the high molecular weight fraction. This result indicates that a fat-soluble carotenoid and a crocetin-monogenthiobioside ester complex are formed, and the complex is dispersed in water as micelles. On the other hand, crocin was not detected in the high molecular weight fraction, but was detected alone in the low molecular weight fraction, and was not used for micelle formation, and was presumed to be in a single dispersed state. In addition, when the low molecular fraction was analyzed by HPLC in Method 2, no paprika oleoresin-derived fat-soluble carotenoid was detected. From the above results, it was revealed that crocetin-monogenthiobioside ester improves the emulsifiability of fat-soluble carotenoids by forming micelles with fat-soluble carotenoids in paprika oleoresin.
また、前記実施例2で得られた脂溶性カロテノイド水分散液を用いて、同様に試験を行った。図3のAに高分子量画分について方法1にてHPLC分析した結果、図3のBに高分子量画分について方法2にてHPLC分析した結果を示す。この結果でも、クロセチンが脂溶性カロテノイドとのミセル)を形成していることが確認され、クロセチンとの複合体(ミセル)形成によって脂溶性カロテノイドの乳化性が向上していることが明らかとなった。
Further, the same test was performed using the fat-soluble carotenoid aqueous dispersion obtained in Example 2. FIG. 3A shows the result of HPLC analysis of the high molecular weight fraction by Method 1, and FIG. 3B shows the result of HPLC analysis of the high molecular weight fraction by Method 2. This result also confirmed that crocetin formed micelles with fat-soluble carotenoids), and it became clear that the emulsifiability of fat-soluble carotenoids was improved by forming a complex (micelle) with crocetin. .
なお、ノルビキシンのモノグリコシドエステルについては試験を行っていないが、ノルビキシン自体が脂溶性カロテノイドの水分散性を向上させたこと(実施例3)、クロセチンとクロセチン-モノゲンチオビオシドエステルの双方とも脂溶性カロテノイドとミセルを形成し、その水分散性を向上させたことを考慮すると、ノルビキシンのモノグリコシドエステルについても、脂溶性カロテノイドとミセルを形成し、その乳化性を向上させ得ることが当然に推定される。従って、以上の結果から、クロセチン、ノルビキシン、及びそれらのモノグリコシドエステルは、脂溶性カロテノイドの乳化性を向上させ得ることが明らかとなった。
Norbixin monoglycoside ester was not tested, but norbixin itself improved the water-dispersibility of fat-soluble carotenoids (Example 3), both crocetin and crocetin-monogentiobioside ester In consideration of the formation of micelles with soluble carotenoids and improved water dispersibility, it is naturally estimated that monoglycoside esters of norbixin can also form micelles with fat-soluble carotenoids and improve their emulsifiability. Is done. Therefore, the above results revealed that crocetin, norbixin, and their monoglycoside esters can improve the emulsifiability of fat-soluble carotenoids.
試験例2:脂溶性カロテノイドの安定性の評価
(1)クロシンによる安定性の向上効果の評価-1
前記試験例1において脂溶性カロテノイド乳化液(実施例1)をPD-10カラムにてゲル濾過することにより取得した高分子量画分(脂溶性カロテノイドとクロセチン-モノゲンチオビオシドエステルとのミセル含有)に、クロシンを添加して、50℃で20時間加熱処理を行った。また、比較として、クロシンを添加せずに同様の条件で熱処理を行った。加熱処理後に、前記方法2のHPLC分析を行い、脂溶性カロテノイドの測定を行った。 Test Example 2: Evaluation of stability of fat-soluble carotenoid (1) Evaluation of stability improvement effect by crocin-1
High molecular weight fraction obtained by gel filtration of fat-soluble carotenoid emulsion (Example 1) in PD-10 column in Test Example 1 (containing micelle of fat-soluble carotenoid and crocetin-monogenthiobioside ester) Then, crocin was added and heat treatment was performed at 50 ° C. for 20 hours. For comparison, heat treatment was performed under the same conditions without adding crocin. After the heat treatment, the HPLC analysis of themethod 2 was performed, and the fat-soluble carotenoid was measured.
(1)クロシンによる安定性の向上効果の評価-1
前記試験例1において脂溶性カロテノイド乳化液(実施例1)をPD-10カラムにてゲル濾過することにより取得した高分子量画分(脂溶性カロテノイドとクロセチン-モノゲンチオビオシドエステルとのミセル含有)に、クロシンを添加して、50℃で20時間加熱処理を行った。また、比較として、クロシンを添加せずに同様の条件で熱処理を行った。加熱処理後に、前記方法2のHPLC分析を行い、脂溶性カロテノイドの測定を行った。 Test Example 2: Evaluation of stability of fat-soluble carotenoid (1) Evaluation of stability improvement effect by crocin-1
High molecular weight fraction obtained by gel filtration of fat-soluble carotenoid emulsion (Example 1) in PD-10 column in Test Example 1 (containing micelle of fat-soluble carotenoid and crocetin-monogenthiobioside ester) Then, crocin was added and heat treatment was performed at 50 ° C. for 20 hours. For comparison, heat treatment was performed under the same conditions without adding crocin. After the heat treatment, the HPLC analysis of the
得られた結果を図4に示す。この結果から、クロシンを添加しなかった場合には、パプリカオレオレジン由来の脂溶性カロテノイドのピークは完全に消失していたが、クロシンを添加した場合には、当該脂溶性カロテノイドのピークが認められた。以上の結果から、クロシンは、脂溶性カロテノイドの乳化性には寄与しないものの、その安定化には顕著に寄与できることが判明した。
The obtained results are shown in FIG. From this result, when crocin was not added, the peak of the fat-soluble carotenoid derived from paprika oleoresin disappeared completely, but when crocin was added, the peak of the fat-soluble carotenoid was observed. It was. From the above results, it has been found that crocin does not contribute to the emulsifiability of the fat-soluble carotenoid, but can contribute significantly to its stabilization.
(2)クロシンによる安定性の向上効果の評価-2
パプリカオレオレジン含有製剤の調製
比較例2~4では、水20gに、表2に示す各界面活性剤0.16gとパプリカオレオレジン0.1gを添加して撹拌することにより、パプリカオレオレジンを水に分散させた。 (2) Evaluation of stability improvement effect by crocin-2
Preparation of preparations containing paprika oleoresin In Comparative Examples 2 to 4, 0.16 g of each surfactant shown in Table 2 and 0.1 g of paprika oleoresin were added to 20 g of water and stirred, so that paprika oleoresin was added to water. Dispersed.
パプリカオレオレジン含有製剤の調製
比較例2~4では、水20gに、表2に示す各界面活性剤0.16gとパプリカオレオレジン0.1gを添加して撹拌することにより、パプリカオレオレジンを水に分散させた。 (2) Evaluation of stability improvement effect by crocin-2
Preparation of preparations containing paprika oleoresin In Comparative Examples 2 to 4, 0.16 g of each surfactant shown in Table 2 and 0.1 g of paprika oleoresin were added to 20 g of water and stirred, so that paprika oleoresin was added to water. Dispersed.
比較例5~7では、水20gに、表2に示す各界面活性剤0.16gとパプリカオレオレジン0.1gを添加して撹拌することによりパプリカオレオレジンを水に分散させ、その後、クチナシ黄色素[クロシン40重量%、クロセチン-モノゲンチオビオシドエステル18重量%、その他クロシン類縁体(クロセチン-ジゲンチオビドエステル、クロセチン-モノゲンチオビオシド-モノグルコシドエステル、クロセチン-ジグルコシドエステル、クロセチン-モノグルコシドエステル他)42重量%]を添加して撹拌した。
In Comparative Examples 5 to 7, 0.16 g of each surfactant shown in Table 2 and 0.1 g of paprika oleoresin were added to 20 g of water and stirred to disperse paprika oleoresin in water. Dye [crocin 40% by weight, crocetin-monogenthiobioside ester 18% by weight, other crocin analogues (crocetin-digentiobide ester, crocetin-monogenthiobioside-monoglucoside ester, crocetin-diglucoside ester, crocetin-monoglucose ester 42% by weight of glucoside ester, etc.] was added and stirred.
実施例7~10では、水20gに、クチナシ黄色素[クロシン40重量%、クロセチン-モノゲンチオビオシドエステル18重量%、その他クロシン類縁体(クロセチン-ジゲンチオビドエステル、クロセチン-モノゲンチオビオシド-モノグルコシドエステル、クロセチン-ジグルコシドエステル、クロセチン-モノグルコシドエステル他)42重量%]を表2に示す所定量を添加して撹拌することにより、パプリカオレオレジンを水に乳化させた。
In Examples 7 to 10, 20 g of water was added to 20 g of water, [40% by weight of crocin, 18% by weight of crocetin-monogentiobioside ester, and other crocin analogs (crocetin-digentiobide ester, crocetin-monogentiobioside- Monoglycoside ester, crocetin-diglucoside ester, crocetin-monoglucoside ester, etc.) 42% by weight] were added in predetermined amounts shown in Table 2 and stirred to emulsify paprika oleoresin in water.
加速試験
上記で調製した各パプリカオレオレジン含有製剤を50℃で45時間保存し、各パプリカオレオレジン含有製剤に残存するカプサンチン(パプリカオレオレジンに含まれる脂溶性カロテノイドの1種)を経時的に測定してカプサンチンの残存率を算出し、これを脂溶性カロテノイドの残存率とした。カプサンチンの測定は、前記方法2のHPLC分析によって行った。 Accelerated test Each paprika oleoresin-containing preparation prepared above is stored at 50 ° C for 45 hours, and the capsanthin remaining in each paprika oleoresin-containing preparation (one of the fat-soluble carotenoids contained in paprika oleoresin) is measured over time. Thus, the residual ratio of capsanthin was calculated, and this was defined as the residual ratio of fat-soluble carotenoid. Capsanthin was measured by the HPLC analysis ofMethod 2 above.
上記で調製した各パプリカオレオレジン含有製剤を50℃で45時間保存し、各パプリカオレオレジン含有製剤に残存するカプサンチン(パプリカオレオレジンに含まれる脂溶性カロテノイドの1種)を経時的に測定してカプサンチンの残存率を算出し、これを脂溶性カロテノイドの残存率とした。カプサンチンの測定は、前記方法2のHPLC分析によって行った。 Accelerated test Each paprika oleoresin-containing preparation prepared above is stored at 50 ° C for 45 hours, and the capsanthin remaining in each paprika oleoresin-containing preparation (one of the fat-soluble carotenoids contained in paprika oleoresin) is measured over time. Thus, the residual ratio of capsanthin was calculated, and this was defined as the residual ratio of fat-soluble carotenoid. Capsanthin was measured by the HPLC analysis of
得られた結果を表2に示す。界面活性剤を使用してパプリカオレオレジンを水に分散させた場合(比較例2~4)には、加速試験において脂溶性カロテノイドの残存率が顕著に低下しており、脂溶性カロテノイドの安定性が不十分であった。また、界面活性剤を使用してパプリカオレオレジンを水に分散させた後に、クチナシ黄色素を添加した場合(比較例5~7)でも、脂溶性カロテノイドの残存率は、クチナシ黄色素を添加しなかった場合と同程度であった。これは、界面活性剤を使用してパプリカオレオレジンを水に分散させた時点で、パプリカオレオレジン由来の脂溶性カロテノイドが界面活性剤とミセルを既に形成しているため、その後、クチナシ黄色素を添加しても、当該脂溶性カロテノイドが、クチナシ黄色素に含まれるクロセチン-モノゲンチオビオシドエステルと複合体(ミセル)を形成できなかったことに起因していると考えられる。一方、水中でパプリカオレオレジンとクチナシ黄色素を混合し、クチナシ黄色素に含まれるクロセチン-モノゲンチオビオシドエステルと、パプリカオレオレジン由来の脂溶性カロテノイドの複合体(ミセル)を形成させた場合(実施例7~10)では、加速試験において脂溶性カロテノイドの残存率が飛躍的に高い値を示しており、脂溶性カロテノイドの安定性が顕著に向上していた。前記「(1)クロシンによる安定性の向上効果の評価-1」の結果を踏まえれば、クロセチン-モノゲンチオビオシドエステルと脂溶性カロテノイドの複合体(ミセル)と共に、クチナシ黄色素に含まれるクロシンが共存していることによって、実施例7~10では脂溶性カロテノイドの安定性が向上したと考えられる。
Table 2 shows the results obtained. When paprika oleoresin was dispersed in water using a surfactant (Comparative Examples 2 to 4), the residual ratio of the fat-soluble carotenoid was significantly reduced in the accelerated test, and the stability of the fat-soluble carotenoid Was insufficient. Even when paprika oleoresin is dispersed in water using a surfactant and then gardenia yellow pigment is added (Comparative Examples 5 to 7), the residual ratio of the fat-soluble carotenoid is that of gardenia yellow pigment added. It was about the same as when there was no. This is because when the paprika oleoresin is dispersed in water using a surfactant, the fat-soluble carotenoid derived from paprika oleoresin has already formed micelles with the surfactant. Even when added, it is considered that the fat-soluble carotenoid could not form a complex (micelle) with the crocetin-monogentiobioside ester contained in gardenia yellow. On the other hand, when paprika oleoresin and gardenia yellow are mixed in water to form a complex (micelle) of fat-soluble carotenoid derived from paprika oleoresin and crocetin-monogentiobioside ester contained in gardenia yellow ( In Examples 7 to 10), the residual rate of the fat-soluble carotenoid showed a remarkably high value in the accelerated test, and the stability of the fat-soluble carotenoid was remarkably improved. Based on the result of “(1) Evaluation of stability improvement effect by crocin-1”, crocin contained in gardenia yellow is combined with a complex (micelle) of crocetin-monogenthiobioside ester and fat-soluble carotenoid. By coexistence, it is considered that the stability of the fat-soluble carotenoid was improved in Examples 7 to 10.
なお、ノルビキシンのジグリコシドエステルについては試験を行っていないが、クロシンが脂溶性カロテノイドの安定性に寄与していること(実施例7~10)、ノルビキシンのジグリコシドエステルはクロシンと同様にアポカロテノイドの2つの糖の配糖体であること等を勘案すると、ノルビキシンのジグリコシドエステルについても、脂溶性カロテノイドの安定性を向上させ得ることが当然に推定される。
Although no test was conducted for norbixin diglycoside ester, crocin contributed to the stability of fat-soluble carotenoids (Examples 7 to 10), and norbixin diglycoside ester was apocarotenoid as well as crocin. In view of the fact that it is a glycoside of these two sugars, it is naturally assumed that the stability of the fat-soluble carotenoid can be improved also for the diglycoside ester of norbixin.
以上の結果より、クロセチン、ノルビキシン、及び/又はそれらのモノグリコシドエステルと、脂溶性カロテノイドとが複合体(ミセル)を形成し、且つクロセチンのジグリコシドエステル及び/又はノルビキシンのジグリコシドエステルを共存させることによって、脂溶性カロテノイドの安定性を向上できることが明らかとなった。
From the above results, crocetin, norbixin, and / or their monoglycoside esters and fat-soluble carotenoids form a complex (micelle), and crocetin diglycoside ester and / or norbixin diglycoside ester coexist. Thus, it was revealed that the stability of the fat-soluble carotenoid can be improved.
(3)アスタキサンチンの安定性の向上効果の評価
サンプル調製
比較例8では、水20gに、ポリソルベート80 0.16gとアスタキサンチン0.1gを添加して撹拌することにより、アスタキサンチンを水に分散させた。 (3) Evaluation of the effect of improving the stability of astaxanthin
In Sample Preparation Comparative Example 8, 0.16 g ofpolysorbate 80 and 0.1 g of astaxanthin were added to 20 g of water and stirred to disperse astaxanthin in water.
サンプル調製
比較例8では、水20gに、ポリソルベート80 0.16gとアスタキサンチン0.1gを添加して撹拌することにより、アスタキサンチンを水に分散させた。 (3) Evaluation of the effect of improving the stability of astaxanthin
In Sample Preparation Comparative Example 8, 0.16 g of
実施例11では、水20gに、クチナシ黄色素(クロシン40重量%、クロセチン-モノゲンチオビオシドエステル18重量%含有、その他クロシン類縁体42重量%)0.16gとアスタキサンチン0.1gを添加して撹拌することにより、アスタキサンチンを乳化させた。
In Example 11, 0.16 g of gardenia yellow pigment (40% by weight of crocin, 18% by weight of crocetin-monogentiobioside ester, 42% by weight of other crocin analogs) and 0.1 g of astaxanthin were added to 20 g of water. Astaxanthin was emulsified by stirring.
加速試験
前記「(2)クロシンによる安定性の向上効果の評価-2」と同様の方法で加速試験を行い、アスタキサンチンの残存率を測定した。 Accelerated test An accelerated test was performed in the same manner as in "(2) Evaluation of stability improvement effect by crocin-2", and the residual ratio of astaxanthin was measured.
前記「(2)クロシンによる安定性の向上効果の評価-2」と同様の方法で加速試験を行い、アスタキサンチンの残存率を測定した。 Accelerated test An accelerated test was performed in the same manner as in "(2) Evaluation of stability improvement effect by crocin-2", and the residual ratio of astaxanthin was measured.
得られた結果を表3に示す。この結果から、脂溶性テルペノイドとして、アスタキサンチンを用いた場合であっても、通常の界面活性剤では安定性を向上できないが、クチナシ黄色素を使用して、クロセチン-モノゲンチオビオシドエステルとアスタキサンチンの複合体(ミセル)を形成し、更にクチナシ黄色素に含まれるクロシンを共存させることによって、アスタキサンチンの安定性を格段に向上できることが明らかとなった。
Table 3 shows the obtained results. From this result, even when astaxanthin is used as a fat-soluble terpenoid, stability cannot be improved with a normal surfactant, but crocetin-monogentiobioside ester and astaxanthin can be obtained using gardenia yellow. It was revealed that the stability of astaxanthin can be remarkably improved by forming a complex (micelle) and coexisting crocin contained in gardenia yellow.
試験例3:植物性油脂の乳化性の評価
(1)クロセチン-モノゲンチオビオシドエステルによる植物油の乳化
表4に示す組成となるように、大豆油とクロセチン-モノゲンチオビオシドエステル又はクロセチン-ジゲンチオビドエステルを含む溶液を調製し、ボルテックスにて乳化処理を行い、その後、外観を観察した。 Test Example 3: Evaluation of emulsifiability of vegetable oil
(1) Emulsification of vegetable oil with crocetin-monogentiobioside ester A solution containing soybean oil and crocetin-monogentiobioside ester or crocetin-digentiobioside ester was prepared so as to have the composition shown in Table 4, and vortexed. The emulsification treatment was performed, and then the appearance was observed.
(1)クロセチン-モノゲンチオビオシドエステルによる植物油の乳化
表4に示す組成となるように、大豆油とクロセチン-モノゲンチオビオシドエステル又はクロセチン-ジゲンチオビドエステルを含む溶液を調製し、ボルテックスにて乳化処理を行い、その後、外観を観察した。 Test Example 3: Evaluation of emulsifiability of vegetable oil
(1) Emulsification of vegetable oil with crocetin-monogentiobioside ester A solution containing soybean oil and crocetin-monogentiobioside ester or crocetin-digentiobioside ester was prepared so as to have the composition shown in Table 4, and vortexed. The emulsification treatment was performed, and then the appearance was observed.
乳化処理後の各溶液の外観を観察した結果を図5に示す。この結果から、クロセチン-モノゲンチオビオシドエステルには、大豆油を乳化させる作用があることが確認された。
The result of observing the appearance of each solution after the emulsification treatment is shown in FIG. From these results, it was confirmed that crocetin-monogentiobioside ester has an action of emulsifying soybean oil.
(2)植物油とクロセチン-モノゲンチオビオシドエステルとの複合体(ミセル)形成の確認
表5に示す組成となるように、大豆油とクロセチン-モノゲンチオビオシドエステル、及びクロセチン-ジゲンチオビドエステルを含む溶液を調製し、ボルテックスにて乳化処理を行い、大豆油乳化液を調製した。
(2) Confirmation of complex (micelle) formation of vegetable oil and crocetin-monogenthiobioside ester Soybean oil and crocetin-monogenthiobioside ester, and crocetin-digentiobioside ester so as to have the composition shown in Table 5 Was prepared, and emulsified by vortexing to prepare a soybean oil emulsion.
表5に示す組成となるように、大豆油とクロセチン-モノゲンチオビオシドエステル、及びクロセチン-ジゲンチオビドエステルを含む溶液を調製し、ボルテックスにて乳化処理を行い、大豆油乳化液を調製した。
得られた大豆油乳化液を水で2倍に希釈し、得られた希釈液1mlをPD-10カラム(GEヘルスケアライフサイエンス社製)を用いたゲル濾過に供して水で溶出させて1ml毎に採取し、溶出が早い順にフラクション1~フラクション10に分画した。
The obtained soybean oil emulsion was diluted 2 times with water, and 1 ml of the obtained diluted solution was subjected to gel filtration using a PD-10 column (GE Healthcare Life Sciences) and eluted with water to 1 ml. Each sample was collected and fractionated into fractions 1 to 10 in order of elution.
得られた各フラクションの外観を観察した結果を図6に示す。図6から分かるように、エマルジョンを含む画分は、フラクション2(2番目に採取した画分)において認められた。また、フラクション3及び4は黄色を呈しており、フラクション6では黄色が薄くなったが、フラクション7以上では再び黄色を呈していた。
The result of observing the appearance of each obtained fraction is shown in FIG. As can be seen from FIG. 6, the fraction containing the emulsion was observed in fraction 2 (the second fraction collected). In addition, fractions 3 and 4 were yellow, and yellow was light in fraction 6, but yellow was again present in fractions 7 and above.
次いで、乳化処理前の溶液、得られたフラクション2、フラクション3~5の混合画分、フラクション7以降の混合画分について、HPLCで分析した。HPLC分析は、クチナシ黄色素類の分析に使用した前記方法1と同条件で行った。なお、フラクション2については、大豆油が含まれているため、大豆油を除去(エマルジョンを破壊)した後に、HPLC分析に供した。大豆油の除去は、フラクション2をカラム(Waters社製Sep-Pak C18 Cartridges)に通液し、油性成分をカラムに吸着させた後に、メタノールで大豆油以外の成分を溶出させることによって行った。
Next, the solution before the emulsification treatment, the obtained fraction 2, the mixed fraction of fractions 3 to 5, and the mixed fraction after fraction 7 were analyzed by HPLC. The HPLC analysis was performed under the same conditions as in Method 1 used for the analysis of gardenia yellow. In addition, since the soybean oil was contained about the fraction 2, after removing soybean oil (breaking an emulsion), it used for the HPLC analysis. Soybean oil was removed by passing fraction 2 through a column (Sep-Pak C18 Cartridges manufactured by Waters), adsorbing oily components to the column, and then eluting components other than soybean oil with methanol.
得られた結果を図7に示す。エマルジョンを含んでいたフラクション2では、クロセチン-モノゲンチオビオシドエステルのみが検出され、大豆油の乳化にはクロセチン-モノゲンチオビオシドエステルが寄与していることが明らかとなった。一方、エマルジョンが含まれていなかったフラクション3以降において、クロセチン-ジゲンチオビドエステルが検出され、クロセチン-ジゲンチオビドエステルは自己ミセルを形成していることが示唆された。
The obtained results are shown in FIG. In fraction 2 containing the emulsion, only crocetin-monogentiobioside ester was detected, which revealed that crocetin-monogentiobioside ester contributed to the emulsification of soybean oil. On the other hand, crocetin-digenthiobide ester was detected after fraction 3 in which no emulsion was contained, suggesting that crocetin-digenthiobide ester forms self-micelles.
(2)クロセチン-ジゲンチオビオシドエステルを添加した乳化液における植物油とクロセチン-モノゲンチオビオシドエステルとの複合体形成の確認
前記実施例13の乳化液では、クロセチン-モノゲンチオビオシドエステルを添加していないにもかかわらず、大豆油を乳化できている。そこで、実施例13の乳化液の乳化液について、前記と同様の方法で、PD-10カラム(GEヘルスケアライフサイエンス社製)を用いたゲル濾過にて分画を行った。 (2) Confirmation of complex formation between vegetable oil and crocetin-monogentiobioside ester in emulsion added with crocetin-digentiobioside ester In the emulsion of Example 13, crocetin-monogentiobioside ester was added Despite not being able to emulsify soybean oil. Therefore, the emulsion of Example 13 was fractionated by gel filtration using a PD-10 column (GE Healthcare Life Science) in the same manner as described above.
前記実施例13の乳化液では、クロセチン-モノゲンチオビオシドエステルを添加していないにもかかわらず、大豆油を乳化できている。そこで、実施例13の乳化液の乳化液について、前記と同様の方法で、PD-10カラム(GEヘルスケアライフサイエンス社製)を用いたゲル濾過にて分画を行った。 (2) Confirmation of complex formation between vegetable oil and crocetin-monogentiobioside ester in emulsion added with crocetin-digentiobioside ester In the emulsion of Example 13, crocetin-monogentiobioside ester was added Despite not being able to emulsify soybean oil. Therefore, the emulsion of Example 13 was fractionated by gel filtration using a PD-10 column (GE Healthcare Life Science) in the same manner as described above.
得られた各フラクションの外観を観察した結果を図8に示す。図8から分かるように、エマルジョンを含む画分は、前記と同様、フラクション2(2番目に採取した画分)において認められた。
The results of observing the appearance of each obtained fraction are shown in FIG. As can be seen from FIG. 8, the fraction containing the emulsion was observed in fraction 2 (the second collected fraction) as described above.
次いで、乳化処理前の溶液と、エマルジョンを含んでいたフラクション2について、前記と同様の方法でHPLC分析を行った。得られた結果を図9に示す。エマルジョンを含んでいたフラクション2では、多量のクロセチン-モノゲンチオビオシドエステルが検出され、実施例13の乳化液では、実際には、大豆油のミセル形成にはクロセチン-モノゲンチオビオシドエステルが寄与していることが明らかとなった。これは、乳化工程において、クロセチン-ジゲンチオビオシドエステルが熱や物理的刺激により加水分解を受けて、クロセチン-モノゲンチオビオシドエステルが生成し、これが大豆油のミセル形成に寄与したと考えられる。
Next, HPLC analysis was performed on the solution before the emulsification treatment and the fraction 2 containing the emulsion by the same method as described above. The obtained results are shown in FIG. In fraction 2 containing the emulsion, a large amount of crocetin-monogentiobioside ester was detected. In the emulsion of Example 13, crocetin-monogentiobioside ester actually contributed to the micelle formation of soybean oil. It became clear that This is probably because crocetin-digentiobioside ester was hydrolyzed by heat and physical stimulation in the emulsification process to produce crocetin-monogentiobioside ester, which contributed to micelle formation of soybean oil. .
試験例4:植物性油脂の乳化性の評価
表6に示す原料を混合し、ホモジナイザー(TKホモミクサーMARKII、プライミクス株式会社製)を用いて10,000rpmで5分間乳化処理を行った。その結果、菜種油が均一に乳化した製剤が得られた。また、当該製剤に含まれるミセルの平均粒子径を測定したところ、0.617μmであった。なお、ミセルの平均粒子径の測定は、レーザー回折式粒度分布測定装置(SALD2100、株式会社島津製作所)にて、希釈溶媒として水を使用し、屈折率1.60-0.10iに設定して行った。 Test Example 4: Evaluation of emulsifiability of vegetable oils and fats The raw materials shown in Table 6 were mixed and emulsified for 5 minutes at 10,000 rpm using a homogenizer (TK homomixer MARKII, manufactured by Primix Co., Ltd.). As a result, a preparation in which rapeseed oil was uniformly emulsified was obtained. Moreover, it was 0.617 micrometer when the average particle diameter of the micelle contained in the said formulation was measured. The average particle size of micelles was measured with a laser diffraction particle size distribution analyzer (SALD2100, Shimadzu Corporation) using water as a diluent solvent and setting the refractive index to 1.60-0.10i.
表6に示す原料を混合し、ホモジナイザー(TKホモミクサーMARKII、プライミクス株式会社製)を用いて10,000rpmで5分間乳化処理を行った。その結果、菜種油が均一に乳化した製剤が得られた。また、当該製剤に含まれるミセルの平均粒子径を測定したところ、0.617μmであった。なお、ミセルの平均粒子径の測定は、レーザー回折式粒度分布測定装置(SALD2100、株式会社島津製作所)にて、希釈溶媒として水を使用し、屈折率1.60-0.10iに設定して行った。 Test Example 4: Evaluation of emulsifiability of vegetable oils and fats The raw materials shown in Table 6 were mixed and emulsified for 5 minutes at 10,000 rpm using a homogenizer (TK homomixer MARKII, manufactured by Primix Co., Ltd.). As a result, a preparation in which rapeseed oil was uniformly emulsified was obtained. Moreover, it was 0.617 micrometer when the average particle diameter of the micelle contained in the said formulation was measured. The average particle size of micelles was measured with a laser diffraction particle size distribution analyzer (SALD2100, Shimadzu Corporation) using water as a diluent solvent and setting the refractive index to 1.60-0.10i.
試験例5:d-δ-トコフェロールの乳化性の評価
表7に示す原料を混合し、ホモジナイザー(TKホモミクサーMARKII、プライミクス株式会社製)を用いて10,000rpmで5分間乳化処理を行った。その結果、d-δ-トコフェロールが均一に乳化した製剤が得られた。また、当該製剤に含まれるミセルの平均粒子径を測定したところ、1.215μmであった。なお、ミセルの平均粒子径の測定は、レーザー回折式粒度分布測定装置(SALD2100、株式会社島津製作所)にて、希釈溶媒として水を使用し、屈折率1.60-0.10iに設定して行った。 Test Example 5: Evaluation of emulsifiability of d-δ-tocopherol The raw materials shown in Table 7 were mixed and emulsified at 10,000 rpm for 5 minutes using a homogenizer (TK homomixer MARK II, manufactured by Primix Co., Ltd.). As a result, a preparation in which d-δ-tocopherol was uniformly emulsified was obtained. Moreover, it was 1.215 micrometers when the average particle diameter of the micelle contained in the said formulation was measured. The average particle size of micelles was measured with a laser diffraction particle size distribution analyzer (SALD2100, Shimadzu Corporation) using water as a diluent solvent and setting the refractive index to 1.60-0.10i.
表7に示す原料を混合し、ホモジナイザー(TKホモミクサーMARKII、プライミクス株式会社製)を用いて10,000rpmで5分間乳化処理を行った。その結果、d-δ-トコフェロールが均一に乳化した製剤が得られた。また、当該製剤に含まれるミセルの平均粒子径を測定したところ、1.215μmであった。なお、ミセルの平均粒子径の測定は、レーザー回折式粒度分布測定装置(SALD2100、株式会社島津製作所)にて、希釈溶媒として水を使用し、屈折率1.60-0.10iに設定して行った。 Test Example 5: Evaluation of emulsifiability of d-δ-tocopherol The raw materials shown in Table 7 were mixed and emulsified at 10,000 rpm for 5 minutes using a homogenizer (TK homomixer MARK II, manufactured by Primix Co., Ltd.). As a result, a preparation in which d-δ-tocopherol was uniformly emulsified was obtained. Moreover, it was 1.215 micrometers when the average particle diameter of the micelle contained in the said formulation was measured. The average particle size of micelles was measured with a laser diffraction particle size distribution analyzer (SALD2100, Shimadzu Corporation) using water as a diluent solvent and setting the refractive index to 1.60-0.10i.
製造例1:飲料
実施例8で得られたパプリカオレオレジン含有製剤を用いて、以下の表8に示す処方に従ってオレンジエードを調製した。具体的には、表8に示す各原材料を混合し、容器に加熱充填することにより、オレンジエードを得た。このオレンジエードは、パプリカオレオレジン水分散性製剤に由来するパプリカオレオレジンを5mg含んでいる。 Production Example 1 : Beverage Using the paprika oleoresin-containing preparation obtained in Example 8, an orangeade was prepared according to the formulation shown in Table 8 below. Specifically, each raw material shown in Table 8 was mixed and heated in a container to obtain an orangeade. This orangeade contains 5 mg of paprika oleoresin derived from a paprika oleoresin water dispersible formulation.
実施例8で得られたパプリカオレオレジン含有製剤を用いて、以下の表8に示す処方に従ってオレンジエードを調製した。具体的には、表8に示す各原材料を混合し、容器に加熱充填することにより、オレンジエードを得た。このオレンジエードは、パプリカオレオレジン水分散性製剤に由来するパプリカオレオレジンを5mg含んでいる。 Production Example 1 : Beverage Using the paprika oleoresin-containing preparation obtained in Example 8, an orangeade was prepared according to the formulation shown in Table 8 below. Specifically, each raw material shown in Table 8 was mixed and heated in a container to obtain an orangeade. This orangeade contains 5 mg of paprika oleoresin derived from a paprika oleoresin water dispersible formulation.
製造例2:ゼリー飲料
実施例8で得られたパプリカオレオレジン含有製剤を用いて、以下の表9に示す処方に従ってオレンジ風味のゼリー飲料を調製した。具体的には、水に糖類と寒天を加えて加熱溶解後、その他の原料を溶解する。次いで所定のpHに調整後、1次殺菌工程を経て、スパウト付きアルミパウチに80g/包体ずつ充填後、更に2次殺菌を行い、ゼリー飲料とした。オレンジ風味のゼリー飲料80gにはパプリカオレオレジン水分散性製剤に由来するパプリカオレオレジンを4mg含んでいる。 Production Example 2 : Jelly Beverage Using the paprika oleoresin-containing preparation obtained in Example 8, an orange-flavored jelly drink was prepared according to the formulation shown in Table 9 below. Specifically, saccharides and agar are added to water and dissolved by heating, and then other raw materials are dissolved. Next, after adjusting to a predetermined pH, after passing through a primary sterilization step and filling an aluminum pouch with a spout 80 g / pack at a time, secondary sterilization was further performed to obtain a jelly beverage. 80 g of orange-flavored jelly beverage contains 4 mg of paprika oleoresin derived from a water-dispersible preparation of paprika oleoresin.
実施例8で得られたパプリカオレオレジン含有製剤を用いて、以下の表9に示す処方に従ってオレンジ風味のゼリー飲料を調製した。具体的には、水に糖類と寒天を加えて加熱溶解後、その他の原料を溶解する。次いで所定のpHに調整後、1次殺菌工程を経て、スパウト付きアルミパウチに80g/包体ずつ充填後、更に2次殺菌を行い、ゼリー飲料とした。オレンジ風味のゼリー飲料80gにはパプリカオレオレジン水分散性製剤に由来するパプリカオレオレジンを4mg含んでいる。 Production Example 2 : Jelly Beverage Using the paprika oleoresin-containing preparation obtained in Example 8, an orange-flavored jelly drink was prepared according to the formulation shown in Table 9 below. Specifically, saccharides and agar are added to water and dissolved by heating, and then other raw materials are dissolved. Next, after adjusting to a predetermined pH, after passing through a primary sterilization step and filling an aluminum pouch with a spout 80 g / pack at a time, secondary sterilization was further performed to obtain a jelly beverage. 80 g of orange-flavored jelly beverage contains 4 mg of paprika oleoresin derived from a water-dispersible preparation of paprika oleoresin.
製造例3:化粧水
実施例8で得られたパプリカオレオレジン含有製剤を用いて、以下の表10に示す組成の化粧水を常法に従って調製した。 Production Example 3 Toilet lotion Using the paprika oleoresin-containing preparation obtained in Example 8, a lotion having the composition shown in Table 10 below was prepared according to a conventional method.
実施例8で得られたパプリカオレオレジン含有製剤を用いて、以下の表10に示す組成の化粧水を常法に従って調製した。 Production Example 3 Toilet lotion Using the paprika oleoresin-containing preparation obtained in Example 8, a lotion having the composition shown in Table 10 below was prepared according to a conventional method.
製造例4:美容液
実施例8で得られたパプリカオレオレジン含有製剤を用いて、以下の表11に示す組成の美容液を常法に従って調製した。 Production Example 4 : Cosmetic liquid Using the paprika oleoresin-containing preparation obtained in Example 8, a cosmetic liquid having the composition shown in Table 11 below was prepared according to a conventional method.
実施例8で得られたパプリカオレオレジン含有製剤を用いて、以下の表11に示す組成の美容液を常法に従って調製した。 Production Example 4 : Cosmetic liquid Using the paprika oleoresin-containing preparation obtained in Example 8, a cosmetic liquid having the composition shown in Table 11 below was prepared according to a conventional method.
製造例5:エナジードリンク
実施例8で得られたパプリカオレオレジン含有製剤を用いて、以下の表12に示す組成のエナジードリンクを調製した。具体的には、表12に示す各原材料を混合し、容器に加熱充填することにより、エナジードリンクを得た。このエナジードリンクは、パプリカオレオレジン含有製剤に由来するパプリカオレオレジンを5mg含んでいる。 Production Example 5 : Energy drink Using the paprika oleoresin-containing preparation obtained in Example 8, an energy drink having the composition shown in Table 12 below was prepared. Specifically, energy drinks were obtained by mixing the raw materials shown in Table 12 and heating and filling the containers. This energy drink contains 5 mg of paprika oleoresin derived from a paprika oleoresin-containing preparation.
実施例8で得られたパプリカオレオレジン含有製剤を用いて、以下の表12に示す組成のエナジードリンクを調製した。具体的には、表12に示す各原材料を混合し、容器に加熱充填することにより、エナジードリンクを得た。このエナジードリンクは、パプリカオレオレジン含有製剤に由来するパプリカオレオレジンを5mg含んでいる。 Production Example 5 : Energy drink Using the paprika oleoresin-containing preparation obtained in Example 8, an energy drink having the composition shown in Table 12 below was prepared. Specifically, energy drinks were obtained by mixing the raw materials shown in Table 12 and heating and filling the containers. This energy drink contains 5 mg of paprika oleoresin derived from a paprika oleoresin-containing preparation.
製造例9:スポーツドリンク
実施例8で得られたパプリカオレオレジン含有製剤を用いて、以下の表13に示す処方に従ってスポーツドリンクを調製した。具体的には、表13に示す各原材料を混合し、容器に加熱充填することにより、スポーツドリンクを得た。このスポーツドリンクは、パプリカオレオレジン水含有製剤に由来するパプリカオレオレジンを5mg含んでいる。 Production Example 9 : Sports drink Using the paprika oleoresin-containing preparation obtained in Example 8, a sports drink was prepared according to the formulation shown in Table 13 below. Specifically, sports drinks were obtained by mixing the raw materials shown in Table 13 and heating and filling the containers. This sports drink contains 5 mg of paprika oleoresin derived from a paprika oleoresin water-containing preparation.
実施例8で得られたパプリカオレオレジン含有製剤を用いて、以下の表13に示す処方に従ってスポーツドリンクを調製した。具体的には、表13に示す各原材料を混合し、容器に加熱充填することにより、スポーツドリンクを得た。このスポーツドリンクは、パプリカオレオレジン水含有製剤に由来するパプリカオレオレジンを5mg含んでいる。 Production Example 9 : Sports drink Using the paprika oleoresin-containing preparation obtained in Example 8, a sports drink was prepared according to the formulation shown in Table 13 below. Specifically, sports drinks were obtained by mixing the raw materials shown in Table 13 and heating and filling the containers. This sports drink contains 5 mg of paprika oleoresin derived from a paprika oleoresin water-containing preparation.
Claims (22)
- (A)脂溶性物質と、(B)クロセチン、ノルビキシン、及びこれらのモノグリコシドエステルよりなる群から選択される少なくとも1種とを、ミセル構成成分として含む、脂溶性物質の乳化性製剤。 An emulsifiable preparation of a fat-soluble substance, comprising (A) a fat-soluble substance and (B) at least one selected from the group consisting of crocetin, norbixin, and monoglycoside esters thereof as micelle constituents.
- 更に、(C)クロセチンのジグリコシドエステル及び/又はノルビキシンのジグリコシドエステルを含む、請求項1に記載の脂溶性物質の乳化性製剤。 The emulsifiable preparation of a fat-soluble substance according to claim 1, further comprising (C) a diglycoside ester of crocetin and / or a diglycoside ester of norbixin.
- 前記(B)成分が、クロセチン、ノルビキシン、及びクロセチン-モノゲンチオビオシドエステルよりなる群から選択される少なくとも1種である、請求項1又は2に記載の脂溶性物質の乳化性製剤。 The emulsifiable preparation of a fat-soluble substance according to claim 1 or 2, wherein the component (B) is at least one selected from the group consisting of crocetin, norbixin, and crocetin-monogentiobioside ester.
- 前記(C)成分が、クロシンである、請求項1~3のいずれかに記載の脂溶性物質の乳化性製剤。 The emulsifiable preparation of a fat-soluble substance according to any one of claims 1 to 3, wherein the component (C) is crocin.
- 前記(B)及び(C)成分として、クチナシ黄色素を含む、請求項2~4のいずれかに記載の脂溶性物質の乳化性製剤。 The emulsifiable preparation of a fat-soluble substance according to any one of claims 2 to 4, comprising gardenia yellow as the components (B) and (C).
- 前記(A)成分が、脂溶性カロテノイド及び/又は植物性油脂である、請求項1~5のいずれかに記載の脂溶性物質の乳化性製剤。 The emulsifiable preparation of a fat-soluble substance according to any one of claims 1 to 5, wherein the component (A) is a fat-soluble carotenoid and / or vegetable oil.
- 前記(A)成分が脂溶性カロテノイドであり、色素製剤として使用される、請求項1~6のいずれかに記載の脂溶性物質の乳化性製剤。 The emulsifiable preparation of a fat-soluble substance according to any one of claims 1 to 6, wherein the component (A) is a fat-soluble carotenoid and is used as a pigment preparation.
- (A)脂溶性物質と、(B)クロセチン、ノルビキシン、及びこれらのモノグリコシドエステルよりなる群から選択される少なくとも1種とを含むミセルを含有する、ハイドロゲル。 A hydrogel containing micelles comprising (A) a fat-soluble substance and (B) at least one selected from the group consisting of crocetin, norbixin, and monoglycoside esters thereof.
- 更に、(C)クロセチンのジグリコシドエステル及び/又はノルビキシンのジグリコシドエステルを含む、請求項8に記載のハイドロゲル。 The hydrogel according to claim 8, further comprising (C) a diglycoside ester of crocetin and / or a diglycoside ester of norbixin.
- (A)脂溶性物質と、(B)クロセチン、ノルビキシン、及びこれらのモノグリコシドエステルよりなる群から選択される少なくとも1種とを含むミセル、又は当該ミセルの乾燥物を含有する、飲食品。 A food or drink containing a micelle comprising (A) a fat-soluble substance and (B) at least one selected from the group consisting of crocetin, norbixin, and monoglycoside esters thereof, or a dried product of the micelle.
- 更に、(C)クロセチンのジグリコシドエステル及び/又はノルビキシンのジグリコシドエステルを含む、請求項10に記載の飲食品。 The food or drink according to claim 10, further comprising (C) a diglycoside ester of crocetin and / or a diglycoside ester of norbixin.
- (A)脂溶性物質と、(B)クロセチン、ノルビキシン、及びこれらのモノグリコシドエステルよりなる群から選択される少なくとも1種とを含むミセル、又は当該ミセルの乾燥物を含有する、化粧料。 Cosmetics containing a micelle comprising (A) a fat-soluble substance and (B) at least one selected from the group consisting of crocetin, norbixin, and monoglycoside esters thereof, or a dried product of the micelle.
- 更に、(C)クロセチンのジグリコシドエステル及び/又はノルビキシンのジグリコシドエステルを含む、請求項12に記載の化粧料。 The cosmetic according to claim 12, further comprising (C) a diglycoside ester of crocetin and / or a diglycoside ester of norbixin.
- (A)脂溶性物質と、(B)クロセチン、ノルビキシン、及びこれらのモノグリコシドエステルよりなる群から選択される少なくとも1種とを含むミセル、又は当該ミセルの乾燥物を含有する、医薬品。 A pharmaceutical containing a micelle comprising (A) a fat-soluble substance and (B) at least one selected from the group consisting of crocetin, norbixin, and monoglycoside esters thereof, or a dried product of the micelle.
- 更に、(C)クロセチンのジグリコシドエステル及び/又はノルビキシンのジグリコシドエステルを含む、請求項14に記載の医薬品。 The pharmaceutical product according to claim 14, further comprising (C) a diglycoside ester of crocetin and / or a diglycoside ester of norbixin.
- クロセチン、ノルビキシン、及びこれらのモノグリコシドエステルよりなる群から選択される少なくとも1種を有効成分とする、脂溶性物質の乳化性向上剤。 An emulsifying agent for fat-soluble substances, comprising as an active ingredient at least one selected from the group consisting of crocetin, norbixin, and monoglycoside esters thereof.
- 飲食品添加剤である、請求項16に記載の脂溶性物質の乳化性向上剤。 The emulsifiability improver of a fat-soluble substance according to claim 16, which is a food or drink additive.
- クロセチン、ノルビキシン、及びこれらのモノグリコシドエステルよりなる群から選択される少なくとも1種を有効成分とする、脂溶性物質の吸収性向上剤。 An agent for improving the absorption of fat-soluble substances, comprising as an active ingredient at least one selected from the group consisting of crocetin, norbixin, and monoglycoside esters thereof.
- 飲食品添加剤である、請求項18に記載の脂溶性カロテノイドの吸収性向上剤。 The fat-soluble carotenoid absorbability improver according to claim 18, which is a food and drink additive.
- クロセチン、ノルビキシン、及びこれらのモノグリコシドエステルよりなる群から選択される少なくとも1種の、脂溶性物質の乳化性向上剤の製造のための使用。 Use for the production of an emulsification improver of at least one fat-soluble substance selected from the group consisting of crocetin, norbixin, and monoglycoside esters thereof.
- クロセチン、ノルビキシン、及びこれらのモノグリコシドエステルよりなる群から選択される少なくとも1種の、脂溶性物質の吸収性向上剤の製造のための使用。 Use for the production of an absorbent enhancer of at least one fat-soluble substance selected from the group consisting of crocetin, norbixin, and monoglycoside esters thereof.
- (A)脂溶性物質と、(B)クロセチン、ノルビキシン、及びこれらのモノグリコシドエステルよりなる群から選択される少なくとも1種とを水存在下で乳化させる工程を含む、脂溶性物質の乳化方法。 A method for emulsifying a fat-soluble substance, comprising the step of emulsifying (A) a fat-soluble substance and (B) at least one selected from the group consisting of crocetin, norbixin, and monoglycoside esters thereof in the presence of water.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2015516313A JP5934840B2 (en) | 2013-09-25 | 2014-09-25 | Emulsifiable preparations of fat-soluble substances |
CN201480048852.6A CN105517575B (en) | 2013-09-25 | 2014-09-25 | The emulsibility preparation of liposoluble substance |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013198613 | 2013-09-25 | ||
JP2013-198613 | 2013-09-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2015046365A1 true WO2015046365A1 (en) | 2015-04-02 |
Family
ID=52743495
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2014/075499 WO2015046365A1 (en) | 2013-09-25 | 2014-09-25 | Emulsifiable formulation of liposoluble substance |
Country Status (3)
Country | Link |
---|---|
JP (1) | JP5934840B2 (en) |
CN (1) | CN105517575B (en) |
WO (1) | WO2015046365A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPWO2016098562A1 (en) * | 2014-12-19 | 2017-09-28 | グリコ栄養食品株式会社 | Solubilized or dispersed composition of π-conjugated system poorly soluble or insoluble substance |
WO2017195504A1 (en) * | 2016-05-13 | 2017-11-16 | グリコ栄養食品株式会社 | Agent for improving carotenoid balance in blood |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0723736A (en) * | 1993-06-30 | 1995-01-27 | Taishiyoo Technos:Kk | Method for solubilizing carotenoid coloring matter |
JPH07501211A (en) * | 1991-09-06 | 1995-02-09 | ベータティーン・リミテッド | carotenoid composition |
JP2010285364A (en) * | 2009-06-10 | 2010-12-24 | Riken Vitamin Co Ltd | Singlet oxygen scavenger |
WO2012104576A2 (en) * | 2011-01-31 | 2012-08-09 | Ip Science Limited | Carotenoid particles and uses thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS578758A (en) * | 1980-06-16 | 1982-01-18 | Q P Corp | Preparation of light green acidic food |
JPS6036226B2 (en) * | 1981-11-28 | 1985-08-19 | 三栄化学工業株式会社 | Method for imparting acid resistance to annatto dyes |
US6428816B1 (en) * | 1994-04-08 | 2002-08-06 | Cognis Australia Pty., Ltd. | Carotenoid agent for inhibiting the conversion of epithelial cells to tumors |
JPH11209642A (en) * | 1998-01-27 | 1999-08-03 | Taito Kk | Annatto color preparation and its production |
-
2014
- 2014-09-25 CN CN201480048852.6A patent/CN105517575B/en active Active
- 2014-09-25 JP JP2015516313A patent/JP5934840B2/en active Active
- 2014-09-25 WO PCT/JP2014/075499 patent/WO2015046365A1/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07501211A (en) * | 1991-09-06 | 1995-02-09 | ベータティーン・リミテッド | carotenoid composition |
JPH0723736A (en) * | 1993-06-30 | 1995-01-27 | Taishiyoo Technos:Kk | Method for solubilizing carotenoid coloring matter |
JP2010285364A (en) * | 2009-06-10 | 2010-12-24 | Riken Vitamin Co Ltd | Singlet oxygen scavenger |
WO2012104576A2 (en) * | 2011-01-31 | 2012-08-09 | Ip Science Limited | Carotenoid particles and uses thereof |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPWO2016098562A1 (en) * | 2014-12-19 | 2017-09-28 | グリコ栄養食品株式会社 | Solubilized or dispersed composition of π-conjugated system poorly soluble or insoluble substance |
WO2017195504A1 (en) * | 2016-05-13 | 2017-11-16 | グリコ栄養食品株式会社 | Agent for improving carotenoid balance in blood |
JPWO2017195504A1 (en) * | 2016-05-13 | 2019-03-22 | グリコ栄養食品株式会社 | Blood carotenoid balance improver |
JP7004644B2 (en) | 2016-05-13 | 2022-02-10 | グリコ栄養食品株式会社 | Blood carotenoid balance improver |
Also Published As
Publication number | Publication date |
---|---|
JPWO2015046365A1 (en) | 2017-03-09 |
CN105517575A (en) | 2016-04-20 |
CN105517575B (en) | 2018-03-09 |
JP5934840B2 (en) | 2016-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2280611B1 (en) | Compositions of fat-soluble active ingredients containing gum ghatti | |
KR101411072B1 (en) | The novel stabilized carotenoid composition | |
JP4673273B2 (en) | Water-dispersible oil-soluble dye crystal formulation | |
JP5147239B2 (en) | Coenzyme Q10-containing emulsion composition | |
JP5534681B2 (en) | Method for inhibiting discoloration of crystalline carotenoid pigment | |
JP5936796B1 (en) | Emulsified composition | |
JP6004938B2 (en) | How to prevent carotenoid pigments from sticking to containers | |
JP5675079B2 (en) | Stable fat-soluble component-containing emulsion composition | |
JP2009142180A (en) | Packaged beverage | |
JP2018512879A (en) | Nanoparticles, nanoemulsions, and their formation by mixing chamber micronization | |
WO2006030850A1 (en) | Method of preparing solution of lipid-soluble ingredient | |
JP5631941B2 (en) | Container drink | |
JP5934840B2 (en) | Emulsifiable preparations of fat-soluble substances | |
JP5878590B2 (en) | Container drink | |
US20200146951A1 (en) | Emulsion composition | |
JP6027345B2 (en) | Emulsified dye preparation with stability against heating and stirring and use thereof | |
JP2002053857A (en) | Anti-fading agent for carotenoid dyes and method for preventing fading | |
JP2021029207A (en) | Pharmaceutical preparation, and oral composition | |
WO2019208539A1 (en) | Emulsion composition | |
JP2024040054A (en) | Method for producing oil-soluble dye emulsion preparation | |
JP2012040018A (en) | Packaged beverage | |
JP2008212763A (en) | Emulsification method of oil soluble substance, composition and use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ENP | Entry into the national phase |
Ref document number: 2015516313 Country of ref document: JP Kind code of ref document: A |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 14849604 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 14849604 Country of ref document: EP Kind code of ref document: A1 |